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ABSTRACT 
 
Elongation factor Tu (EF-Tu), bound to GTP, delivers aminoacyl-tRNA 
(aa-tRNA) as a ternary complex (TC) to the translating ribosome for the purpose of 
decoding messenger-RNA (mRNA). As such, TC is fundamentally important to the 
speed and fidelity of mRNA decoding. Here, a quantitative, kinetic framework for the 
formation and stability of ternary complex is presented. This framework includes 
novel features of Elongation Factor Ts (EF-Ts), a guanosine nucleotide exchange 
factor for EF-Tu. Specifically, EF-Ts accelerates both the formation and dissociation 
of TC by directly loading EF-Tu∙GTP onto aa-tRNA as an EF-Tu/Ts∙GTP∙aa-tRNA 
quaternary complex. This newly described intermediate species quickly resolves into 
the canonical TC, which is then competent to participate in the decoding process. A 
major impact of this interaction is that, under cellular conditions, EF-Ts accelerates 
the formation of TC to a rate that is above the rate of tRNA selection and above the 
rate of protein synthesis in general. Leveraging these insights, a new model is 
proposed predicting that EF-Ts facilitates the dissociation of the deactivated 
EF-Tu∙GDP species from the ribosome at the conclusion of the tRNA selection 
process. These results suggest a broader role for GEFs arguing in favor of a model 
wherein GEFs catalyze the formation of activated G-protien∙effector complexes. 
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CHAPTER 1 
REGULATION OF TERNARY COMPLEX BY ELONGATION FACTOR TS 
 
 
1.1 OVERVIEW 
This chapter provides a foundation for the work discussed in subsequent chapters. 
First, a plenary overview of G-protein biology is discussed, with a focus on the 
subclass of G-proteins involved in protein synthesis. The current model of protein 
synthesis and tRNA accommodation is then presented. This chapter ends by 
highlighting some of the major shortcomings with the generally accepted, canonical 
models of protein synthesis. 
In Chapter 2, the preparation of reagents and experimental procedures is 
discussed in detail. Experimental results demonstrating the kinetics underpinning the 
formation of critical components of the protein synthesis machinery will be discussed 
in Chapter 3 and in Chapter 4. Chapter 5 will summarize new insights and ongoing 
efforts to leverage these data towards a more complete and comprehensive model of 
protein synthesis. The indications of these findings will be summarized in Chapter 6. 
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1.2 THE SWITCHING CYCLE OF G-PROTEINS 
G-proteins are a superfamily of regulatory guanosine triphosphate (GTP) 
hydrolases that are ubiquitous throughout all phylogeny of life having been found in 
every living organism studied to date
5,6
. Even within a single cell, G-proteins are 
found in high abundance and are involved in a diverse assortment of cellular processes 
including cell motility, signal transduction across cell membranes, cellular growth and 
differentiation, and gene expression
7,8
. G-proteins likely evolved into such a diverse 
set of roles because of their ability to cycle between two distinct states, thus making 
them ideally suited for decision making in biological processes
9
.  
The distinct states of G-proteins are achieved by the binding of guanosine 
nucleotides to a conserved three dimensional protein domain, termed the G-domain 
(Figure 1.1)
10
. Activation requires binding to GTP, which enables the G-protein to 
adopt an active conformation (Figure 1.1A)
7,10
. Deactivation of G-proteins occurs 
through the intrinsic hydrolysis of GTP to guanosine diphosphate (GDP), an 
irreversible process that leads to an inactive conformation (Figure 1.1B)
7,10
. 
Comparison of the active and inactive conformations reveals a dramatic repositioning 
of an alpha helix, termed the “switch” helix. Positioning of this helix occurs through 
allosteric coordination by either the GTP or the GDP, thus coupling the distinct 
conformations of the G-protein to guanosine nucleotide binding. 
Many G-proteins require additional proteins to facilitate switching between the 
active- and inactive-states (Figure 1.2)
7,11,12
. Guanosine nucleotide Exchange Factors 
(GEFs) are a class of proteins that catalyze both the removal of GDP and the 
subsequent binding of GTP, thereby positively regulating G-protein function
7,13
. Once 
GTP bound, the activated G-protein is released from the GEF and is then competent to 
interact with secondary molecules to propagate a downstream signal or process. In the 
G-protein vernacular, these secondary molecules are referred to as Effectors, as their 
3 
 
function is modulated by activated, GTP-bound G-proteins for the purpose of eliciting 
a downstream effect. 
Although G-proteins have intrinsic GTP hydrolysis capabilities, they rarely 
perform this function on their own. In vitro, the rate of GTP hydrolysis is measured to 
be very slow with respect to biological timescales (minutes to hours)
14
. In the cellular 
context, GTPase Activating Proteins (GAPs) are required to accelerate the rate of GTP 
hydrolysis, thereby negatively regulating G-protein function (Figure 1.2)
13
. GAPs, also 
known as Regulators of G-protein Signaling (RGS), interact directly with the effector-
bound G-proteins and accelerate the hydrolysis reaction, often by many orders of 
magnitude. Catalogued rates of GTP hydrolysis range from ca. 10 s
-1
 to as much as 
500 s
-1
 
11
. As a result of the hydrolysis reaction, the gamma phosphate (terminal 
FIGURE 1.1 The G-domain adopts distinct conformations that correlate with nucleotide binding. The 
The G-domain consists of a central β-sheet surrounded by a group of 5 α-helices. Shown here is the Ras 
G-domain bound to either a GTP analog, A (PDB accession code 5P21), or GDP, B (PDB accession 
code 4Q21). Nucleotide binding has a dramatic impact on one α-helix in particular, referred to as the 
switch helix (blue). The γ-phosphate of GTP positions the switch helix in close proximity and parallel to 
the β-sheet backbone. When GDP bound, the switch helix assumes a more distal, orthogonal position.  
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phosphate) is released and the G-protein adopts an inactive, GDP-bound 
conformation. 
In some G-protein systems, Guanosine nucleotide Dissociation Inhibitors (GDIs) 
serve an important role in regulating G-protein function by binding to, and 
sequestering the inactive form of G-proteins (Figure 1.2)
12
. In doing so, they inhibit 
the dissociation of GDP and therefore compete with GEFs to negatively regulate G-
protein function. 
 
 
 
FIGURE 1.2 Life cycle of G-proteins. The general mechanism for G-protein activation and 
inactivation is a cyclical process that is unidirectional. The G-protein (blue) is inactive when bound 
to GDP (brown). Many G-proteins require a GEF (red) to facilitate the exchange of GDP for GTP 
(yellow). The GTP-bound G-protein is then released in an active state that is competent to bind to 
effector molecules (purple) which leads to further downstream processes. The inactivation of 
G-proteins occurs through the interaction of GAPs (green) which accelerate the GTPase 
mechanism intrinsic to all G-proteins. GTP hydrolysis results in an inactive GDP-bound form of 
the G-protein which, in some cases, can be sequestered by GDIs (grey) to compete with GEF 
interactions and thus maintain the G-protein in an inactive state. Adapted from Wittinghoffer et 
al.{Wittinghofer, 2011 #560} 
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1.3 TRAFAC G-PROTEINS ARE CRITICAL TO PROTEIN SYNTHESIS  
G-proteins have been found in a myriad of processes within the cell, especially in 
the context of decision making. A subclass of G-proteins known as TRAFAC 
(translation factor)
7,15
 G-proteins are critical to the fidelity of gene expression at the 
messenger RNA (mRNA) level
16,17
. Translation of mRNA occurs in three broad 
stages: initiation, elongation, and termination/recycling
18-21
. During initiation, the 
ribosome, a large megadalton ribonuclear protein complex, assembles on an mRNA at 
the start codon. This process is facilitated by a host of translation factors, including the 
G-protein Initiation Factor-2 (IF-2) in bacteria (eIF2 in humans). In the GTP bound 
state, IF2 delivers the initiator tRNA to the mRNA assembled 30S subunit of the 
ribosome. Upon correct 50S assembly, GTP is hydrolyzed and IF2 releases the 
initiator tRNA, leaving it positioned in the peptidyl site of the fully assembled 
ribosome. Owing to its relative affinity for GDP (KD = 4.5 µM) and GTP (KD = 10.6 
FIGURE 1.3 G-proteins play key roles in each of the three phases of protein synthesis. 
Translation occurs in three general steps. During Initiation, the translational machinery assembles 
onto the mRNA transcript, a process that requires the G-protein IF2 in bacteria, or eIF2 and eIF5B 
in eukaryotes. Elongation then proceeds with the cyclical action of EF-Tu delivering aa-tRNAs to 
the ribosome and EF-G translocating it to the next triplet codon in bacteria, or by the action of eEF-
1A and eEF-2 in eukaryotes respectively). Termination requires an additional G-protein, RF3 in 
bacteria and eRF3 in eukaryotes.  
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µM), and given the relative abundance of these nucleotides in bacterial cells (100uM 
and 900uM respectively)
22
, IF2 readily exchanges GTP for GDP without the need of a 
GEF
23
.  
During the elongation phase of protein synthesis, the initiated ribosome translates 
the mRNA open reading frame by decoding each triplet codon and catalyzing the 
polymerization of the ciphered amino acid to the nascent polypeptide chain. Each 
decoding step minimally requires the action of two G-proteins, Elongation Factor-Tu 
(EF-Tu) and Elongation Factor G (EF-G)
17
. EF-Tu plays a pivotal role in the decoding 
mechanism by delivering aminoacyl-tRNA (aa-tRNA) to the elongating ribosome in a 
process called tRNA selection
17,24-26
. Specifically, EF-Tu facilitates the binding of the 
tRNA anticodon with the mRNA codon. Upon correct pairing, EF-Tu hydrolyzes GTP 
and releases the aa-tRNA, allowing it to fully accommodate into the aminoacyl (A)-
site of the ribosome
27,28
. The functional importance of EF-Tu in the decoding 
mechanism is highlighted by the fact that small molecule antibiotics that target EF-Tu 
and disrupt aa-tRNA binding have been shown to kill cells by inhibiting protein 
synthesis
29,30
.  
Unlike IF2, EF-Tu requires a GEF to achieve an active, GTP-bound state. EF-Tu’s 
affinity for GDP (KD(EF-Tu•GDP) = 1 nM) is 60 fold higher than is its affinity for GTP 
(KD(EF-Tu•GTP) = 60 nM)
31
. Given that there is only about a 9 fold excess of GTP over 
GDP in the cell, EF-Tu would preferentially remain in an inactive, GDP-bound state in 
the absence of a GEF. In bacteria, the GEF for EF-Tu is Elongation Factor-Ts (EF-Ts) 
and it serves to increase the pool of active EF-Tu in the cell by catalyzing the 
formation of the GTP-bound form. Interestingly, EF-Ts does not increase EF-Tu’s 
affinity for GTP, but, in a seemingly paradoxical way, reduces EF-Tu’s affinity for 
both guanosine nucleotides. EF-Tu’s affinity for GDP in the presence of EF-Ts is ~9 
µM, roughly 1.5 fold higher than its affinity for GTP, ~14 µM. However, given the 9 
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fold excess of GTP in the cell, EF-Tu will be driven towards an active, GTP-bound 
state. The precise role of EF-Tu and EF-Ts in protein synthesis is the subject of this 
body of work and will be discussed in greater detail in subsequent sections. 
Once aa-tRNA is fully accommodated, EF-G catalyzes the translocation of the 
ribosome by one codon along the mRNA open reading frame
32
. In doing so, the 
occupied tRNAs are shifted by one position within the ribosome, thus clearing the A-
site and preparing the ribosomes for the next round of tRNA selection. When EF-G 
engages the ribosome, its affinity for GTP increases roughly 150 fold from ca. ~22 
µM to ca. ~150 nM
33
. Given that EF-G’s affinity for GDP is ca. 10 µM, EF-G is 
driven towards an active, GTP-bound state without the need of a GEF. 
Protein synthesis concludes via the termination and recycling processes. Upon 
reaching a stop codon, a release factor (RF1 or RF2 depending on the stop codon) 
catalyzes the liberation of the nascent polypeptide chain. Release factor 3 (RF3) then 
binds to the A-site of the large subunit and facilitates the removal of the bound release 
factor (RF1 or RF2) in a GTP dependent manner. RF3 has a roughly 4.5 fold higher 
affinity for GDP than GTP (23 nM vs 108 nM)
34
. As such, RF3 is naturally driven 
towards the active, GTP-bound state under normal cellular conditions of guanosine 
nucleotides without the aid of a GEF. The disassembly of the post-termination 
complex is carried out in tandem with ribosome release factor (RRF) and EF-G, a 
process that requires the hydrolysis of GTP. 
Protein synthesis is an energy intensive process, with the elongation phase 
requiring the lions share. The decoding of each codon minimally requires the 
hydrolysis of 2 GTP molecules per amino acid (the first by EF-Tu upon aa-tRNA 
delivery and the second by EF-G upon translocation)
14,33
. The rate at which a cell 
hydrolyzes GTP is directly proportional to both the rate of protein synthesis and to the  
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number of ribosomes actively engaged in protein synthesis. During fast growth 
conditions, protein synthesis occurs at a rate of ~20 amino acids per second per 
ribosome
35
. Under these conditions, ribosome concentrations can reach as high as 100 
µM
36,37
. With the assumption that at least 10% of these ribosomes are actively 
engaged in protein synthesis, it becomes apparent that roughly half of a cell’s GTP 
reserve must be devoted to the production of new proteins every second.  
 
𝐸𝑛𝑒𝑟𝑔𝑦
𝑇𝑖𝑚𝑒⁄ = (20
𝑎𝑚𝑖𝑛𝑜 𝑎𝑐𝑖𝑑𝑠
𝑅𝑖𝑏𝑜𝑠𝑜𝑚𝑒 ∙ 𝑠−1
) (10 𝜇𝑀 𝑅𝑖𝑏𝑜𝑠𝑜𝑚𝑒𝑠) (2
𝐺𝑇𝑃
𝑎𝑚𝑖𝑛𝑜 𝑎𝑐𝑖𝑑
)
= 400 𝜇𝑀 𝐺𝑇𝑃 𝑠⁄  
EQUATION 1.1 
TABLE 1.1. Relative nucleotide affinities predict the need for GEFs. G-proteins typically 
have differing affinities for GDP and GTP. GEFs are needed when a G-protein’s affinity for 
GDP is greater than ~9-fold higher than is its affinity for GTP as a result of the relative 
abundance of guanine nucleotides in the cell. 
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Indeed, measurements of energy consumption suggest that up to two-thirds of the 
total energy produced by rapidly growing Escherichia coli (E. coli) cells is devoted to 
protein synthesis
38
. TRAFAC G-proteins are thus incredibly expensive tools to 
implement. Thus, their prevalent use underscores the importance of G-proteins to the 
translation phase of gene expression. 
 
 
1.4 THE ARCHITECTURE OF THE RIBOSOME 
Proteins synthesis requires the orchestration of an immense arsenal of proteins and 
RNA molecules, but at the forefront of this process is the 2.5 MDa ribonuclear particle 
called the ribosome (Figure 1.4). In E. coli, ribosomes consist of two subunits: a small 
FIGURE 1.4 Structural elements of the bacterial ribosome. In bacteria, the 70S ribosome 
consists of two subunits. A small subunit, comprised of a 16S rRNA (white) and 21 proteins (grey), 
binds to the mRNA transcript (purple) and provides a platform for the anticodon loop of the tRNA 
substrates (orange). The large subunit consists of a 23S and a 5S rRNA (white) as well as 31 
proteins (red). The leading edge of the ribosome (right-hand side) accepts aa-tRNA into the A-site. 
The nascent polypeptide (not shown) stemming from the peptidyl-tRNA in the P-site is then 
transferred to the A-site tRNA. The mRNA, along with the tRNAs, is then translocated through the 
ribosome by one position such that the leading edge tRNA is now positioned in the P-site, and the 
central tRNA is now positioned in the E-site. The E-site tRNA is ejected, setting up the ribosome 
to accept a new tRNA at the leading edge. Note that three tRNAs are shown here to clarify the 
three classical positions within the tRNA tunnel though, in actuality, under normal circumstances 
there are only two tRNA substrates in the ribosome at a time. Components of the leading edge of 
the large subunit are not shown (L7/L12 stalk). Adapted from PDB accession code 4V5L. 
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and large subunit referred to by their sedimentation coefficient 30S and 50S 
respectively. The 30S subunit is constructed from 21 proteins and a 16S rRNA that is 
1,540 nucleotides in length. The 50S subunit is comprised of 31 proteins, a 5S rRNA 
that is 120 nucleotides in length, and a much larger 23S rRNA that stretches 2,900 
nucleotides. Together, these subunits associate on an mRNA transcript to form a 70S 
particle
39
. 
During elongation, tRNAs transit through the interior tRNA-tunnel of ribosome 
occupying distinct positions
40,41
. First, EF-Tu delivers aa-tRNA to the A-site of the 
ribosome on the leading edge of the tRNA tunnel. After the nascent polypeptide is 
transferred to the A-site tRNA, EF-G translocates the ribosome and bound substrates 
by one codon, shifting the A-site tRNA towards the interior of the ribosome to the 
peptidyl-site (P-site). Another round of tRNA selection and translocation further 
moves the tRNA towards the exit-site (E-site) of the tunnel where it is ultimately 
ejected from the ribosome 
FIGURE 1.5 tRNA selection occurs in two phases. aa-tRNAs are delivered to the empty A-site 
ribosome as a ternary complex with EF-Tu∙GTP. This leads to a testing of the codon-anticodon 
residues in a multistep process globally referred to as Initial Selection. If not rejected, GTP is 
hydrolyzed and a second testing of the codon-anticodon ensues through a process termed 
Proofreading. Upon correct pairing, the aa-tRNA fully accommodates into the ribosome and the tRNA 
selection process then concludes with the formation of a peptide bond. 
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The translational machinery ultimately exists to decode mRNA. Biochemical and 
structural data have provided key insights to the decoding mechanism and indicate that 
it is a multistep process dependent on the GTPase function of EF-Tu. 
 
 
1.5 THE DECODING MECHANISM 
The primary function of the ribosome is to decode an mRNA transcript so that a 
polypeptide can be faithfully synthesized. This process requires testing the interaction 
between the mRNA codon with an anticodon of an adaptor tRNA molecule. The 
FIGURE 1.6 The fidelity of tRNA selection stems from proper codon-anticodon interactions.  A, full 
view of the A/T-state ribosome (PDB accession code 4V5L). Large subunit proteins are colored red, 
small subunit proteins are colored grey, rRNA is colored white, tRNAs are yellow, mRNA is purple, EF-
Tu is blue. B, closer view of the A/T-tRNA bound to EF-Tu. C, detailed view of the tryptophan codon 
(blue)-anticodon (yellow) interaction.  
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fidelity of protein synthesis is approximately five orders of magnitude less accurate 
than DNA replication, with error rates of about one incorrect amino acid incorporated 
per ten thousand (ca. 5x10
-3
 – 6x10-4)42-44. Under the gross assumption that the average 
protein contains roughly 400 amino acids, one out of twenty five proteins will contain 
an error at the amino acid level as a result of translational infidelity. Functional studies 
of the decoding process have revealed that the translational machinery can be driven to 
even higher levels of fidelity
45,46
. However, this has been speculated to occur at the 
expense of speed such that the rate of protein synthesis is inversely proportional to the 
accuracy of protein synthesis
42,47-50
.  
 
Specifically, this model postulates two distinct interactions that lead to either 
tRNA accommodation or tRNA rejection termed initial selection and proofreading 
(Figure 1.5). First, ternary complex interacts with an empty A-site ribosome in a 
bimolecular manner. Pre-steady state data of this process demonstrate that ternary 
complex binds to the ribosome with a very fast on-rate of 140 µM
-1
s
-1 1
. The anticodon 
of the aa-tRNA is first tested with the codon of the mRNA through a process termed 
codon recognition (Figure 1.6). The anticodon loop of the aa-tRNA is situated in the 
A-site of the small subunit, while the t-stem remains bound to EF-Tu in a bent 
conformation termed the A/T State. The codon-anticodon interaction is, in part, 
coordinated by key residues in the small subunit 16S rRNA. Improper placement leads 
to rapid ternary complex rejection
1,24
. If the tRNA is not rejected, the t-stem of the aa-
tRNA begins to sample the A-site of the large subunit during the proofreading phase. 
The selection process completes when either the tRNA is rejected, or the CCA- end is 
fully accommodated into the A-site of the large subunit. If accommodated, a peptide 
bond is rapidly catalyzed by the peptidyl transferase center of the ribosome which 
leads to the transfer of the nascent polypeptide from the P-site tRNA to the A-site 
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tRNA. This final step is irreversible in this context and thus commits the ribosome to 
the selection of the A-site tRNA. Although this process has been studied extensively 
from the perspective of the incorporating tRNA
1,24,26,40,51-55
, little is known about the 
precise contribution of EF-Tu during this process. 
 
 
1.7 GTP ENABLES EF-TU TO RECOGNIZE THE AMINOACYL MOIETY 
OF tRNA 
Ternary complex is the primary substrate for the ribosome during the decoding 
process. As such, errors in the construction of ternary complex could potentially result 
in the addition of an incorrect amino acid to the polypeptide chain being synthesized. 
Interestingly, EF-Tu∙GTP exhibits extremely low affinity for non-acylated tRNAs (ca. 
KD > 1 M) prohibiting the delivery of a tRNA without an amino acid. Structural and 
biochemical data has shed significant light on precisely how the aminoacylated state 
FIGURE 1.7 Structural elements of phenylalanyl ternary complex. A, EF-Tu (blue) bound to the GTP 
analog GDPNP (carbon atoms are grey, nitrogen are blue, oxygen are red, and phosphorus are orange, 
Mg
2+
 is yellow) and Phe-tRNA
Phe
. Elements of the tRNA are colored for clarity (acceptor stem is yellow, 
T-loop is pink, D-loop is cyan, anticodon loop is green) along with the site of fluorophore conjugation 
(acp
3
U47, purple). B, detailed view of the allosteric pathway linking nucleotide binding to the formation 
of an amino acid binding pocket. The terminal phosphate of the nucleotide, along with the Mg
2+
 ion 
coordinate the switch regions (switch 1, S1, in red; switch 2, S2, in orange) which in turn orient the 
critical residue His66. C, detailed view of EF-Tu interactions with the T-stem of the tRNA (which 
collectively refers to the acceptor stem and the T-loop). The caroxy terminus (CTerm) of EF-Tu is 
highlighted. 
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of tRNAs are recognized. EF-Tu∙GTP binds to aa-tRNA along the acceptor stem and 
T-loop, collectively referred as the T-stem
56
. Domains I and II of EF-Tu are observed 
to fold around the aminoacyl-moiety of aa-tRNA, forming the amino acid binding 
pocket
57
. In the case of phenylalanyl-ternary complex (Phe-TC), the imidazole moiety 
of residue His66 of EF-Tu is oriented in a planar stacking configuration with the 
phenol element of the aminoacyl moiety of Phe-tRNA
Phe
 (Figure 1.7). His66 is 
accordingly positioned by the neighboring switch 1 region consisting of EF-Tu 
residues 40-62. The switch 1 region derives its name because it adopts vastly different 
conformations depending on whether EF-Tu is bound to either GTP or GDP (Figures 
1.7, 1.8). When EF-Tu binds GTP, it does so in conjunction with a Mg
2+
 ion that is 
coordinated by the β and γ phosphates. The Mg2+ ion in turn plays a role in 
coordinating the switch 1 helix thus allosterically coupling GTP binding with aa-tRNA 
binding.  
FIGURE 1.8 Inactive EF-Tu adopts a unique switch conformation. EF-Tu (blue) bound to GDP 
(carbon atoms are grey, nitrogen are blue, oxygen are red, phosphorous are orange, Mg
2+
 is yellow) 
adopts an extended conformation with the G-domain positioned distal from domain II. This is state 
is characterized by the switch 1 (red) which adopts a helix-loop-helix secondary structure, a 
dramatic change from the α-helix structure that it assumes in the GTP-bound state. 
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In contrast, when EF-Tu is bound to GDP, the Mg
2+
 ion is coordinated by the α 
and β the phosphates of the nucleotide and is therefore not positioned appropriately to 
stabilize the switch 1 motif as a helix. Rather, the switch 1 motif adopts a beta hairpin 
structure (Figure 1.8). As such, EF-Tu∙GDP does not form an amino acid binding 
pocket and exhibits no biological affinity for aa-tRNA. tRNA delivery to the ribosome 
is thus restricted by two conditions: EF-Tu must be bound to GTP and the tRNA must 
be aminoacylated. 
 
 
1.8 EF-TS IS THE GUANOSINE NUCLEOTIDE EXCHANGE FACTOR FOR 
EF-TU 
Owing to EF-Tu’s relatively high affinity for GDP over GTP, EF-Tu requires the 
auxiliary protein EF-Ts to facilitate the formation of EF-Tu∙GTP. This is a critical step 
since each round of tRNA selection has the ultimate effect of converting EF-Tu∙GTP 
into its inactive form, EF-Tu∙GDP (Figure 1.9). Mutagenesis studies have revealed 
FIGURE 1.9 Activation of EF-Tu requires the GEF EF-Ts. EF-Tu (blue) disembarks from the 
ribosome (pink/grey) in an inactive state bound to GDP (brown). EF-Ts binds to this complex with 
high affinity and catalyzes the exchange of GDP for GTP (yellow). The canonical model then predicts 
that EF-Tu∙GTP is released from EF-Ts in an active form that is then competent to bind aa-tRNA 
(white) and participate in tRNA selection with the ribosome. 
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that EF-Ts is critical to cell survival
58
. Indeed, efforts to recapitulate protein synthesis 
in vitro have revealed that the process is severely compromised without the inclusion 
of EF-Ts
59
. Current models predict that when EF-Tu∙GDP disembarks from the 
ribosome, EF-Ts binds to this complex with high affinity
31
. This interaction leads to 
the removal of GDP and to the binding of GTP. Activated EF-Tu is then released and 
competent to bind to an aa-tRNA so as to engage in another round of tRNA selection.  
EF-Ts facilitates nucleotide exchange by stabilizing the transition state of 
nucleotide binding (Figure 1.10)
60
. Crystallographic data show that when bound to EF-
Ts, EF-Tu can adopt a conformation that is globally similar to its GDP-bound 
conformation. EF-Ts largely interacts with domains I and III of EF-Tu with the 
addition of a protruding C-terminal alpha helix, termed the C-domain, which interacts 
with helix D of EF-Tu. This causes a rearrangement of Lys136 and Leu175 which are 
normally involve the stabilization of the ribose and guanosine base
60
. A conserved 
residue of EF-Ts, Phe81, inserts between EF-Tu residues His118 in helix C and His84 
in helix B of the switch 2 region. The repositioning of these residues are believed to 
lead to a rearrangement of the P-loop negatively impacting the stabilization of the 
FIGURE 1.10 EF-Ts stabilizes the nucleotide binding transition state of EF-Tu. Critical EF-Ts 
residues E274 and F81 destabilize the guanosine binding surface (EF-Tu residues L175 and K136) and 
the Mg
2+
 ion (EF-Tu residues D80, H118, and H84). 
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nucleotide’s β-phosphate. The intrusion of EF-Ts residue Glu274 of the C-domain 
abolishes the coordination of the Mg
2+
 ion by altering the configuration of EF-Tu 
residues Asp80, Cys81, and Pro82
60
. The net effect of this interaction is that the 
nucleotide binding site is highly destabilized. Both the on-rate, and the off-rate of 
GDP and GTP are increased substantially
31
 consistent with a lowering of the 
activation energy between the bound and unbound states. 
 
 
1.9 CURRENT MODELS OF tRNA SELECTION ARE TOO SLOW 
Protein synthesis has been studied from both in vivo and in vitro perspectives. 
Pulse-chase experiments conducted in vivo with a variety of bacterial species measure 
the rate of protein synthesis to be between 2 and 20 amino acids polymerized per 
ribosome per second depending on growth conditions
35,61,62
. Importantly, these 
measurements place an upper and lower limit to the molecular processes which lead to 
protein synthesis. As models are developed, they must ultimately operate within these 
limits. However, current models predict an upper limit to the rate of amino acid 
polymerization of 7 s
-1
, about 3-fold too slow. These models stem from bulk 
measurements of peptide bond formation
2
 and EF-Tu release from the ribosome after 
GTP hydrolysis
4,24
. Rectification of these short comings requires a more complete 
understanding of how TC is formed and decoded by the ribosome. 
To advance our understanding of protein synthesis, and to reconcile the rate of 
protein synthesis with in vivo measurements, we examined the both the formation and 
stability of TC and the process of tRNA selection from multiple perspectives. The data 
presented in subsequent chapters highlights new assays designed to directly examine 
the molecular processes that lead to aa-tRNA accommodation. These data focus on the 
precise role of EF-Tu in this process and how EF-Tu activation is regulated.  
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CHAPTER 2 
METHODS 
2. OVERVIEW 
Section 2.1 describes general operating procedures for the instrumentation used to 
acquire the data presented in subsequent chapters. Section 2.2 provides detailed 
reagent purification methods followed by fluorophore conjugation methods in section 
2.3. This chapter concludes with a description of experimental procedures in 
section 2.4. 
 
 
2.1 INSTRUMENTATION 
This section describes the instruments used to perform the assays discussed in later 
sections and chapters. Specifically, a detailed description of the PTI-QM4 fluorometer 
and the Applied Photophysics SX20 are presented. 
 
2.1.1 PTI-QM4 Fluorometer 
A fluorometer (also referred to as a spectrofluorometer or a florimeter) is an 
instrument capable of measuring parameters of fluorescence. The experiments 
discussed in this document used a Photon Technology International QuantaMaster 4 
fluorometer (Figure 2.1) to monitor time-dependent changes in fluorescence and, to a 
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lesser extent, to measure emission and excitation spectrums. This instrument was used 
to conduct both relative fluorescence and FRET experiments. Specifically, this 
instrument was used to acquire the data shown in Figures 3.1, 3.2, 3.3, 3.6, 4.2, 4.4, 
4.5, and 5.3 Specific experimental procedures will be described in subsequent 
sections. This section serves as a practical guide towards understanding and operating 
a PTI-QM4 fluorometer. 
The instrument consists of a reaction chamber as well as an excitation source and 
an emission detector (Figure 2.2). The light source used in this configuration is a high 
powered Xenon flash lamp with a repetition rate of up to 300 Hz with usable intensity 
between 185 nm and ~850 nm. Immediately after the lamp housing unit, along the 
direction of the emitted light path, is a light-side aperture with a manually adjustable 
diameter, ranging of 1 – 5 microns. Next, the light encounters an excitation diffraction 
grating with 1200 line/mm, blazed at 300 nm. The selected wavelength is then directed 
through a grating-side aperture, and then into the reaction chamber capable of housing 
a standard 3mL quartz cuvette. Included in the housing chamber is a temperature-
stabilizing unit that can circulate fluid around the cuvette holder. A reaction-side 
aperture is located 90° offset from the incoming light path to direct light towards an 
emission grating with 1200 line/mm, blazed at 400nm. From there, the light is directed 
FIGURE 2.1 PTI-QM4 Fluorometer. Photon Technology International QuantaMaster 4 
spectrofluorometer.  
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through another grating-side aperture and is then detected by a single-shot transient 
digitizer (SSTD) detector. 
This instrument is amenable to bulk fluorescence assays involving a standard sized 
cuvette. As a benchmark for designing fluorescence assays, a 5 nM dye solution of 
Cy3 is about the minimum that can be reliably detected with the current configuration.  
The general steps for operating the PTI-QM4 fluorometer are as follows: 
 
STEP 1 
Warm up the lamp. Turn on the Xenon lamp 30 minutes prior to the experiment. 
Failure to do this may result in a slow drift in fluorescence, possibly due to 
FIGURE 2.2 Light path of PTI-QM4 fluorometer. A pulsed xenon lamp emits light along the light path 
(black dotted line) through apertures (blue) and diffraction gratings (red) via a reaction chamber (green) to 
a K-171B red sensitive detector (brown). 
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temperature fluctuations in the lamp. 
 
STEP 2 
Turn on hardware. When ready to begin the experiment, turn on remaining 
hardware as needed. In order to operate the fluorometer, turn on the controller power 
box, the stir bar power box (if needed), and the PC. In the controlling PC, open the 
PTI software ‘FelixGX’. 
 
STEP 3 
Manually adjust apertures. The apertures should be set so that the amount of 
fluorescence being detected is within the range of 100,000 – 1,000,000 counts/second. 
Operating above or below this range will yield irreproducible results and may damage 
the detector. Since diffraction gratings are used to select for both excitation and 
emission wavelengths, the grating-side apertures should be set to the smallest value 
amenable so as to reduce the likelihood that neighboring wavelengths of light will also 
be 
FIGURE 2.3 Manual aperture knob. This is the manual knob that is used to open and 
close the light apertures.  
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selected. If more signal is needed to raise the counts/second into the usable range, first 
open the reaction-side aperture. If more signal is still needed, open the light-side 
aperture. Note that this will illuminate the sample with greater intensity so be weary of 
photobleaching. If there is still not enough signal reaching the detector, increase the 
grating-side apertures, or increase the concentration of fluorophore in the reaction. 
 
STEP 4 
Set up reaction. Place the cuvette in the reaction chamber. Afterwards, make sure 
the lid is securely in place, the sliding apertures are open, and that the side ports are 
properly closed. If needed, make sure that the stir bar is set appropriately (stir speed 
can be modulated on the stir bar power box). 
 
STEP 5 
Excitation correction. If excitation correction is desired, select Digital Excor 
(default is Digital) located on the top right-hand side of the computer screen in the 
FelixGX software. This will generate a warning titled ‘FelixGX Hardware 
Configuration Changed’. Click OK. 
 
STEP 6 
Timebased Data Acquisition 
i. In the FelixGX software, select Setup. 
ii. Under the tab Acquisition Type, Select Timebased. 
iii. Navigate to the Acquisition Settings tab and enter excitation and 
emission wavelengths. 
iv. Enter data points per second (10 is a good starting point). 
v. Enter the duration of the experiment in seconds. 
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vi. Navigate to the Real-time Corrections tab and enable Excitation 
Correction. 
vii. A dialog box will open titled ‘Open Ex Corr Lookup Table’. 
Select excorr and click OK. 
viii. Input the excitation wavelength that will be used in the 
experiment and click the Go to button. 
ix. Adjust the gain so that the Signal(V) reading is approximately 
1.0. This must be done while illuminating the fluorescent reaction. 
x. Click Accept to close dialog box. 
xi. In the main screen select Start to begin data acquisition.  
xii. To save an acquisition, right click on the data set in the text 
dialog box, and select export. This can be exported in a FelixGX format or 
a text file format (text is usually preferred). 
xiii. To save the session, navigate to the File menu and select Save. 
 
Timebased Data Acquisition – Steady State Titration Experiments 
       i. – iv.  Proceed as indicated in the Timebased Data Acquisition procedure. 
v. Enter the duration of acquiring each data point (10 seconds is a 
good starting point). 
vi. Navigate to the Real-time Corrections tab and enable Excitation 
Correction. 
i. A dialog box will open titled ‘Open Ex Corr Lookup Table’. 
Select excorr and click OK.  
ii. Input the excitation wavelength that will be used in the 
experiment and click the Go to button. 
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iii. Adjust the gain so that the Signal(V) reading is approximately 
1.0. This must be done while illuminating the fluorescent reaction. 
vii. Navigate to the Preferences tab.  
viii. Uncheck Always create a new Session. This will allow multiple 
acquisitions to be made within one session. 
ix. Click Accept to close dialog box. 
x. In the main screen select Start to begin data acquisition.  
xi. After acquisition, the cuvette can be accessed if needed. Wait a 
sufficient amount of time for the reaction to reach equilibrium (5 minutes is 
a good starting point). Proceed back to step x as needed. 
xii. To save an acquisition, right click on the Session title of the 
data set in the text dialog box, and select export. This can be exported in a 
FelixGX format or a text file format. 
xiii. To save the session, navigate to the File menu and select Save. 
 
Spectral Data Acquisition 
      i. – iii.  Proceed as indicated in the Timebased Data Acquisition procedure 
iv. In the FelixGX software, select Setup. 
v. Under the tab Acquisition Type, select Emission (or Excitation) 
Scan. 
vi. Navigate to the Acquisition Settings tab and enter excitation and 
emission range. 
vii. Enter Step Size (1 nm is a good starting point). 
viii. Enter the Integration time of each data point in seconds (1 
second is a good starting point) 
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ix. Enter the number of repeats (default is 0). This is the number of 
additional scans that will be executed. The final output will be an average 
of all of the scans. 
x. Navigate to the Real-time Corrections tab and enable Excitation 
Correction. 
xi. A dialog box will open titled ‘Open Ex Corr Lookup Table’. 
Select excorr and click OK. 
xii. Input the excitation wavelength that will be used in the 
experiment and click the Go to button. 
xiii. Adjust the gain so that the Signal(V) reading is approximately 
1.0. 
xiv. Click Accept to close dialog box. 
xv. In the main screen select Start to begin data acquisition.  
xvi. To save an acquisition, right click on the data set in the text 
dialog box, and select export. This can be exported in a FelixGX format or 
a text file format. 
xvii. To save the session, navigate to the File menu and select Save. 
 
STEP 7 
Data analysis can be done with any number of data analysis software. This 
discussion will focus on using Origin8, distributed by OriginLab.  
i. Open Origin8 and create a new excel spreadsheet. 
ii. Navigate to the Data tab, and select Import Text Data, making 
sure to delineate appropriately. 
iii. Copy the data into an Origin workbook; omit any header and 
footer information. Note: data can be imported directly into a workbook, 
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though this is not recommended. Large datasets can lead to stability issues 
with the software. 
a. Represent data by fold change. 
i. In a new column, divide each raw data column by the 
average of the baseline. 
ii. Highlight normalized data columns. 
iii. Navigate to the Statistics menu and select Descriptive 
Statistics followed by Statistics on Rows. 
iv. Plot data. 
b. Represent data by percent change. 
i. Right-click on a new column and select Set Column 
Values. 
ii. In the dialog box, input (col(data) - AvgMin) / (AvgMax 
– AvgMin), where AvgMax and AvgMin are the average 
maximum and minimum values of the data respectively 
(Figure2.1.1.4). 
iii. Highlight normalized data columns. 
iv. Navigate to the Statistics menu and select Descriptive 
Statistics followed by Statistics on Rows. 
v. Plot data. 
iv. To fit the data, select the Analysis tab and then select fitting 
followed by the desired method. 
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FIGURE 2.4 Importing data into OriginLab. The raw data is imported into an excel workbook 
within Origin. The relevant data is then copied into an origin workbook for analysis (shown). 
Column A(X) contains time data and Column B(Y) contains the raw fluorescence data. 
FIGURE 2.5 Data processing. Data analysis can be done by right-clicking on a new column 
(Column C(Y) shown here), and navigating to Set Column Values... 
FIGURE 2.6 Normalize data by percent change. The Set Values dialogue box opens when selecting 
Set Column Values.... The normalization procedure to achieve percent change is shown.  
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2.1.2 SX20 Stopped-flow Spectrometer 
A Stopped-flow spectrometer is a rapid mixing device used to measure changes in 
fluorescence intensity at fast time resolution. The experiments discussed in this 
document use an Applied Photophysics Single-Push SX20 Stopped-Flow 
spectrometer. This instrument was used to conduct both fluorescence and FRET 
experiments presented in Figures 3.4, 4.3, 4.6, 4.7, 5.3, 5.4, 5.5, 5.6, 5.7, 2.10, and 
5.11. Specific experimental procedures will be described in subsequent sections. This 
section serves as a practical guide towards understanding and operating a SX20 
Stopped-flow spectrometer. 
At a basic level, this instrument consists of a T-mixer flow cell which resembles 
the shape of a tuning fork (Figure 2.7). The two arms of the fork contain separate 
reagents that are then mixed by direct flow into the central mixing chamber. The 
instrument is configured to complete the mixing process and begin data acquisition 
within approximately 1 ms. This instrument can be setup using either a 
monochromatic light source connected in line with an excitation side diffraction 
grating, or a light emitting diode (LED). The benefit of the monochromator is the 
inherent flexibility of selecting excitation wavelengths, though generally speaking this 
tends to be much dimmer than an LED. As a rule of thumb, use the monochromatic 
light source to pilot a new assay. Once established, purchasing a LED at the 
appropriate wavelength will likely increase the signal to noise substantially (user 
experience has been LEDs increase S/N by two to three fold over monochromators). 
FIGURE 2.7 Schematic of T-mixer flow cell. Two reagents are mixed by a converging flow path. The 
rate of mixing is tightly controlled by the rate of fluid flow through the T-mixer. Once mixed, the 
solution flow is directed to the reaction chamber where fluorescence measurements can be made. 
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To use the SX20, reagents are first loaded into the injection ports (Figure 2.8). The 
sample is then driven through the T-mixer by an air-pressurized drive piston (Figures 
2.8, 2.9). The volume of reagent that is driven through the T-mixer is controlled by a 
stopper and can be manually adjusted via a wheel located on the underneath side of the 
stopper. The reaction chamber is temperature stabilized by continuous flow of a 
thermostable fluid whose temperature is maintained by a water bath (Figure 2.9).  
FIGURE 2.8 Applied Photophysics SX20 Stopped-flow spectrometer. Each reagent is added using a 
3 mL syringe connected to injection ports (top right). The Drive piston (bottom right) provides the 
mechanical energy to direct each reagent through the T-mixer (schematized, center) and into a reaction 
chamber monitored by a PMT Detector (top left). The sample is then dispensed as output waste (left). 
The volume driven through the T-mixer is regulated by the stopper (bottom) and temperature controlled 
by circulating thermostable fluid around the reaction chamber (right). 
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Practical applications of this instrument include kinetic investigations of 
biomolecular interactions. When more complicated reactions are the subject of 
investigation, it is preferable to design the experiment in such a way as to interrogate a 
single kinetic step. This instrument is designed to probe kinetic processes that have a 
fluorescent readout at time scales of ~1 ms to ~1 minute. As a benchmark, 10 nM 
Cy3B is scarcely resolvable with the 532 nm LED. To reliable measure kinetic 
processes at fast time resolution, it is recommended to not use less than 60 nM Cy3B 
or equivalent fluorescence. The general steps for operating the SX20 are: 
 
STEP 1 
Configure the system and warm up the lamps. Assemble the appropriate PMT 
detector and emission filter (Figure 2.10). If using the monochromator, turn on the 
lamp at least 30 minutes prior to taking data. Failure to do this may result in a slow 
drift in fluorescence, possibly due to temperature fluctuations in the lamp. If using an  
 
FIGURE 2.9 Air tank and water bath for the SX20. Pressurized air tanks and regulator service the 
SX20 drive mechanism (left). A temperature controlled water bath regulates the temperature of the 
reaction chamber by circulating fluid (right).   
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LED light source, assemble the appropriate LED to a power source and connect it to 
the SX20 (Figure 2.11). 
 
STEP 2 
Wash the system. To reduce the likelihood that a prior experiment will cause 
contamination, wash the system with water followed by methanol, then water a second 
time, and finally buffer. Specifically: 
i. Water 
a. Manually push 4.5 mL of ddH2O. 
b. Drive 120 µL of ddH2O 10 times. 
FIGURE 2.10 Filter assembly. The filter is fitted into a filter house and assembled onto the SX20 
with a housing gasket. The PMT is then screwed into the SX20, sandwiching the filter housing unit. 
FIGURE 2.11 LED assembly. The LED light source is connected to a power modulator and is 
subsequently connected to a power cord via an adaptor. 
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c. Manually push 1 mL of ddH2O. 
ii. Methanol 
a. Manually push 4.5 mL of 30%V methanol. 
b. Drive 120 µL of 30%V methanol. 
c. Manually push 1 mL of30%V methanol. 
iii. Water 
a. Manually push 4.5 mL of ddH2O. 
b. Drive 120 µL of ddH2O 10 times. 
c. Manually push 1 mL of ddH2O. 
iv. Buffer 
a. Manually push 3 mL of buffer. 
 
STEP 3 
Prepare samples. Load samples into 3 mL Leur-Lok Syringes (Becton, Dickinson 
and Company). Pay careful attention to remove any air that may have been introduced 
FIGURE 2.12 Sample chamber valves. The sample chamber valves can be toggled to allow for 
sample injection. The chamber valve must be open to inject sample and during air extraction process. 
When operating the SX20 with the drive piston, the sample chamber valves must be in their closed 
position. 
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during this process. Using the Luer-Lok tip, screw the syringes into the injector ports 
(Figure 2.8). Open the injector valves (Figure 2.12) and inject the sample into the 
sample chamber. With the valves open, manually push the sample back into the 
syringe using the piston leg (Figure 2.13A). Repeat this forward and backwards 
process 4 to 5 times to flush out air bubbles that may have been introduced into the 
sample chamber. As an extra precaution, when the sample is manually driven back 
into the syringe for the last time, gently pull upwards on the syringe plunger (Figure 
2.13B,C). This will help to withdraw any remain gas from the sample chamber. 
 
STEP 4 
Set software parameters. In the Pro-Data SX software, navigate to the Signal 
section at the top left-hand side and select Fluorescence from the drop-down menu 
(Figure 2.14). Next, navigate to the Detector High Voltages section at the top right-
hand side and input the appropriate gain setting in the Abs. / Flu. field. For best 
results, keep the voltage between 1.0 and 10 volts. Next, navigate to the KSHU 
FIGURE 2.13 Extracting contaminating gas. If not appropriately degassed, air bubbles in the 
system can propagate into the reaction chamber and distort the signal. It is therefore imperative that 
all gas is removed from the system. A, after injecting the sample into the sample chamber, flow the 
sample back into the syringe in rapid succession by push up on the piston leg. This should be 
repeated 4 to 5 times. B, pull upwards on the syringe plunger to purge they sample chamber of any 
remaining gas. C, a close-up of gas being purged in B.    
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(Single Mixing) section at the right-hand side and select the Setup button. Adjust the 
shot counts appropriately and select Okay. If using a monochromator, navigate to the 
Monochromator section on the left-hand side and input the excitation wavelength and 
click Set. Proceed to the Trigger section of the menu, just below the Monochromator 
section and select External in the drop-down menu. Select Pressure hold if conducting 
experiments at time spans of one second or less. Otherwise, leave this unchecked. 
Move to the Timebase section and enter the total timeframe of the experiment and the 
desired number of data points. For a 250 ms experiment, 5,000 data points is ideal. 
FIGURE 2.14 Pro-Data SX20 software interface. Screen shot of the Pro-Data SX20 software 
interface with typical parameters for a 250 ms timebased experiment. For fluorescence experiments 
using an LED, the monochromator settings can be ignored. 
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Finally, navigate to the Sequencer section and enable Repeats if desired. Unless 
specifically necessary, leave the Triggered box unchecked and the Kinetics selected. 
To begin data acquisition, select Acquire. 
 
2.1.4 Single Molecule TIRF Microscopy 
The single-molecule fluorescence imaging platform described here is a custom 
built instrument that is continually evolving to accommodate technological 
innovations in optics, data acquisition, and throughput. Thus, the particular 
components and methods described here are specifically applicable to its current setup 
as described by Juette et al.
63
.  
Single-molecule fluorescence resonance energy transfer (smFRET) experiments 
were conducted on a total internal reflection (TIR) setup achieved with a prism. Wide-
field, fast-detection sCMOS cameras were used for data acquisition. Fluorescently 
labeled molecules were immobilized on chemically treated quartz surfaces and excited 
with an evanescent wave as detailed in Michael Wasserman’s PhD dissertation.  
All fluorescence data is analyzed with the SPARTAN program suite to generate 
fluorescence traces that contain FRET
63
. These traces are then idealized in QuB
64
 and 
analyzed in Matlab (2014b) and Origin8. 
 
 
 2.2 REAGENT EXPRESSION AND PURIFICATION 
This section describes the methods used to generate the reagents used in the assays 
discussed in later sections and chapters. 
 
2.2.1 Bacterial Elongation Factor Tu Purification 
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The primary aim of this research is to understand the precise role of Elongation 
Factor Tu (EF-Tu) in bacterial protein synthesis. As such, this reagent was used 
extensively in various forms. In Escherichia coli, there are two isoforms of EF-Tu 
encoded by the genes tufA and tufB. The product of tufB is the primary form of EF-Tu 
expressed in the K12 strain of E. coli and is therefore the gene used in our 
investigations. Through previous efforts, the open reading frame of tufB was cloned 
into the high copy number expression vector pProEX HT-b which introduces a 
cleavable N-terminal six Histidine (His6) affinity tag (Figure 2.15)
40
. The cleavability 
of the His6 tag is achieved by the insertion of a Tobacco Etch Virus (TEV) protease 
recognition sequence: 5′-ENLYFQˇG-3′. This amino acid sequence is recognized by 
the TEV protease and subsequently cleaved between the glutamine and glycine amino 
acids. This plasmid has been transformed into the bacterial cell strain DH5α and is 
cataloged as SCB41. 
Expression of pProEX HT-b follows standard procedures. A small culture is 
grown over night and used to inoculate a large preparative culture. In the preparative 
culture, the expression of the plasmid is induced and the cultures are grown to a 
sufficient cell density. These cells are then harvested and prepared following standard 
FIGURE 2.15 Map of His6-EF-Tu expression vector. tufB has been cloned into the expression vector 
pProEX HT-b. The construct contains an N-terminal His6 tag that is cleavable with TEV protease.  
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Ni-NTA purification procedures. A detailed method for the expression of pProEX HT-
b N-His6 EF-Tu is as follows: 
Overnight culture. Following sterile procedures, 10 mL of autoclaved LB media is 
measured into a glass 28 mL culture tube. Filtered ampicillin antibiotic is added to a 
final concentration of 100 µg/mL and inoculated with SCB41. The tube is placed in 
the rotating incubator at 37°C and left overnight. The ideal growth time is between 12 
– 16 hrs. 
Preparative cultures. Large 2.8L baffled culture flasks are filled with 1.5 L 
autoclaved LB media. Filtered ampicillin antibiotic is added to the flasks at a final 
concentration of 100 µg/mL and brought to 37°C. Although this may vary by demand, 
a typical preparation of EF-Tu uses 6 L of media. 2 mL of the overnight culture is then 
added to each flask. The flasks are then shaken at 225 rpm at 37°C. 
Expression of EF-Tu. The flasks are grown at 37°C until an optical density (OD) 
of 0.1 is reached. At this point, the temperature is dropped to 30°C, maintaining 
225 rpm shaking. The culture is then grown for another doubling and induced with 
filtered IPTG to a final concentration of 300 µM. The target OD for induction is 0.2 – 
0.25. 
Harvest Cells. Continue growing cultures until an OD of 1.0 is reached. Cultures 
are pelleted using 1 L JLA canisters and the JLA 8.1 rotor at 6,000 rpm, for 6 minutes 
at 4°C. Decant the supernatant and dry the pellets by inverting the canisters for 
5 minutes at 4°C. Add cold EF-Tu Lysis Buffer (20 mM Tris-HCl, pH 7.5, 200 mM 
KCl, 1 mM BME) and resuspend the pellets by swirling or light pipetting with a 
serological pipettor. If resuspending pellets from 6 L of culture, use 100 mL of buffer. 
Pellet the cell resuspension by transferring into pre-weighed 50 mL falcon conical 
tubes and pelleting for 10 minutes at 4,000 rpm, 4°C. Decant the supernatant and flash 
38 
 
freeze the pellet(s) in liquid nitrogen (LN2). Pellets are thawed and used immediately 
or stored long-term at -80°C. 
Purification of His6 tagged EF-Tu follows standard Ni-NTA purification 
procedures as outlined in the QIAexpressionist handbook
65
. Typically, 6-12 grams of 
cells are purified in a single preparation which yields roughly 200 nmols of fully 
purified EF-Tu. A detailed method for the purification His6 EF-Tu is as follows: 
Lyse cells. Resuspend cells in 25 mL EF-Tu Lysis Buffer. Cells are then lysed by 
sonication. This is achieved by sonicating the cell resuspension with the output control 
set to 6 and the duty cycle set to 60% for 45 seconds. The resuspension is then 
removed from the sonicator tip and incubated on ice for 5 minutes at 4°C. The 
sonication process is repeated 5 more times for a total of 6 sonication steps. 
Remove insoluble debris. The cell lysate is transferred into a JA 20 tube and 
pelleted with the JA 20 rotor for 15 minutes at 15,000 rpm, 4°C. The supernatant is 
transferred into a Ti-70 tube and pelleted in the Ti-70 rotor for 2 hours at 45,000 rpm, 
4°C. 
Isolate His6 tagged EF-Tu using affinity Ni-NTA chromatography. In a 4°C cold 
room or a sliding door refrigerator, 4 mL of QIAGEN Ni-NTA Agarose slurry 
(QIAGEN – material no. 1018240) is deposited into a disposable Poly-Prep 
Chromatography Column (BioRad – material no. 7311550). The resin is then washed 
with 10 volumes ddH2O (twice dialyzed MilliQ water), followed by 5 volumes EF-Tu 
Lysis Buffer With 10 mM imidazole, pH 8. 
When the cell lysate is finished spinning in the Ti-70 rotor, decant the supernatant 
into a 50 mL conical falcon tube and add imidazole, pH 8, to a final concentration of 
10 mM. Using a serological pipettor, slowly transfer the clarified lysate onto the resin, 
taking care not to disturb the resin bed. Allow the clarified lysate to completely flow 
through the column. Once finished, add 5 volumes of EF-Tu Wash Buffer (20 mM 
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Tris-HCl, pH 7.5, 500 mM KCl, 10 mM Imidazole, pH8, 1 mM BME) and allow to 
completely flow through the column. In 500 µL increments, add EF-Tu Elution Buffer 
(20 mM Tris-HCl, pH 7.5, 200 mM KCl, 250 mM Imidazole, pH 8, 1 mM BME) to 
the resin and collect the flow through. To verify the presence of eluted protein, add 
5 µL of the collected fraction to 250 µL of Bradford Reagent. A transformation of the 
reagent from brown to blue indicates the presence of protein in the eluted fraction. The 
elution process is continued until there is no indication of protein. 
The fractions containing protein are then pooled together and transferred into a 
MWCO 3kD dialysis bag, previously washed in ddH2O. The dialysis bag is then 
transferred into a 2 L beaker containing EF-Tu Dialysis Buffer (20 mM Tris-HCl, pH 
7.5, 200 mM KCl, 1 mM BME, 0.05%V Triton X-100 Surfactant), previously chilled 
to 4°C, and a stir bar. At 4°C, stir the container such that the dialysis bag is partially 
submerged in the buffer.  
Cleave the His6 tag. After 2 hours, transfer the dialysis bag into a new 2 L beaker 
containing EF-Tu Dialysis Buffer, previously chilled to 4°C. Add TEV protease at a 
molar ratio of 1:100 moles EF-Tu as verified by Bradford Reagent. The cleavage 
reaction is allowed to persist overnight at 4°C. 
Isolate cleaved EF-Tu. The following day, collect the contents of the dialysis bag 
into 2 (or more) 2 mL Eppendorf centrifuge tubes. Spin the samples for 10 minutes at 
15,000 rpm in the table top centrifuge to pellet away aggregated protein. Pool the 
supernatants of each tube into a 15 mL conical falcon tube and add imidazole, pH 8, to 
a final concentration of 10 mM.  
Add sample to 1 mL Ni-NTA Agarose slurry prepared in the same manner as 
indicated in STEP 3. Collect the flow-through. Add 1.5 volumes of EF-Tu Lysis 
Buffer With Imidazole to the resin and collect the flow-through. Pool collected 
fractions together.  
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Transfer the sample into a 4.5 mL 10 kDa Amicon Ultra Centrifugal Filter and 
spin at 4,000 rpm for 10 minutes, 4°C. Repeat until the volume of the sample is 
concentrated to within a range of 750 µL to 1 mL. Transfer sample to a 1.5 mL 
centrifugation tube and spin at 15,000 rpm for 10 minutes, 4°C. Transfer the 
supernatant to a new centrifugation tube. 
FPLC purification. Bring the volume of the tube up to 1,050 µL with EF-Tu Lysis 
Buffer. Inject the sample over a Superdex 75 gel filtration column, previously 
equilibrated in EF-Tu Lysis Buffer by running the program “Sephadex75 prepgrade 
fractionation” on the Äkta Purifier FPLC or “Superdex75” on the Äkta Pure FPLC. 
Natively folded EF-Tu will elute at around 58 mL. Collect this peak and buffer 
exchange into 2xFactor (20 mM Tris Acetate, pH 7, 100 mM KCl) Buffer using a 
4.5 mL 10 kDa Amicon Ultra Centrifugal Filter, spinning at 4,000 rpm, 4°C.  
Concentrate to around 150 µL and transfer to a 1.7 mL Eppendorf tube. Add DTT 
such that the final concentration is 1 mM. Finally, add 1 volume of 100% molecular 
biology grade glycerol and mix well. If bubbles appear, spin for 30 seconds at 
15,000 rpm, 4°C. Store sample at -20°C. 
FIGURE 2.16 SDS-PAGE of EF-Tu purification. Lane 1) Cell lysate, Lane 2) low speed spin 
supernatant, Lane 3) high speed spin supernatant, Lane 4) Ni-NTA column flow-through, Lane 5) Ni-
NTA column wash, Lane 6) Ni-NTA column elution, Lane 7) TEV protease treated EF-Tu. 
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2.2.2 Bacterial Elongation Factor Tu-ACP Purification 
In order to conduct experiments directly testing EF-Tu function, a fluorophore 
conjugated version of EF-Tu was made. Previous efforts to label EF-Tu via maleimide 
chemistry have failed to reproduce wild type activity
66
. As a result, an enzymatic 
labeling approach is used which leverages a 12 amino acid peptide tag on the carboxyl 
terminus of EF-Tu
67-69
. This peptide tag is a recognition sequence for the acyl carrier 
protein synthase (AcpS), a bacterial phosphopantetheinyl transferase. In E. coli, AcpS 
transfers 4′-phosphopantetheinyl (Ppant) groups from coenzyme A (CoA) to a 
conserved serine residue on acyl carrier protein (ACP) domains. Interestingly, AcpS 
exhibits promiscuity in transferring Ppant derivatives – including fluorescent small 
molecule probes. Here, we use AcpS to site specifically label our ACP-tagged EF-Tu. 
The AcpS recognizes the consensus sequence 5′-GDSLDMLEWSLM-3′ and 
catalyzes Ppant addition onto the 5′ serine (denoted as S)67. The EF-Tu construct used 
here contains the AcpS consensus sequence on the carboxy terminus of the His6-
FIGURE 2.17 Chromatograph of EF-Tu purification. EF-Tu, purified using standard Ni-NTA 
strategies, is further purified on a Superdex75 gel filtration column using an ÄKTA purifier.  
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tagged EF-Tu (Figure 2.18). Expression of this construct, His6-EF-TuACP, follows the 
procedures outlined in section 2.2.1. Specifically, a 10 mL overnight culture of LB 
media containing ampicillin at a concentration of 1 μg/mL is inoculated with a 
glycerol stock of DH5α cells containing a pProEx plasmid with His6-EF-TuACP (Figure 
2.18). This is grown for 14 hours with light agitation at 37°C. 
Once this growth is complete, 2 mL of the overnight culture are used to inoculate 
1.5 L of LB media containing ampicillin at a concentration of 1 μg/mL prepared in 
baffled 2.8 L flasks. Cultures are left to shake at 225 rmp at 37°C until an OD600 of 0.1 
is reached. The temperature is then reduced to 20°C and the cultures are allowed to 
grow to an OD600 of 0.2 – 0.25. Once this cell density is reached, the cultures are 
induced with 300 μM IPTG and allowed to continue to grow until an OD600 of 1.0 is 
reached. Cells are harvested according to procedures outlined in section 2.2.1 using 
EF-Tu Lysis Buffer. 
Purification of His6-EF-TuACP is generally similar to the purification of His6-EF-
Tu outlined in section 2.2.1, with the exception that the His6 tag is not proteolytically 
cleaved. Ultimately, the His6 tag will be used to aid in the purification of fluorescently 
labeled EF-Tu and subsequently cleaved thereafter. Specifically, the cells are lysed 
using EF-Tu Lysis Buffer and His6-EF-TuACP is isolated using standard Ni-NTA 
purification techniques. Here, both EF-Tu Wash Buffer and EF-Tu Elution Buffer are 
used to purify His6-EF-TuACP. Once purified, the sample is then dialyzed in 2 L of EF-
Tu Dialysis Buffer for 2 hours at 4°C. After this process, the sample is then dialyzed 
in a fresh 2 L supply of EF-Tu Dialysis Buffer for a minimum of 2 hours or overnight 
Figure 2.18 Map of His6-EF-TuACP construct. The construct contains an N-terminal His6 tag that is 
cleavable with TEV protease in addition to a C-terminal ACP tag. 
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at 4°C. After dialysis, the sample is concentrated in a 10K MW Amicon filter 
concentrator to a volume of 900 μL. The sample is further purified using a Superdex74 
gel filtration column with EF-Tu Lysis Buffer as the running buffer. The eluted 
sample is then buffer exchanged into 2xFactor Buffer using a 10K MWCO Amicon 
filter concentrator. Glycerol is then added to a final concentration of 50%V. The 
sample is stored at -20°C. 
 
2.2.5 Bacterial Elongation Factor Ts Purification 
Elongation Factor Ts (EF-Ts) is an essential protein
58
 and is the GEF for EF-Tu in 
bacteria
31
. In E. coli, EF-Ts is encoded by the gene tsf located downstream of the gene 
rpsB on the same operon
70
. The tsf gene has been previously cloned into the vector 
pProEX HT-b
40
 (Figure 2.19). This construct includes an amino terminal His6 tag that 
is cleavable by TEV protease. As such, expression and purification of EF-Ts mimics 
the protocol described in section 2.2.1. 
 
2.2.6 Bacterial Elongation Factor Ts-A106C Purification 
Fluorescently labeled EF-Ts was created to enable direct measurements of this 
protein in the context of other components of the translational machinery. This was 
achieved via cysteine labeling methods. EF-Ts has two native cysteines (C23 and C78) 
which do not participate in disulfide bonding. Using the pProEX His6-EF-Ts construct 
(Figure 2.19), each cysteine was mutated to a serine following standard site directed 
mutagenesis procedures
71
 to create a cysteine null EF-Ts (EF-Ts
∆C
). The primers used 
to create the C23S mutation are:  
Forward Primer: 5′-GGCGCAGGCATGATGGATTCGAAAAAAGCACTGAC-′3. 
Reverse Primer: 5′-GTCAGTGCTTTTTTCGAATCCATCATGCCTGCGCC-′3. 
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The primers used to create the C78S mutation are: 
Forward Primer: 5′-CATTCTGGAAGTTAACTCGCAGACTGACTTCG-′3. 
Reverse Primer: 5′-CGAAGTCAGTCTGCGAGTTAACTTCCAGAATG-′3. 
 
In each case, a 50 µL reaction was made containing 200 µM forward and reverse 
primer, 100 ng of the pProEx-His6-EF-Ts plasmid, 200 µM dNTP, and 1 unite of 
PfuUltra Hotstart DNA polymerase in Agilent PfuUltra Hotstart buffer. An 18 cycle 
reaction was conducted on the thermocycler (Figure 2.2.6.2) and then digested with 1 
unit of DpnI for one hour at 37°C. In this background, the alanine at position 160 was 
removed and replaced with a cysteine with site directed mutagenesis (EF-Ts
A160C
). 
The primers used to create the A160C mutation are: 
Forward Primer: 5′-GGTTGCTGCTAAAGGCTGCGACGAAGAGCTGG-′3. 
Reverse Primer : 5′-CCAGCTCTTCGTCGCAGCCTTTAGCAGCAACC-′3. 
 
All mutations were verified by Sanger sequencing. Purification of His-EF-Ts
A106C
 
is conducted following standard Ni-NTA purification techniques as described in 
section 2.2.1. 
FIGURE 2.19 Site directed mutagenesis thermocycler protocol. Each mutation required the 
modification of two nucleotides. Standard procedures, as outlined in the QuikChange handbook, were 
followed. 
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2.2.7 Phenylalanyl-tRNA Synthetase Purification 
Phenylalanyl-tRNA synthetase (PheRS, also referred to as phenylalanyl-tRNA 
ligase) is used to aminoacylate phenylalanyl-tRNA for in vitro experiments. PheRS is 
a tetramer of two heterodimers composed of an alpha and beta subunit. The alpha and 
beta subunits are encoded by the genes pheS and pheT respectively. Both genes are 
cloned into a pET SUMO expression vector in a tandem fashion and is catalogued as 
the plasmid MRW1 (see Figure 2.20). The vector harbors a T7 RNA polymerase 
promoter, which controls expression of the PheRS open reading frame, and a 
kanamycin antibiotic resistance cassette. This plasmid is stored in TOP10 bacterial 
cells and therefore must be transformed into a cell strain that contains the T7 RNA 
polymerase machinery. The expression system used here is the BL21(DE3) cell strain. 
This strain is unique in that it contains a chromosomal copy of the phage T7 RNA 
polymerase gene under the control of a lac promoter. The procedure for the expression 
of PheRS is as follows: 
Transform MRW1 plasmid into BL21(DE3) expression strain. 100 ngrams of 
MRW1 plasmid is added to a 50 µL BL21(DE3) competent cell aliquot. The mixture 
is incubated on ice for 30 minutes. The cells then are heat-shocked by incubating at 
42°C for 45 seconds followed by a 2 minute incubation on ice. Next, 200 µL of SOC 
media is added and the culture is placed in a rotator (or agitator) at 37°C for 1 hour. 
After the out growth is completed, 10 mL of autoclaved LB in a glass culture tube 
containing 40 µg/mL of kanamycin is inoculated with 25 µL of the transformed cell 
culture. The 10 mL culture is then placed in a rotator at 37°C. 
Inoculate preparative cultures. Add 5 mL of the overnight culture to 200 mL 
autoclaved LB with kanamycin (40 µg/mL). Cultures are grown until mid-log phase is 
reached (~2 hrs). When the OD of the log cultures are 0.5, inoculate 2 baffled culture 
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flasks containing 1.5 L autoclaved LB media and 40 µg/mL kanamycin with 95 of the 
log culture. The flasks are then shaken at 225 rpm, 37°C. 
Induce expression of PheRS. The flasks are grown at 37°C until an optical density 
(OD) of 0.2 is reached. At this point, the temperature is dropped to 20°C, maintaining 
225 rpm shaking. The culture is then grown to an OD of 0.4 and induced with filtered 
IPTG to a final concentration of 100 µM. Let cultures grow until an OD of 1.0 is 
reached. 
Harvest cells. Cells are harvested as described in section 2.2.1 STEP 4, with the 
modification of using the low salt PheRS Lysis Buffer in place of EF-Tu Lysis Buffer. 
Typically, 6-12 grams of cells are purified in a single preparation which yields roughly 
500 nmols of fully purified PheRS. Purification of His6 tagged PheRS follows 
standard Ni-NTA purification procedures as outlined section 2.2.1. Cells are lysed in 
PheRS Lysis Buffer (50 mM NaH2PO4, 1 mM BME) by sonication. The lysate is 
clarified by centrifugation. Imidazole is added to a final concentration of 10 mM. The 
sample is then applied to a Ni-NTA column pre equilibrated in PheRS Lysis Buffer 
with 10 mM Imidazole, pH 8. The bound sample is washed with 5 column volumes of 
PheRS Wash Buffer (50 mM NaH2PO4, 200 mM NaCl, 10 mM Imidazole, pH 8, 
1 mM BME) and eluted with PheRS Elution Buffer (50 mM NaH2PO4, 100 mM NaCl, 
250 mM Imidazole, pH 8, 1 mM BME). The eluted sample is immediately dialyzed in 
cold PheRS Dialysis Buffer (10 mM Tris Acetate, pH 7.5, 100 mM KCl, 1 mM BME) 
at 4°C. 
FIGURE 2.20 Map of His6-PheRS construct. Both the α and the β subunit of PheRS have been cloned 
in to a pET-SUMO vector in tandem. The α subunit contains an N-terminal His6 tag that is cleavable 
with SUMO protease. 
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After 2 hours, transfer the dialysis bag into a new 2 L beaker containing PheRS 
Dialysis Buffer, previously chilled to 4°C. Add SUMO protease at a molar ratio of 
1:30 moles PheRS as verified by Bradford Reagent. The cleavage reaction was 
allowed to persist for 2.5 hr at 4°C. The cleaved PheRS is isolated as described in 
section 2.2.1 and buffer exchanged into Factor Storage Buffer. If bubbles appear, spin 
for 30 seconds at 15,000 rpm, 4°C. Store sample at -20°C. 
 
2.2.8 Arginyl-tRNA Synthetase Purification 
Arginyl-tRNA synthetase (ArgRS, also referred to as arginyl-tRNA ligase) is used 
to aminoacylate arginyl-tRNA (tRNA
Arg
) for in vitro experiments. ArgRS is a class I 
synthetase that catalyzes the addition of arginyl-adenylate to the 2′ hydroxyl of the 
terminal adenosine of tRNA
Arg
. ArgRS is encoded by the gene argS and has been 
previously cloned into a pET-SUMO vector. This plasmid is stored in TOP10 bacterial 
cells, cataloged as BJB15, and must be transformed into BL21(DE3) cells for 
expression. Once transformed, the purification of ArgRS is carried out as described in 
section 2.2.7. 
  
2.2.9 TEV Protease Purification 
Tobacco Etch Virus (TEV) protease is a cysteine protease that cleaves polypeptide 
bonds according to a highly specific amino acid sequence. The consensus recognition 
sequence is 5′-EXLYΦQˇφ-3′ where X is any amino acid, Φ is any large bulky 
hydrophobic amino acid and φ is any small hydrophobic or polar amino acid, typically 
serine or glycine
72,73. TEV protease cleaves the polypeptide on the 3′ side of the 
glutamine, denoted by ˇ. In practice, this enzyme is used to remove a purification tag, 
such as the His6 tag used to purify EF-Tu. Given the proximity of the cleavage site in 
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the consensus sequence, this strategy is ideally suited for removing tags located on the 
amino terminus of the protein being purified (Figure 2.15).  
The active fragment of TEV protease used to here is 27 kDa and has been 
previously cloned into the pMAL expression vector. This construct contains a non-
cleavable His6 tag used to remove TEV during the purification of other His6 tagged 
proteins. This plasmid has been previously transformed into DH5α cells and is 
cataloged as strain SCB51. A detailed procedure for the expression of TEV protease is 
as follows: 
Overnight culture. Following sterile procedures, 10 mL of autoclaved TB media is 
measured into a glass 28 mL culture tube. This is repeated for a total of 2 culture 
tubes. Filtered ampicillin antibiotic is added to a final concentration of 100 µg/mL in 
each culture tube. One tube is inoculated with SCB51 and the other tube is brought 
into contact with the inoculation device, but is not inoculated – this will act as a 
contamination control. Both tubes are placed in the rotating incubator at 37°C and left 
overnight. The ideal growth time is between 12 – 16 hrs. 
Preparative cultures. Large 2.8L baffled culture flasks are filled with 1.5 L 
autoclaved TB media. Filtered ampicillin antibiotic is added to the flasks at a final 
concentration of 100 µg/mL and brought to 37°C. Although this may vary by demand, 
a typical preparation of TEV protease uses 4.5 L of media. 2 mL of the overnight 
culture is then added to each flask. The flasks are then shaken at 225 rpm at 37°C. 
Expression of TEV protease. The flasks are grown at 37°C until an optical density 
(OD) of 1.0 is reached. At this point, the temperature is dropped to 30°C, maintaining 
225 rpm shaking. The culture is induced with filtered IPTG to a final concentration of 
500 µM. The target OD for induction is 1.5. This is then left to grow overnight. 
Harvest Cells. Typical OD at the time of harvest, the following morning, is about 
8.5. The cells are harvested as described in section 2.2.1 using TEV Lysis Buffer 
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(20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM BME, Protease inhibitor (1:10,000 
by volume)). 
Typically, 6-12 grams of cells are purified in a single preparation that yields 
roughly 2000 nmols of fully purified His6-TEV. Purification of His6 tagged TEV 
follows standard Ni-NTA purification procedures as outlined in section 2.2.2 using 
TEV Lysis Buffer, TEV Wash Buffer (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 
10 mM Imidazole, pH 8, 1 mM BME), TEV Elution Buffer, and TEV Dialysis Buffer 
(20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM BME). Once purified, TEV protease 
is stored at -20°C in Factor Storage Buffer until further use.  
 
2.2.9 Bacterial Phosphate Binding Protein Purification 
In order to measure GTP hydrolysis, we utilized an orthogonal inorganic 
phosphate (Pi) biosensor developed by Martin Webb
74-76
. Phosphate Binding Protein 
(PBP) from E. coli binds soluble Pi readily, having an on-rate of >100 μM
-1
s
-1
.  The 
protein utilized here has an A197C mutation making it amenable to sulfhydryl labeling 
strategies. The PBP gene has been previously cloned into a pET22b which contains a 
C-terminal His6 tag. However, during the cloning process the natural termination 
codon was inserted upstream of the C-terminal His6 tag is therefore not transcribed. 
Thus, affinity purification strategies cannot be used. However, the native purification 
protocol has been well vetted and produces ample amounts of protein. This plasmid is 
stored in TOP10 cells cataloged as BJB26.  
Expression of PBP. To express this protein, the pET22b-PBP plasmid is first 
transformed into BL21(DE3) cells as described in section 2.2.7. The transformance is 
then used to inoculate 10 mL of LB media containing 100 μg/mL ampicillin. The 
starter culture is incubated for 7 hours at 37°C in a rotating incubator. The starter 
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culture is added to 90 mL of LB media containing 100 μg/mL ampicillin in a baffled 
flask. The sample is then incubated overnight at 37°C, shaking at 225 rpm.  
The next morning, 4 L of LB media containing 100 μg/mL ampicillin is inoculated 
with the overnight culture and incubated at 37°C, shaking at 225 rpm. Preparative 
cultures are grown to an OD of 1.0 and induced with 400 μg IPTG and left to grow fro 
3 hours.  
Harvest Cells. The cells are harvested as described in section 2.2.1 using PBP 
Lysis Buffer (20 mM Tris-HCl, pH 8, 1 mM EDTA, 5 mM BME). 
Purification of PBP. Cell pellets are thawed with 20 mL PBP Lysis Buffer. 
Clarified lysate is then obtained as outlined in section 2.2.1. The clarified lysate is 
loaded onto a 120 mL Q-Sepharose FF column, equilibrated in PBP Buffer A (10 mM 
Tris-HCl, pH 7.6, 1 mM BME). This is then washed with two column volumes of PBP 
Buffer A followed by a shallow gradient into PBP Buffer B (10 mM Tris-HCl, pH 7.6, 
200 mM NaCl, 1 mM BME). PBP is rather loosely bound and elutes around 50 mM 
NaCl. The eluted sample is then buffer exchanged into PBP Storage Buffer (20 mM 
Tris-HCl, pH 7.6, 2 mM DTT) and concentrated using an Amicon MWCO 10k filter 
concentrator. An equal volume of 100% molecular grade glycerol is added and the 
sample is stored at -20°C until further use. 
 
2.2.10 Bacterial Phenylalanyl-tRNA Purification 
Historically, the bacterial phenylalanyl-tRNA (tRNA
Phe
) has been the workhorse 
of protein synthesis research. Expression of tRNA
Phe
 is less straightforward than the 
FIGURE 2.21 Map of tRNA
Phe
 construct. The pheV gene, along with ~175 nt of the native upstream 
elements, is cloned into a Lac operon in a pBS plasmid.  
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expression of single gene proteins. In bacteria, there are two genes that encode for 
tRNA
Phe
, though the research described in this document exclusively uses the gene 
PheV for recombinant expression of this molecule. Through previous efforts
77
, the 
PheV gene has been cloned into a pBS vector (Figure 2.21). This vector includes an 
IPTG inducible Lac operon and is engineered to express the open reading frame of 
genes. In this case however, the precise open reading frame of PheV is not known. 
Initially, PheV encodes for a precursor tRNA
Phe
 which undergoes maturation by 
RNAases and base modifying enzymes. Ultimately, this maturation process leads to 
the removal of both 3′ and 5′ RNA elements yielding a 76 nucleotide tRNA product. 
Because the open reading frame is not precisely known, large DNA fragments, both 
upstream and downstream of the annotated PheV, were included in cloning into the 
pBS vector. As such, this construct houses a LacZ controllable transcription site as 
well as a native PheV promoter that is likely to be constitutively expressed. 
Additionally, this construct also contains an ampicillin resistance cassette.  
Expression of tRNA
Phe
 follows similar methods utilized in protein expression. An 
overnight culture is grown to saturation and used to induce a log-phase culture, so 
named because it is used to grow cells to mid log phase. This culture is then 
subsequently used to inoculate preparative cultures. Once expressed, purification of 
tRNA
Phe
 relies upon methods that take advantage of both chemical and structural 
properties that are unique to this molecule. This protocol takes five days to complete 
and yields 50 – 80 nmoles of crude tRNAPhe. 
Overnight culture. Cell strain RA113 is used to inoculate 10 mL of LB media with 
100 μg/mL ampicillin. Culture is grown overnight at 37°C in a rotating incubator. 
Log culture. When the overnight culture is saturated, a baffled flask of 100 mL of 
LB media containing 100 μg/mL ampicillin is inoculated with 10 mL of the saturated 
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overnight culture. This culture is grown at 37°C with shaking at 225 rpm to an OD600 
of 0.6.  
Preparative culture. 9 L of LB media with 100 μg/mL ampicillin is prepared in 6 
large 2.8 L baffled flask (1.5 L pre flask). Each large flask is inoculated with 15 mL of 
the log culture. Cultures are incubated at 37°C, 225 rpm shaking, until an OD600 of 
0.25 is reached. Cultures are then innoculated with 300 μM IPTG and grown until an 
OD600 of 0.85 is achieved. 
Harvest cells. Cultures are pelleted at 6,000 rpm for 6 minutes at 4°C using the 
JLA 8.1 rotor. Pellets are dried for 5 minutes by inverting over a paper towel for 
5 minutes. Following this, pellets are resuspended in tRNA
Phe
 Lysis Buffer by 
swirling. The resuspended cells are then pelleted at 4,000 rpm for 20 minutes at 4°C. 
Typically, 9 L of culture is used to create two tRNA
Phe
 pellets. As such, no more than 
80 mL of tRNA
Phe
 Lysis Buffer is used when resuspending pellets so that two 50 mL 
falcon tubes can be used to pellet cells. After pelleting, the supernatant is decanted and 
the cells are weighted. The pellets are then flash frozen in LN2 and stored at -80°C.  
Lyse cells. Cell pellet(s) are resuspended with 20 mL cold tRNA
Phe
 Lysis Buffer. 
Cells are lysed by sonicating six times at an output of 60%, duty cycle of 6 at 45-
second intervals. The sample is allowed to cool down, on ice, for 5 minutes between 
cycles. To ensure rapid cooling, the sonicated tip is removed from the sample in 
between sonication rounds.  
tRNA extraction. After lysis is complete, the cells are pelleted in a JA20 rotor for 
15 minutes at 15,000 rpm, 4°C. The supernatant is collected and pelleted a second 
time in a Ti70 rotor for 2 hours at 45,000 rpm, 4°C. Once pelleted, the supernatant is 
collected and dispensed into phenol:chloroform tubes (decommissioned JA20 tubes 
allocated for this purpose only). An equal volume of cold phenol:chloroform is added 
and shaken vigorously (vortexing is specifically avoided). Because of the difference in 
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density, the organic phenol will naturally sink below the aqueous sample. 
Furthermore, the polar nature of the aqueous solution requires energy to mix with the 
hydrophobic phenol so mixing must be done vigorously.  
The purpose of this process is to denature all proteins present in the sample. Owing 
to the large negative charge of nucleic acids, most of the tRNA
Phe
 will partition into 
the aqueous phase. When properly mixed, the solution appears completely white and 
opaque. The mixture is pelleted in a JA20 rotor for 15 minutes at 15,000 rpm, 4°C. 
The centrifugal force accelerates the natural separation of the organic and aqueous 
phases. The top aqueous layer is collected and set aside on ice. A middle solid layer 
that mostly contains aggregated proteins also fomrs. This layer is avoided when 
collecting the aqueous layer. Next, ½ volume tRNA
Phe
 Lysis Buffer is added to the 
remaining organic phase. This is referred to as a back extraction and has the purpose 
of extracting any remaining tRNA
Phe
 that did not partition into the aqueous phase. The 
sample is mixed vigorously and pelleted as previously done. The top aqueous layer is 
collected and combined with the previously collected aqueous layer.  
A second extraction is performed by again adding one volume of cold 
phenol:chloroform. The sample is mixed vigorously and pelleted as done previously. 
The aqueous layer is collected and one volume of chloroform is added. The purpose of 
this is to remove any phenol that may have partitioned into the aqueous phase. The 
sample is mixed vigorously and pelleted in a JA20 rotor for 5 minutes at 15,000 rpm, 
4°C. The aqueous phase is collected and 1/10
th
 volume of 3M NaOAc, pH 3.7, is 
added to the sample. The tRNA
Phe
 is concentrated by ethanol precipitation. 3 volumes 
of cold ethanol is added and the sample is inverted a few times to induce mixing. The 
reaction is allowed to precipitate at 4°C for a minimum of 30 minutes or up to 24 
hours.  
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Isolating bulk tRNAs. The precipitation reaction yields a significant amount of 
particulate that is readily visible by eye. The solution is pelleted at 4,000 rpm for 
10 minutes at 4°C. The supernatant is decanted and the pellets are dried by inverting 
over a paper towel at 4°C for 5 minutes. Pellets appear yellow in color. The pellets are 
then resuspend in cold 300 mM NaOAc, pH 7, in 50 mL conical tubes. The solution is 
diluted with this buffer to a concentration of 100 μM as calculated by assuming a 
molar extinction coefficient of 625,000 M
-1
cm
-1
 at an absorbance wavelength of 
260 nm. Typically, this concentration is achieved by resuspending the pellets to a final 
volume of 30 – 40 mL. As a benchmark, there should be roughly 3,000 – 3,500 
nmoles of material at this stage. 
Once diluted appropriately, 0.54 volumes of cold isopropanol are added to the 
resuspension while mixing. This is done so that as the isopropanol is added to the 
solution, it is immediately mixed. The purpose of this is to bring up the percentage of 
isopropanol from 0% to 35% so that large molecules precipitate out of solution but 
FIGURE 2.22 Isopropanol precipitation of tRNA
Phe
. Components of the isopropanol precipitation 
reaction are analyzed on a 7 M Urea, 12% Bis-acrylamide gel made with Tris-Borate-EDTA buffer. 
Lane 1) Bulk tRNA before isopropanol precipitation, lane 2) Soluble fraction of the first isopropanol 
precipitation reaction, note that the majority of material is small, lane 3) insoluble material from the 
first isopropanol precipitation reaction, note that the majority of the material is large, lane 4) soluble 
fraction of the second isopropanol precipitation reaction, lane 5) insoluble material from the second 
isopropanol precipitation reaction.  
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smaller, tRNA sized molecules remain soluble (Figure 2.2.10.2). If the isopropanol is 
added without mixing, there is a risk of temporarily having a very high concentration 
of alcohol near the surface of the solution which will have the undesired effect of 
precipitating some tRNA
Phe
. Once mixed, the precipitation reaction is incubated at 
room temperature for 10 minutes. Following this, the precipitated material is pelleted 
in the clinical centrifuge by spinning at 4,000 rpm for 10 minutes at 4°C. The 
supernatant is collected and put aside on ice. 
This process is repeated by resuspending the pellet (now much whiter in color) 
with cold 300 mM NaOAc, pH 7, to a concentration of 100 μM. Typically, this 
requires roughly 10 mL. 0.54 volumes of isopropanol is added while mixing. The 
precipitation reaction is incubated at room temperature for 10 minutes. As before, the 
sample is pelleted and the supernatant is combined with that of the previous 
precipitation.  
The tRNA
Phe
 is concentrated by ethanol precipitation. First, 1/100
th
 of the sample 
and set aside to be used subsequently as an analytical sample. Next, 3 volumes of cold 
ethanol is added to the remaining solution and mixed. Separately, 3 volumes of cold 
ethanol is added to the 1/100
th
 sample and mixed. Note that no additional salt is added. 
Samples are precipitated at -20°C for a minimum of 30 minutes or up to 24 hours. 
Acylatyion of tRNA
Phe
. Using the FPLC, the lines A1 and B1 are equilibrated in 
tRNA
Phe
 Buffer A and tRNA
Phe
 Buffer B respectively. Then, the analytical TSK 
Phenyl-5PW hydrophobic column is equilibrated with tRNA
Phe
 Buffer A. The 
analytical precipitation reaction is pelleted by spinning for 10 minutes at the maximum 
force allowable for the tube being used for the reaction. If using a conical tube, the 
sample is spun in the clinical centrifuge at 4,000 rpm. If using an Eppendorf tube, the 
sample is spun in a table top centrifuge at 15,000 rpm. The supernatant is decanted and 
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the pellet is dried with a vacuum or by inversion on a paper towel at 4°C for 
5 minutes.  
The pellet is resuspended in tRNA
Phe
 Buffer A and loaded into the FPLC injection 
loop. Next, the program Cy3 tRNA purification analytical is executed which 
implements a tRNA
Phe
 Buffer A to tRNA
Phe
 Buffer B gradient (Figure 2.2.10.3). 
Acylated tRNA
Phe
 elutes at 19.75 mL. 
In addition to acylated tRNA
Phe
, there is also a significant amount of deacylated-
tRNA
Phe
. To isolate this, the bulk tRNA sample is charged with amino acid by 
incubating with a 10-fold excess of phenylalanine and a 1:100 dilution of PheRS in 
buffer (50 mM HEPES, pH 8, 20 mM KCl, 100 mM NH4Cl, 1 mM DTT, 2.5 mM 
ATP, 0.5 mM EDTA, 10 mM MgCl2) for 20 minutes in a 37°C water bath. The 
reaction is then quenched with 1/10
th
 volume of 3M NaOAc, pH 3.75. Following this, 
the sample is phenol:chloroform extracted and ethanol precipitated for a minimum of 
FIGURE 2.23 Hydrophobic separation of bulk tRNAs. The small RNA molecules that did 
not precipitate when mixed with isopropanol, collectively referred to as ‘bulk tRNAs’ is 
purified over a Phenyl-5PW TSK column. The shaded peak contains Phe-tRNA
Phe
. 
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30 minutes or overnight. As done previously, 1/100
th
 of the sample is set aside for 
analysis. 
The analytical sample is pelleted as previously described and purified over a 
Phenyl-5PW TSL column. The charged Phe-tRNA
Phe
 peak is now much 
larger (Figure 2.2.10.4). 
The precipitation reaction is pelleted as previously described and resuspended in 
tRNA Buffer A. The sample is then purified over a larger 40 mL Phenyl-5PW TSK 
column using tRNA
Phe
 Buffer A and B. The charged Phe-tRNA
Phe
 is isolated (Figure 
2.2.10.4) and dialyzed into 2 L of tRNA Dialysis Buffer (10 mM KOAc, pH 6, 1 mM 
MgCl2) for 2 hours. The sample is then transferred to a fresh 2 L supply of tRNA 
Dialysis Buffer and dialyzed overnight. 
The following day, the sample is concentrated using a MCWO 10k Amicon 
centrifugation filter, previously blocked with a 0.5% triton solution. The sample is 
FIGURE 2.24 Hydrophobic separation of Phe-tRNA
Phe
. An analytical sample of charged 
tRNA
Phe
 is purified over a 3 mL Phenyl-5PW TSK column. The dominant peak, eluting at 
19.75 mL (shaded) represents Phe-tRNA
Phe
.  
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then flash frozen in LN2 and stored at -130°C to -196°C in a LN2 storage tank. 
 
2.1.11 Tight Coupled 70S Ribosome Purification 
Prokaryotic ribosome particles consist of 3 large rRNA molecules, composed of a 
total of 4,560 nucleotides, and 52 proteins. Altogether, the fully formed ribosome is 
2.5 MDa and is often referred to by its measured centrifugal sedimentation rate of 70S. 
Historically, the fraction of purified ribosomes that are active in translation are 
referred to as tight-coupled 70S (TC70) ribosomes. Here, a detailed description of the 
purification of TC70s from BL21 cells is described. 
Overnight culture. A 10 mL culture of LB media is inoculated with BL21 cells 
from a glycerol stock. The culture is incubated overnight at 37°C in a rotating 
incubator. 
Preparative growth. Overnight cultures are diluted 1:4000 into 4 L of LB media in 
FIGURE 2.25 Hydrophobic separation of Phe-tRNA
Phe
. Charged tRNA
Phe
 is purified over a 40 mL 
Phenyl-5PW TSK column. The dominant peak, eluting at 165 mL (shaded) represents Phe-tRNA
Phe
.  
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baffled flasks. Preparative cultures are incubated at 37°C and shaken at 225 rpm.  
Harvest cells. Cells are harvested in early log phase at an OD of 0.3 to 0.5. Flasks 
are taken out of the incubator and subsequently incubated on ice for 30 minutes. The 
cultures are then pelleted in a Beckman JLA 8.1 rotor by centrifuging at 6,000 rpm for 
6 minutes at 4°C. The supernatant is discarded and the pellets are dried on a paper 
towel for 5 minutes at 4°C. Pellets are resuspended in cold TC70 Buffer A (20 mM 
Tris-HCl, pH 7.5, 100 mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA, 6 mM BME) by 
swirling. The resuspension is pelleted a second time at 4,000 rpm for 20 minutes at 
4°C. The supernatant is discarded and the pellets are flash frozen in LN2 and stored at 
-80°C until further use. 
Cell lysis. Pellets are lysed using a Retch MM400 Ball Mill. Pellets are removed 
from their container (50 mL falcon tube) by freezing in LN2 and hammering the 
container. Pellet fragments are placed into a 50 mL metal canister previously cooled in 
LN2. A 50 mm ball, previously cooled in LN2, is added and the canister is tightly 
closed. The sample is crushed 5 times at 3 minute intervals at 15 Hz. In between 
milling cycles, the canister is incubated in LN2 for 5 minutes. The milled pellet, 
referred to as crushate, is transferred into a JA-18 rotor tube and mixed with 20 mL 
TC70 Buffer A with 1:1000 DNAase added. The sample is incubated at room 
temperature for 10 minutes. Sample is then pelleted in a JA-18 rotor at 15,000 rpm for 
15 minutes at 4°C. 
Sucrose cushion 1. The supernatant is decanted into a Ti-45 rotor tube. Next, 
35 mL of TC70 Buffer B (20 mM Tris-HCl, pH 7.5, 500 mM NH4Cl, 10 mM MgCl2, 
0.5 mM EDTA, 6 mM EDTA) with 1.1 M sucrose is underlayed beneath the clarified 
lysate. The sucrose cushion is centrifuged in a Beckman Ti-45 rotor at 33,000 rpm for 
22 hours at 4°C. 
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Sucrose cushion 2. The supernatant is decanted and the pellet is gently washed 
with 2 mL TC70 Buffer A. It is then gently resuspended with 2 mL TC70 Buffer A. A 
second sucrose cushion is made by adding 30 mL TC70 Buffer A to a clean Ti-45 
rotor tube and underlaying with 35 mL TC70 Buffer B with 1.1 M sucrose. The 
resuspension is then gently applied to the top of the gradient. The sample is then 
centrifuged in a Beckman Ti-45 rotor at 33,000 rpm for 22 hours at 4°C. 
Gradient purification. The supernatant is decanted and the pellet is resuspended in 
2 mL TC70 Buffer A. Resuspension is gently laid onto a 10%-40%w/v sucrose gradient 
prepared using a Gradient Master 107 (BioComp) in a 25x89 polyallomer tubes 
(Beckman) with TC70 Buffer A and sucrose. Gradients are centrifuged in a Beckman 
SW-28 rotor at 22,000 rpm for 19 hours at 4°C. 
FIGURE 2.26 Fractionation of TC70 preparation. TC70s are purified through a sucrose gradient and 
analyzed on a gradient fractionaor. Fraction 2) 30S and 50S subunits. Fraction 3) TC70S. 
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Collect TC70s. Using a BR-186 gradient fractionator, the TC70 fraction is 
collected. Though settings vary depending on experimental conditions, typical settings 
are a chart speed of 30 cm/hr, sensitivity of 1.0, path length of 1 mm, and a push 
velocity of 1.5 mL/minute (Brandel syringe pump). One volume of TC70 Buffer A is 
added to the collected and pooled TC70 fractions and is transferred into a fresh Ti-70 
rotor tube. Sample is centrifuged in a Beckman Ti-45 rotor for 22 hours at 45,000 rpm, 
4°C. The supernatant is decanted and the pellets are resuspended in polymix buffer 
(50 mM Tris-OAc, pH 7.5, 100 mM KCl, 5 mM NH4AOc, 0.5 mM CaCl2, 0.1 mM 
EDTA, 5 mM putrecine, 1 mM spermidine, 5 mM MgCl2, 5 mM BME). TC70s are 
aliquoted as necessary and flash frozen in LN2. Samples are stored at -130°C to -
196°C in a liquid nitrogen tank. 
   
2.2.12 Nucleotide Purification 
Guanosine triphosphate (GTP), guanosine diphosphate (GDP), GDPNP, and 
GTPγS were purchased from Sigma and further purified on a Tricorn Mono Q 5/50 
GL ion exchange column. 2′-/3′-O-(N′-methylanthraniloyl)guanosine-5′-O-
triphosphate (GTPmant) was purchased from Jena Biosciences. 
 
 
2.3 FLUORESCENT LABELING OF BIOMOLECULES  
This section describes the methods used to conjugate fluorophores to the reagents 
used in the assays discussed in later sections and chapters. 
 
2.3.1 Cy5Q EF-TuACP 
The AcpS enzyme is used to site-specifically label ACP-tagged proteins with CoA 
conjugated fluorophores. Cyanine 5 quencher (Cy5Q) with a maleimide side group is 
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conjugated to CoA by sulfhydryl chemistry. A 100-fold excess of CoA is added to 
Cy5Q-maleimide in 100 mM MES, pH 6.5, and incubated at room temperature for 
2 hours in the dark. The reaction is then loaded onto a C18 HPLC column equilibrated 
in degassed C18 Buffer A (10 mM TEA acetate, pH 7). CoA linked Cy5Q is eluted by 
performing a shallow gradient into C18 Buffer B (10 mM TEA acetate, pH 7, 50%V 
acetonitrile). The eluted fraction is then desalted using a Sep-Pak SPE and stored 
at -80°C until further use. 
His6-EF-TuACP is mixed with AcpS enzyme at a 1:1 ratio in ACP Labeling Buffer 
(50 mM HEPES, pH 7.5, 10 mM MgCl2) along with a 10-fold excess of CoA-Cy5Q. 
The labeling reaction is incubated for 2 hours at 4°C in the dark. Afterwards, 
imidazole, pH8, is added to a final concentration of 10 mM. The sample is then 
applied to gravity column prepared with Ni-NTA resin previously equilibrated with 
EF-Tu Lysis Buffer with 10 mM Imidazole, pH 8. The resin is then washed with 
5 volumes of EF-Tu Wash Buffer and eluted with EF-Tu Elution Buffer. The eluted 
fraction is transferred into a 3.5 kDa dialysis bag and placed in 2 L of EF-Tu Dialysis 
Buffer for 2 hours, at 4°C in the dark. Following this, the sample is transferred to a 
fresh 2 L supply of EF-Tu Dialysis Buffer. TEV protease is added at a molar ratio of 
1:100 and left at 4°C in the dark overnight. 
Following cleavage, imidazole, pH 8, is added to the sample at a final 
concentration of 10 mM. The sample is then applied to a gravity column prepared with 
Ni-NTA resin previously equilibrated with EF-Tu Lysis Buffer with 10 mM 
imidazole, pH 8. The flow-through is collected along with the flow-through of a one 
column volume wash with EF-Tu Lysis Buffer containing 10 mM imidazole, pH 8. 
The sample is buffer exchanged into 2xFactor Buffer using a MWCO 10k Amicon 
filter and concentrated. An equal volume of 100% molecular grade glycerol is added 
and the sample is stored at -20°C until further use. 
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2.3.2 Cyanine Dye Labeling Of EF-Ts
A106C
 (Cy3 and Cy5) 
His6-EF-Ts
A106C
 is engineered to have only one cystine such that site-specific 
labeling can be achieved through sulfhydryl labeling strategies. A 100-fold excess of 
either Cy3 or Cy5 containing a maleimide side group is added to EF-Ts in buffer 
(100 mM KPi, pH 6.5, 100 µM TCEP, 100 mM NH4Cl). The reaction is incubated at 
room temperature for 1.5 hours in the dark.  
Purification of labeled EF-Ts(Cy3/5) is carried out as described in section 2.3.1. 
 
2.3.4 MDCC Labeling Of PBP 
PBP is engineered to have only one reactive cystine for the purpose of conjugating 
a maleimide linked fluorophore. Maleimide conjugated MDCC is used to label PBP as 
previously described
74,75
. 
 
2.3.6 NHS-Cyanine Dye Labeling of tRNA 
E. coli tRNA expressed from the gene pheV has a single 3-(3-amino-3-
carboxypropyl) modification on the Uridine at position 47 (acp
3
U47). Importantly, this 
modification adds a unique primary amine to the tRNA (Figure 2.27). By taking 
advantage of N-hydroxysuccinimide (NHS) conjugated cyanine dyes, the tRNA
Phe
 can 
be site specifically labeled at position U47. 
Two nanomoles of crude tRNA
Phe
 is buffer exchanged into 312 mM HEPES, pH 
7.9. The sample concentrated to 40 μM using a MWCO 10k Amicon centrifugation 
filter (the final volume is 50 μL). NaCl is added to a final concentration of 1 M. Next, 
25 nmoles of NHS conjugated Cy3, Cy3B, or Cy5 (previously resuspended in DMSO 
at a concentration of 10 mM) is added to 2 nmoles of tRNA
Phe
 and incubated for 
30 minutes at room temperature in the dark. This is repeated 4 times for a total 
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addition of 100 nmoles of dye and a total incubation of 2 hours. Following this, the 
reaction volume is brought to 400 μL with ddH2O and phenol:chloroform extracted 
and ethanol precipitated as described in section 2.2.10.  
The precipitation reaction is centrifuged in a table-top centrifuge at 15,000 rpm for 
10 minutes at 4°C. The sample is resuspended in 1 mL of tRNA Buffer A and purified 
using a Phenyl-5PW TSQ hydrophobic column. Gradienting into tRNA Buffer B, as 
described in section 2.2.10, tRNA
Phe
 is eluted at 12 mL and dye labeled tRNA
Phe
 is 
eluted at 32 mL for Cy3, Cy3B and Cy5 respectively. The tRNA is buffer exchanged 
into tRNA Storage Buffer using a MWCO 10k Amicon centrifugation filter and flash 
frozen in LN2. Samples are stored at -135°C to -196°C in a LN2 tank until further use. 
 
 
2.4 EXPERIMENTAL PROCEDURES  
This section describes the assays used to generate the data discussed in later 
sections and chapters. 
 
FIGURE 2.27 Purification of Cy3 labeled tRNA
Phe
. Two nmols of tRNA
Phe
 is labeled with 100 nmols 
of Cy3-NHS and purified over a 3 mL Phenyl-5PW TSK column using an ÄKTA purifier. tRNA
Phe
 
elution is tracked using 254 nm (blue) and 550 nm (red) absorbance. 
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2.4.1 Acylation of tRNA
Met
, tRNA
Arg
, and tRNA
Phe
 
tRNA is acylated by mixing 7.5 pmol purified tRNA in buffer (50 mM Tris-HCl, 
pH 8, 20 mM KCl, 100 mM NH4Cl, 1 mM DTT, 2.5 mM ATP, 0.5 mM EDTA, 
10 mM MgCl2) with 6 pmol of tRNA synthetase and 1 mM amino acid (previously 
solubilized in ddH2O). The reaction is then incubated at 37°C for 20 minutes and then 
placed at room temperature until further use.   
 
2.4.2 Acylation and formylation of tRNA
fMet
  
Initiator tRNA (tRNA
fMet
) is prepared by mixing the desired amount into a reaction 
containing 1 mM methionine amino acid, methionyl-tRNA synthetase (at a sub-
saturating ratio of 1:2), transformylase (at a sub-saturating ration of 1:10), FTHF 
(prepared by incubating 5 μL of MTHF with 0.5 μL 1M Tris, pH 8, and 0.5 μL NaOH) 
in buffer ( - am/fm buffer - ). The sample is incubated for 20 minutes at 37°C and 
placed at room temperature until further use. 
 
2.4.3 Formation of Ribosome Initiation Complex 
The initiation complex (IC) described here consists of bacterial ribosomes 
subunits, purified from BL21 cells, programmed on an mRNA transcript start-site with 
an initiator fMet-tRNA
fMet
 positioned in the P-site. The mRNA is purchased from 
Dharmacon and consists of first 6 codons of the tufA open reading frame inline with 
the gp120 viral promoter ( mRNA sequence ).   
IC is generated by first incubating 10 nmoles of TC70 for 10 minutes at 37°C in 
polymix buffer with 10 µM GTP. Next, 15 nmoles of IF1, IF2, and IF3 are added 
along with 10 nmoles of S1. The reaction is incubated at 37°C for 5 minutes. 
15 nmoles of mRNA is added and the reaction is incubated at 37°C for 5 minutes. 
Following this, 15 nmoles of fMet-tRNA
fMet
 is added at the reaction is incubated for 
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another 5 minutes at 37°C. The sample is then incubated on ice for 10 minutes and 
loaded onto a sucrose cushion containing 1.5 mL of polymix buffer with containing 
1.1 M sucrose in six 13x51 mm polycarbonate centrifuge tubes (Beckman Coulter). 
The tubes are spun for 4 hours at 95,000 rpm in a table-top ultra centrifuge. Once 
complete, the supernatant is discarded and the pellets are resuspended in polymix 
buffer and flash frozen in LN2 and stored at -80°C until further use. 
 
2.4.4. Ternary Complex Isolation by Gel Filtration Chromatography 
Ternary complex was formed by adding EF-Tu, or previously formed EF-Tu/Ts 
complex, to Phe-tRNA
Phe
 at a ratio of 4 to 1 in buffer (50 mM HEPES, pH 7, 20 mM 
KCL, 100 mM NH4Cl, 1 mM DTT, 0.5 mM EDTA, 2.5 mM MgCl2, 10 μM GTP) and 
incubating for 15 minutes at 37°C. Samples were purified using a Superdex75 gel 
filtration column on an ÄKTA Purifier pre-equilibrated with buffer in either the 
absence of presence of GTP or GDPNP (10 μM). 
 
2.4.5 Relative Fluorescence Ternary Complex Assay 
All fluorescence experiments were performed using a 532 nm high pass filter 
(LP03-532RS-25 RazorEdge by Semrock) on the emission side. All samples wree 
analyzed in a 3 mL quartz cuvette with constant mixing at 23C in buffer (50 mM 
HEPES, pH 7, 20 mM KCL, 100 mM NH4Cl, 1 mM DTT, 0.5 mM EDTA, 2.5 mM 
MgCl2) with either 10 µM GTP or 400 nM EF-Tu or EF-Tu/Ts. Steady state 
measurements were made by manually adding EF-Tu or EF-Tu/Ts to a solution of 
Phe-tRNA
Phe
 labeled with Cy3 or Cy3B to the modified acp
3
U47 as indicated. The 
dissociation constant, KD, was determined by fitting the fluorescence data obtained to 
Equation 1
78
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𝐹/𝐹°(𝑇𝑢) = 1 +
(𝐹/𝐹°𝑚𝑎𝑥 − 1)
2𝐶𝑡
(𝐶𝑡 + 𝑇𝑢 + 𝐾𝐷 − √(𝐶𝑡 + 𝑇𝑢 + 𝐾𝐷)2 − 4𝐶𝑡𝑇𝑢) 
EQUATION 2.1 
where F is the total fluorescence intensity, Fo is the initial fluorescence intensity, 
Ct is the total aa-tRNA concentration, and Tu is the total EF-Tu concentration.  
Pre-steady state measurements were made by manually adding saturating protein 
factor (400 nM EF-Tu or EF-Tu/Ts) to 5 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47) and 10 μM 
GTP and monitoring fluorescence change over time. Apparent rates, kapp, were 
determined by fitting data to a single exponential function
79
. 
 
2.4.6 Quench-fluorescence Ternary Complex Assay 
All quench-based fluorescence measurements were obtained using a Photon 
Technology International fluorescence spectrometer with a 523 nm long pass emission 
filter (LP03-532RS-25 RazorEdge by Semrock). Reactions were analyzed in buffer 
(100 mM HEPES, pH 7, 20 mM KCL, 100 mM NH4Cl, 1 mM DTT, 0.5 mM EDTA, 
2.5 mM MgCl2, 10 μM GTP) in a 3 mL quartz cuvette with constant mixing at room 
temperature. Measurements were made by manually adding EF-Tu (Cy5Q) or an EF-
Tu(Cy5Q)/Ts complex (preincubated in buffer for 10 minutes at room temperature) to 
a reaction of 5 nM aa-tRNA fluorescently labeled with Cy3B while exciting at 532 nm 
and monitoring at 565 nm. The dissociation constant, KD, was determined as described 
in section 2.3.2. Apparent rates, kapp, were determined from pre-steady state 
measurements where the time-dependent changes in fluorescence observed were fit to 
a single exponential function (ferscht 1985). 
 
2.4.7 Ternary Complex Activity Assay 
Ternary complex is formed by titrating EF-Tu or EF-Tu/Ts (0 nM to 1 μM) into a 
reaction containing 400 nM Cy3 labeled Phe-tRNA
Phe
 and 10 μM GTP as described in 
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section 2.4.5. The fluorescence values are monitored using a PTI QM4 fluorometer 
with excitation set to 532 nm and detecting at 565 nm with a emission side 550 nm 
long pass filter (LP03-532RS-25 RazorEdge by Semrock). Fluorescence values are 
processed by normalizing to the initial data point and evaluated the earliest high 
fluorescence data point. The corresponding concentration of EF-Tu or EF-Tu/Ts is 
compared to the total Phe-tRNA
Phe
 in the reaction (Figure 3.2). 
 
2.4.8 Rapid Stopped-flow Experiments Monitoring Relative Fluorescence 
All experiments were performed at 23C in buffer (50 mM HEPES, pH 7, 20 mM 
KCL, 100 mM NH4Cl, 1 mM DTT, 0.5 mM EDTA, 2.5 mM MgCl2) using an SX20 
stopped-flow spectrometer from Applied Photophysics with a 550 nm long pass filter 
(OG550 by Schott). One injector port was loaded with protein factor preincubated 
with 2 mM GTP, whereas the other injector port was loaded with 400 nM Phe-
tRNA
Phe
 (Cy3-acp
3
U47). Concentrations reported in subsequent chapters are final 
concentrations after mixing. 
 
2.4.9 Rapid Stopped-flow Experiments Monitoring FRET 
Quench-fluorescence measurements were obtained in buffer (100 mM HEPES, pH 
7, 20 mM KCL, 100 mM NH4Cl, 1 mM DTT, 0.5 mM EDTA, 2.5 mM MgCl2, 10 μM 
GTP) at room temperature using an SX20 stopped-flow spectrometer from Applied 
Photophysics equipped with either a 550 nm long pass emission filter (OG550 by 
Schott) or a 633 nm long pass emission filter (LP01-633RS-25 RazorEdge by 
Semrock) for monitoring Cy3 and Cy5 fluorescence respectively. All concentrations 
are stated as final concentrations after mixing. Error bars represent standard error of 
the mean of three separate experiments.  
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2.4.10 GTP Exchange Assay 
EF-Tu (15 nmoles) is incubated with 10 μM GTPmant or GDPmant in buffer (50 mM 
HEPES, pH 7, 20 mM KCl, 100 mM NH4Cl, 1 mM DTT, 0.5 mM EDTA, 2.5 mM 
MgCl2) at a final volume of 1 mL for 10 minutes at room temperature in the dark. 
Samples are rapidly mixed with either 15 nmoles EF-Ts or buffer using an Applied 
Photophysics SX20 exciting 280 nm using the monochromator and detecting 440 nm 
fluorescence. Nucleotide exchange was monitored as a function of time. Apparent 
rates were estimated by fitting fluorescent decay processes to a single exponential 
function. 
 
2.4.11 Ternary Complex GTP Exchange Assay 
Experiments were performed at room temperature in buffer (50 mM HEPES, pH 7, 
20 mM KCL, 100 mM NH4Cl, 1 mM DTT, 0.5 mM EDTA, 2.5 mM MgCl2, 10 μM 
GTP) under conditions > 10-fold above the KD for ternary complex formation to 
ensure that all EF-Tu present in the reaction is bound to aa-tRNA (400 nM Phe-
tRNA
Phe
, 5 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47), 400 nM EF-Tu or EF-Tu/Ts, 10 μM 
GTPmant). Complex formation was monitored by tracking the fluorescence of the Cy3 
and mant fluorophore over time. Measurements of Cy3 and mant fluorescence were 
made by switching detection modes from 532 nm excitation and 565 nm emission to 
280 nm excitation and 440 nm emission, respectively
31
. The mant fluorescence signal 
was processed using the Savitzky-Golay method in OriginLab8 with a window of nine 
points
80
. 
 
2.4.12 Initiation Complex Activity Assay 
Quenched Phe-TC (Cy3B labeled Phe-tRNA
Phe
 previously complex with Cy5Q 
labeled EF-Tu∙GTP) is formed as previously described in section 2.4.6 and aliquoted 
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into 10 20 nM reactions containing varying concentrations of ribosomes (0 nM, 
2.5 nM, 5 nM, 10 nM, 20 nM, 30 nM, 40 nM, 50 nM, 100 nM, 200 nM) in polymix 
buffer with 1 mM GTP. Reactions are transferred into a 384-well flat black-bottom 
microplate (128/85 mm, Greiner Bio-One) and imaged using a TECAN Infinite 
M1000 Pro plate reader with the following settings: 540 nm excitation, 20 nm 
excitation bandwidth, 585 nm emission, 20 nm emission bandwidth, top mode, 122 
gain and using 3x3 square multiple reads per well. Fluorescence values are processed 
by normalizing to the first data point. Activity is determined by evaluating the earliest 
fully dequenced value and its corresponding IC concentration relative to the 
concentration of Phe-TC (Figure 5.9). For a fully active IC, the earliest fully 
dequenced data point occurs at a concentration equal to the concentration of Phe-TC, 
or 20 nM IC. 
 
2.4.13 tRNA Selection Dequench Assay 
Quenched TC (60 nMF) is rapidly mixed with varying concentrations of IC using 
an SX20 in polymix buffer containing 1 mMF GTP. Monitoring Cy3B fluorescence, 
the dequencing process is tracked real time. The apparent rate, kapp, of dequencing is 
determined by fitting the rise process with a single exponential function. The 
calculated rates are then plotted as a function of IC concentration. Error bars represent 
standard deviation.  
 
2.4.14 tRNA Selection GTP Hydrolysis Assay 
Phe-TC (500 pmol) is mixed with the Pi-MOP system (0.1 unit/mL of PNPase and 
1.5 mM 7-methylguanosine (7MG), reagents purchased from Sigma) and 1 nmol of 
MDCC-PBP in 1 mL of polymix buffer with 10 μM GTP for 20 minutes at room 
temperature. Similarly, 800 pmol of IC is incubated with the Pi-MOP system and 
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1 nmol of MDCC-PBP in 1 mL polymix with 10 μM GTP for 20 minutes at room 
temperature. The samples are rapidly mixed using an SX20 stopped-flow spectrometer 
from Applied Photophysics using a 435 nm LED excitation and a 475 nm notch filter 
(FF01-475/35-25, Semrock) and monitoring fluorescence. MDCC fluorescence 
increase is normalized to percent change. The apparent rate of GTP hydrolysis is 
determined by fitting the rise process to a single exponential function.  
 
2.4.15 smFRET tRNA Selection – tRNA Reaction Coordinate 
The procedure followed here closely mimics the procedure described previously 
by Juette et al
63
. Using the custom built TIRF microscope, Phe-TC (Cy5 labeled 
tRNA) is rapidly mixed with either surface immobilized ICs containing Cy3 on the 
initiator tRNA in the P-site, or with surface immobilized ICs containing Cy3B at the 
C-terminus of protein S12 on the small subunit in polymix buffer containing 1 mM 
GTP and photostabilizers (TROLOX, COT, NBA)
81,82
. FRET is measured as the 
percentage of Cy5 intensity detected when illuminating with a 532 nm laser. Raw data 
is first analyzed with the SPARTAN package to generate a set of traces that include 
FRET
63
. These traces are then idealized in QuB
64
 to generate survival histograms of 
each FRET state identified. Survival plots are then analyzed in OriginLab8 to 
determine characteristic time constants (τ) for each FRET state. All time constants are 
reported as rates (1/τ). 
 
2.4.16 smFRET tRNA Selection – EF-Tu Reaction Coordinate 
Experiments are conducted as outlined in section 2.4.15 with the exception that 
Phe-TC containing either Cy5 or Cy7 labeled EF-Tu
SCO
 is delivered to surface 
immobilized ICs containing Cy3B labeled S12 illuminated with a 532 nm laser. Raw 
data is processed as described above in section 2.4.15. 
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2.4.17 smFRET tRNA Selection – EF-Tu & tRNA Reaction Coordinate 
Experiments are conducted as outlined in section 2.4.15 with the exception that 
Phe-TC containing both Cy5 labeled Phe-tRNA
Phe
 and Cy7 labeled EF-Tu
SCO
 is 
delivered to surface immobilized ICs containing Cy3B labeled S12 illuminated with a 
532 nm laser. Raw data is processed as described above in section 2.4.15. 
 
2.4.18 Simulation Of Ternary Complex Formation 
Ternary complex formation was simulated using MATLAB (R2010b) built on the 
following six reactions: 
 
EF-Tu/Ts  +  GTP  
6 ∙ 106𝑀−1𝑠−1
↔
85 𝑠−1
  EF-Tu/Ts∙GTP 
REACTION 2.1 
 
EF-Tu∙GTP  +  EF-Ts  
3 ∙ 107𝑀−1𝑠−1
↔
60 𝑠−1
  EF-Tu/Ts∙GTP 
REACTION 2.2 
 
EF-Tu/Ts∙GTP  +  aa-tRNA  
80 𝑠−1
↔
0.05 𝑠−1
  EF-Tu/Ts∙GTP∙aa-tRNA 
REACTION 2.3 
 
EF-Tu∙GTP  +  aa-tRNA  
10 𝑠−1
↔
0.01 𝑠−1
  EF-Tu∙GTP∙aa-tRNA 
REACTION 2.4 
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EF-Tu∙GTP∙aa-tRNA  +  EF-Ts  
20 𝑠−1
↔
100 𝑠−1
  EF-Tu/Ts∙GTP∙aa-tRNA 
REACTION 2.5 
 
EF-Tu  +  EF-Ts  
1 ∙ 107𝑀−1𝑠−1
↔
0.03 𝑠−1
  EF-Tu/Ts 
REACTION 2.6 
 Rate constants used in reactions 1-3 and reaction 6 were determined previously 
by Gromadski et al{Gromadski, 2002 #532} while the remaining rate constants were 
estimated from Figures 3.3 and 3.4. The simulation was conducted with the ode45 
(Dormand-Prince) solver with an absolute tolerance setting of 1.10x10
-6
 using the 
starting condition of 2 μM EF-Tu/Ts, 1 mM GTP, and 250 nM aa-tRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
 
 
 
 
 
 
 
CHAPTER 3 
DYNAMIC PROPERTIES OF EF-TU∙GTP∙AMINOACYL-tRNA  
TERNARY COMPLEX 
3.1 OVERVIEW 
The data and figures presented in this chapter have been previously published in 
modified form: 
 
Burnett BJ
a
, Altman RB
b
, Ferrao R
b
, Alejo JL
b
, Kaur N
b
, Kanji J
b
, Blanchard SC
c
. 
“Elongation Factor Ts Directly Facilitates the Formation and Disassembly of the 
Escherichia coli Elongation Factor Tu∙GTP∙Aminoacyl-tRNA Ternary Complex” 
Journal of Biological Chemistry. 2013 288:13917-13928
83
. 
 
a
Burnett BJ designed and conducted all experiments solely, or in conjunction with 
other authors. 
b
Authors conducted experiments in conjunction with Burnett BJ. 
c
Corresponding author, designed experiments in conjunction with Burnett BJ. 
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3.2 SUMMARY 
Aminoacyl-tRNA enters the translating ribosome in a ternary complex with 
elongation factor Tu (EF-Tu) and GTP. Here, we describe bulk steady state and pre-
steady state fluorescence methods that enabled us to quantitatively explore the kinetic 
features of Escherichia coli ternary complex formation and decay. The data obtained 
suggest that both processes are controlled by a nucleotide-dependent, rate-determining 
conformational change in EF-Tu. Unexpectedly, we found that this conformational 
change is accelerated by elongation factor Ts (EF-Ts), the guanosine nucleotide 
exchange factor for EF-Tu. Notably, EF-Ts attenuates the affinity of EF-Tu for GTP 
and destabilizes ternary complex in the presence of non-hydrolyzable GTP analogs. 
These results suggest that EF-Ts serves an unanticipated role in the cell of actively 
regulating the abundance and stability of ternary complex in a manner that contributes 
to rapid and faithful protein synthesis.  
 
 
3.3 INTRODUCTION 
GTP-hydrolyzing proteins (GTPases) play a central role in a vast array of 
biological systems
7,9,13,22
. In bacteria, the three-domain GTPase elongation factor (EF) 
Tu, a member of the TRAFAC (translation factors) class of G-proteins
9,15
, chaperones 
the entry of aa-tRNA into the messenger RNA (mRNA)-programmed ribosome during 
the process of protein synthesis
14,84-86
. This multistep and highly conserved process is 
a critical determinant of the mechanism of translational fidelity
1
 and is exquisitely 
regulated by EF-Tu-catalyzed GTP hydrolysis while bound to the ribosome. Efforts to 
understand how EF-Tu facilitates the process of aa-tRNA selection have depended 
critically on high resolution structural information of active (EF-Tu∙GTP) and inactive  
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FIGURE 3.1 Ternary complex structure and steady state measurements of ternary complex 
formation.  A, structure of ternary complex stabilized by the antibiotic kirromycin (Protein Data Bank 
code 1OB2). E. coli EF-Tu (blue) bound to GDPNP (carbon atoms in grey, nitrogen in blue, oxygen in 
red, and phosphorous atoms in orange) is complexed with Saccharomyces cerevisiae Phe-tRNA
Phe
 
(wheat). Domains of EF-Tu are represented as D1, D2, and D3. For simplicity, kirromycin is not 
shown. B, specific functional elements are highlighted: switch 1 (S1) is in red, switch 2 (S2) is in 
orange, His-66 is in green, and the phenylalanine amino acid is in purple. C, the affinity of EF-Tu for 
aminoacyl-tRNA was determined by titrating EF-Tu (open diamonds) or EF-Tu/Ts (closed squares) 
into a solution of Cy3-labeled Phe-tRNA
Phe
 and 10 µM GTP. An identical titration of EF-Tu was 
performed either with deacylated tRNA
Phe
 (circles) or in the absence of GTP (blue squares). D, the 
apparent nucleotide affinity was measured by titrating GTP into a cuvette containing Phe-tRNA
Phe
 
(Cy3-acp
3
U47) and EF-Tu (open diamonds) or EF-Tu/Ts (closed diamonds). Identical titration 
experiments of GDPNP with EF-Tu (open triangles) and EF-Tu/Ts (closed triangles) and GTPγS with 
EF-Tu (open squares) or EF-Tu/Ts (closed squares) are shown. Error bars represent the S.E. of three 
separate experiments. Estimates of the apparent KD were obtained by fitting the titration data as 
described in Chapter 2. Data points are splined for clarity. 
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(EF-Tu∙GDP) forms of EF-Tu. Toward this goal, atomic resolution structures of EF-
Tu bound within its “ternary complex” with GTP and aa-tRNA and bound to GDP 
have been solved
28,87-91
. This work revealed that EF-Tu∙GTP and EF-Tu∙GDP exhibit 
markedly distinct conformations characterized by “compact” and “extended” 
configurations, respectively. Related investigations showing that only EF-Tu∙GTP  
binds aa-tRNA with high affinity (approximately nanomolar) suggested that the 
capacity of EF-Tu to achieve its activated, compact form is a critical determinant of 
high affinity aa-tRNA binding
78,92-95
. In its compact configuration, the three domains 
of EF-Tu (D1, D2, and D3) closely interact with each other and with the tRNA 
acceptor stem (see Figures 3.1, A and B)
29,88
. The high affinity nature of the EF-
Tu∙GTP∙aa-tRNA interaction is further buttressed by the formation of an amino acid 
binding pocket at the interface of domains 1 (also referred to as the G domain) and 2 
of the protein
57,95
. There, histidine 66 (His-66) within domain 1 stacks on the 
aminoacyl side chain linked to the 3′-hydroxyl group of the terminal adenosine residue 
(A76) of tRNA
95
. In EF-Tu∙GDP, domain 1 is distal to domains 2 and 388, 
rationalizing why this form of the protein does not bind aa-tRNA
78,92,94
. These findings 
suggest that compact and extended conformations of EF-Tu define active and inactive 
states of the G-protein, respectively, and that the active EF-Tu fold is somehow 
dependent on the terminal phosphate of GTP. High resolution structures of ternary 
complex bound to the ribosome have revealed that GTP hydrolysis leads directly to 
conformational changes within the GTP binding pocket
28
. This region includes the so-
called switch-1 (S1), switch-2 (S2), and P loop motifs that are conserved in all G-
proteins
9
. The S1 element is structurally linked to the amino acid binding pocket and 
engages the triphosphate moiety of the GTP nucleotide via a bridging magnesium ion 
(Mg
2+
) (see Figure 3.1B). The S1 element becomes disordered following GTP 
hydrolysis on the ribosome
28
 and adopts an alternative β-hairpin conformation in the 
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EF-Tu∙GDP structure91. Collectively, these findings suggest that structural transitions 
within S1 likely contribute to the transition between GTP and GDP-bound 
conformations of the protein and the aa-tRNA selection mechanism.  
Ensemble, steady state measurements of ternary complex
25,78,92,94,96-99
 together 
with estimated intracellular concentrations of EF-Tu, aa-tRNA (approximately tens of 
micromolar), and GTP (approximately millimolar) suggest that most (~90%) aa-tRNA 
is complexed with EF-Tu in actively growing bacteria
31,96
. However, the steady state 
concentration of ternary complex is strongly dependent on numerous biochemical 
processes, including the rates of ribosome-catalyzed protein synthesis, amino acid 
availability, and the relative intracellular concentrations of GTP and GDP. The 
concentration of ternary complex is also dependent on the activity of EF-Ts, the 
guanosine nucleotide exchange factor (GEF) for EF-Tu that is required to convert 
EF-Tu∙GDP released from the ribosome into an EF-Tu∙GTP form that is again 
competent for aa-tRNA binding. Notably, EF-Ts is also present at micromolar 
concentrations in the cell
37,58,100
. EF-Tu has a ~60-fold higher affinity for GDP over 
GTP and a slow rate of spontaneous nucleotide exchange
31
. Correspondingly, EF-Ts 
activity is essential for cellular growth
101,102
 (32, 33) as it regulates ternary complex 
abundance in the cell and consequently the rates of protein synthesis.  
The importance of normal EF-Tu functions to cellular growth is highlighted by the 
prevalence of chemically distinct antibiotics that alter EF-Tu activities
35,103-105
. 
Thiostrepton class peptide antibiotics bind to the large ribosomal subunit GTPase-
activating center to disrupt ternary complex binding to the A site
106
. GE2270A class 
thiazolyl peptide antibiotics bind directly to EF-Tu at the domain 1/2 interface to 
prevent its interaction with aa-tRNA
104
. Kirromycin binds at the domain 1/3 interface 
of EF-Tu to stall ternary complex on actively translating ribosomes
1,3,26,107,108
 
immediately after GTP hydrolysis by preventing conformational changes in EF-Tu 
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required for its release from aa-tRNA. Thus, the dynamics of ternary complex 
formation and stability are critical for cellular viability. However, pre-steady state 
kinetic information regarding the rates of ternary complex formation and decay is 
currently lacking. 
To assess dynamic aspects of the Escherichia coli EF-Tu∙GTP∙aa-tRNA ternary 
complex, here we describe a presteady state, fluorescence-based approach that reports 
on binding between EF-Tu and aa-tRNA. We used this signal to investigate rate-
determining conformational changes that control the high affinity interactions of 
EF-Tu with aa-tRNA. Remarkably, these investigations revealed that the dynamics of 
ternary complex formation and decay are markedly increased in the presence of 
EF-Ts. We conclude that EF-Ts directly interacts with EF-Tu while bound to aa-tRNA 
to regulate its affinity for GTP and aa-tRNA ligands. We speculate that EF-Ts 
regulates the stability and turnover of ternary complex by catalyzing rate-limiting 
conformational processes in the nucleotide binding pocket of EF-Tu that are 
responsible for aa-tRNA binding and release. 
 
 
3.4 RESULTS 
3.4.1. Kinetics of Ternary Complex Formation 
The process of ternary complex formation minimally proceeds through the 
following sequence of biochemical steps
109,110
. 
 
EF-Tu∙GDP  +  EF-Ts  
𝑘1+
↔
𝑘1−
  EF-Tu∙EF-Ts  +  GDP 
REACTION 1 
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EF-Tu∙EF-Ts  +  GTP  
𝑘2+
↔
𝑘2−
  EF-Tu∙GTP  +  EF-Ts 
REACTION 2 
 
EF-Tu∙GTP  +  aa-tRNAaa  
𝑘3+
↔
𝑘3−
  EF-Tu∙GTP∙aa-tRNAaa 
REACTION 3 
Here, Reactions 1 and 2 define the GEF activities of EF-Ts where EF-Ts functions 
to displace GDP from EF-Tu and facilitate the association of EF-Tu with 
GTP
31,93,111,112
. In this minimal reaction scheme, the EF-Tu∙GDP∙EF-Ts complex 
implicit in Reaction 1 exists only transiently (k- = 125 s
-1
)
31
. Likewise, the 
EF-Tu∙GTP∙EF-Ts species implicit in Reaction 2 is also transient in nature 
(k- = 60 s
-1
)
31
. The rates of ternary complex formation and dissociation (Reaction 3 in 
this reaction scheme) have been largely inferred from an array of steady state 
investigations
25,78,92,94,97,98
. Direct presteady state information, however, is currently 
lacking. In particular, little is presently known about how this reaction proceeds in the 
presence of EF-Ts as it natively occurs in the cell.  
 
3.4.2 Steady State Measurements of Ternary Complex Formation  
Following procedures analogous to those previously described using Phe-tRNA
Phe
 
fluorescently labeled at the 4-thiouridine residue at position 8 (s
4
U8)
78
, we first 
attempted to determine the apparent affinity of EF-Tu for Cy3-acp
3
U47-labeled Phe-
tRNA
Phe
 using a steady state approach. Here, the fluorescence intensity of the Cy3 
fluorophore linked to tRNA was tracked as a function of EF-Tu concentration. 
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Titrations were performed by addition of either EF-Tu∙GTP where EF-Tu was 
preincubated with 10 µM GTP or an EF-Tu∙EF-Ts complex (EF-Tu/Ts) to a reaction 
mixture containing 5 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47) and 10 µM GTP at room 
temperature (23°C).  
Under these experimental conditions, both measurements resulted in an EF-Tu-
dependent increase in Cy3 fluorescence intensity that plateaued at ~30% above base 
line (Figure 3.1C). Such changes are speculated to arise from an environment-specific 
increase in Cy3 quantum yield upon ternary complex formation, stemming from 
reductions in solvent-mediated, non-radiative relaxation pathways and/or cis-trans 
isomerization rates
113,114
. Consistent with previous studies
78
 and the determinants of 
ternary complex formation as outlined in Reaction 3, the observed increase in Cy3 
fluorescence intensity was strictly dependent upon the presence of GTP as well as the 
 
 
FIGURE 3.2 EF-Tu is highly active in both the absence and presence of EF-Ts. The fraction of 
active EF-Tu molecules present in our protein preparation was determined by titrating EF-Tu (open 
squares) or EF-Tu/Ts (closed diamonds) into a solution of 400 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47) in the 
presence of 10 µM GTP. Linear fits of the initial and final 10 data points of these two experiments 
intercept at 517 and 496 nM for EF-Tu and EF-Tu/Ts, respectively, indicating that EF-Tu is ~80% 
active in the absence and presence of EF-Ts. 
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acylation of tRNA
Phe
 with the phenylalanine amino acid (Figure 3.1C). The apparent 
dissociation constant for the ternary complex interaction was estimated by fitting the 
raw data to the reaction scheme derived for relative fluorescence measurements (see 
Chapter 2). In agreement with previously described steady state measurements of this 
type, a high affinity interaction was observed both in the absence (KD = 47 ± 3.1 nM) 
and presence of EF-Ts (KD = 12.6 ± 1.1 nM) (Table 3.1)
25,78,92,94,95,115,116
. These 
findings suggest that the observed changes in Cy3 fluorophore intensity specifically 
report on a GTP-dependent interaction of EF-Tu with the acylated acceptor stem of 
Phe-tRNAPhe. They also suggest that EF-Ts substantially increases the apparent 
affinity of this interaction. The observed disparity between EF-Tu and EF-Tu/Ts 
affinities for aa-tRNA could not be explained by differences in EF-Tu activities 
(Figure 3.2). Activity was determined by titrating either EF-Tu or EF-Tu/Ts into a 
solution of 400 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47) and 10 µM GTP. For 100% active 
reagents, a linear increase in signal is expected followed by a sharp inflection at a 
protein concentration equal to the concentration of Phe-tRNA
Phe
 present in the 
reaction
117
. In our experiments, such an inflection was observed at ~500 nM factor, 
indicating that EF-Tu is ~80% active both in the absence and presence of EF-Ts. 
 Analogous steady state measurements were next conducted to assess the 
nucleotide dependence of ternary complex formation. To do so, experiments were 
performed by titrating GTP into a solution of 5 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47) in the 
presence of saturating concentrations of either nucleotide-free EF-Tu or EF- Tu/Ts 
complex both at 500 nM (~10-fold above their apparent KD). For both systems, an 
~30% increase in Cy3 fluorescence intensity was observed at elevated GTP 
concentrations (Figure 3.1D). For the experiments with EF-Tu alone, fitting 
procedures (see Chapter 2) revealed an apparent affinity of KD = 195 ± 12 nM, 
whereas experiments performed with EF-Tu/Ts revealed that the apparent affinity was 
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~3.5-fold weaker (KD = 685 ± 35 nM) (Figure 3.1D). These data suggest that 
additional complexities exist in the ternary complex formation reaction beyond those 
delineated by Reaction 3. Such findings could be explained if ternary complex is in a 
dynamic equilibrium and EF-Ts alters this exchange process by specifically 
modulating the affinity of the nucleotide for EF-Tu.  
This model predicts that the ternary complex formation and thus the observed 
fluorescence intensity change will be sensitive to the precise nature of the EF-Tu∙GTP 
interaction. To examine this hypothesis, identical experiments were repeated with non-
hydrolyzable GTP analogs GDPNP and GTPγS. As anticipated by the model, the 
extent of ternary complex formation was significantly lower in the presence of non-
hydrolyzable GTP analogs (Figure 3.1D and Table 3.1). For each analog, this trend 
was exacerbated in the presence of EF-Ts. These findings suggest that the observed 
fluorescence change reports on conformational events in the system that are sensitive 
to chemical and/or structural features of the γ-phosphate constituent of the nucleotide. 
Inspection of the ternary complex structure (Figure 3.1, A and B) suggests that such 
conformational changes likely entail the formation of contacts between the S1 helix 
and the  γ-phosphate of GTP.  
 
3.4.3 Pre-Steady State Measurements of Ternary Complex Formation 
TABLE 3.1 Dissociation constant of ternary complex. The ternary complex was formed by titrating 
either factor or nucleotide in the absence or presence of EF-Ts. 
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To obtain a deeper understanding of the kinetic parameters underpinning Reaction 
3, we performed pre-steady state measurements to monitor ternary complex formation 
in real time. Data were obtained by rapidly adding saturating (400 nM final) 
concentrations of EF-Tu or EF-Tu/Ts complex to a solution of 5 nM Phe-tRNA
Phe
 
(Cy3-acp
3
U47) and 10 µM GTP. Consistent with our steady state measurements, the 
addition of EF-Tu resulted in a ~30% increase in Cy3 fluorescence intensity that 
reached steady state within seconds (Figure 3.3A) and remained stable over several 
hours (data not shown). Fitting the time course of the fluorescence intensity change to 
an equation for pre-steady state reactions of this kind (see Chapter 2) revealed an 
apparent association rate, kapp,1, of 0.38 s
-1
 for EF-Tu and 0.5 s
-1
 for the EF-Tu/Ts 
complex (Figure 3.3B). The factor concentration-dependence of kapp,1 revealed that the 
maximum rates of ternary complex formation for both systems at 10 µM GTP 
saturated at approximately similar levels: ~0.5 s
-1
 for EF-Tu and 0.55 s
-1
 for the 
EF-Tu/Ts complex.  
Further insights into the on- and off-rate kinetics underpinning ternary complex 
formation and dissociation reactions were obtained by inspecting how kapp,1 changed at 
low factor concentrations where the concentration-dependence is linear. The on-rate of 
the ternary complex formation, determined by setting the slope of kapp,1 to 
kon/(1 + koff/kapp,∞)
79
, revealed that the on-rate in the presence of 10 µM GTP is 
~1.2 ± 0.07 and 1.7 ± 0.1 µM
-1
s
-1
 for EF-Tu and the EF-Tu/Ts complex, respectively 
(Figure 3.3B, inset, and Table 3.2), in close agreement with published values
92
. A 
preliminary estimate of the factor off-rates, defined by the y intercept, revealed that 
EF-Tu dissociates slowly from aa-tRNA (on the order of 0.05 s
-1
). These values are in 
good agreement with both our own (Table1) and previous affinity measurements
95
.  
To directly examine the dissociation kinetics of ternary complex, pre-steady state 
measurements were performed in which a 10-fold molar excess of GDP (100 µM) was  
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FIGURE 3.3 Pre-steady state measurements of ternary complex formation and dissociation: 
dependence on factor concentration. A, the time-dependent response in fluorescence intensity 
observed upon addition of saturating amounts (400 nM) of either EF-Tu (blue) or EF-Tu/Ts (black) 
to  Cy3-labeled  Phe-tRNA
Phe
  (5 nM)  and GTP  (10 µM) or EF-Tu/Ts in the absence of GTP  
(gray). 
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added to ternary complex preformed with 10 µM GTP and a 400 nM concentration of 
either EF-Tu or EF-Tu/Ts. In line with the notion that EF-Tu binds tightly to aa-tRNA, 
the addition of GDP to the preformed ternary complex caused a slow decrease in Cy3 
fluorescence, returning the system to base-line intensity at a rate, kapp,2, of ~0.015 s
-1
 
(Figure 3.3C). This rate was independent of factor (Figure 3.3D) and GTP 
concentrations (Figure 3.3E) and consistent with our off-rate estimates (Figure 3.3B).  
Identical experiments performed with 400 nM EF-Tu/Ts showed a similar overall  
 
 
reduction in fluorescence intensity upon GDP addition but at an ~20-fold faster decay  
rate (kapp,2 ~ 0.3 s
-1
) (Figure 3.3C). Notably, the apparent rate of GDP-induced ternary 
complex dissociation, kapp2, increased linearly as a function of EF-Tu/Ts concentration 
from ~0.03 s
-1
, extrapolated to 0 nM EF-Ts, up to ~0.5 s
-1
 at the highest concentration 
tested (1 µM) (Figure 3.3D). The accelerated rate of GDP-induced ternary complex 
dissociation in the presence of EF-Ts was observed to be independent of GTP 
concentration (Figure 3.3E). Although the concentration of free EF-Ts (not bound to 
EF-Tu) in these experiments is difficult to estimate, it is anticipated to be substantially 
 
Fitting the data (see Chapter 2) provided a quantitative measure of the apparent rate of ternary 
complex formation, kapp,1. A focused plot of the formation process is also shown (inset). B, 
measurements of kapp,1 as a function of either EF-Tu (open diamonds) or EF-Tu/Ts (closed squares). 
The inset shows the linear fits of early factor titration data points. C, the time-dependent response in 
fluorescence intensity observed upon addition of saturating amounts of GDP (100 µM) to ternary 
complex preformed as described in A with either EF-Tu (blue) or EF-Tu/Ts (black). Identical 
experiments were performed using ADP (100 µM) (grey). D, fitting to a single exponential function 
provided a quantitative measure of the off-rate of ternary complex formation, kapp,2, as a function of 
either EF-Tu (open diamonds) or EF-Tu/Ts (closed squares) as described in C. E, similar 
disassociation experiments were performed at varying GTP concentrations. Addition of saturating 
GDP to ternary complex preformed with an excess of EF-Tu (open diamonds) or EF-Tu/Ts (closed 
squares) and 5 nM Phe-tRNA
Phe
 in the presence of GTP (50 nM – 500 µM). Apparent decay rates, 
kapp,2, were estimated by fitting to a single exponential function. F, GDP (100 µM) was delivered to 
ternary complex preformed with EF-Tu/Ts in the absence (black) or presence (tan) kirromycin. The 
rate of GDP mediated dissociation in the absence of kirromycin (kapp,2 = 0.28 s
-1
) was found to be 14 
times faster than in the presence of kirromycin (kapp,2 = 0.002 s
-1
). Error bars represent the S.E. from 
three independent experiments. 
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lower than EF-Tu/Ts concentration given the known KD of the EF-Tu/Ts interaction 
(3 nM)
31
. We conclude that EF-Ts plays a direct role in ternary complex dissociation 
in the presence of GDP and that the recognition process occurs at a rate that is likely to 
significantly exceed 1.5 µM
-1
s
-1
 (determined from the slope of the line shown in 
Figure 3.3D, inset).  
To examine the physical basis of the observed dissociation reaction coordinate, 
identical experiments were performed in the presence of kirromycin, an antibiotic that 
directly binds EF-Tu at the interface between domains 1 and 3
29
. As anticipated from 
its known propensity to prevent EF-Tu dissociation from aa-tRNA
3,107,108
, in the 
presence of kirromycin, ternary complex was observed to be strongly resistant to 
GDP-induced dissociation even in the presence of EF-Ts (Figure 3.3F). This finding is 
FIGURE 3.4 EF-Ts accelerates the rate-determining step in EF-Tu binding to aa-tRNA.  Ternary 
complex was formed by rapid mixing of 200 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47) with EF-Tu or EF-Tu/Ts 
preincubated in the presence of 1 mM GTP. Time courses of complex formation were fit to a single 
exponential function, and apparent rates were plotted as a function of EF-Tu (open diamonds) or 
EF-Tu/Ts (closed squares) concentration. Under these conditions, the apparent rate of complex formation 
observed asymptotically approached ~20 s
-1
 for EF-Tu and ~80 s
-1
 for EF-Tu/Ts. Error bars represent the 
S.E. 
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consistent with a model in which the dissociation of EF-Tu from aa-tRNA proceeds 
via rearrangements at the interface between domains 1 and 3 of EF-Tu.  
To address the physiological relevance of these findings, we performed pre-steady 
state measurements of ternary complex formation at near cellular concentrations of  
protein factors (0.2–15 µM), aa-tRNA (0.2 µM), and GTP (1 mM) using stopped-flow 
instrumentation. Here, EF-Tu and EF-Tu/Ts were pre-incubated with GTP. As shown 
previously (Figure 3.3), the signal obtained was strictly dependent on the aminoacyl 
moiety of Phe-tRNA
Phe
 and GTP (data not shown). At these concentrations, the 
apparent rate of ternary complex formation for EF-Tu alone plateaued at a rate of 
FIGURE 3.5 Physical isolation of ternary complex. Ternary complex formed in the presence of saturating 
concentrations of EF-Tu (circles) or EF-Tu/Ts (diamonds), Cy3-labeled Phe-tRNA
Phe
, and GTP (see 
Chapter 2) was fractionated over a Superdex75 gel filtration column in the presence (black) or absence (red) 
of GTP (10 µM) in the running buffer. Absorbance was recorded at 260 and 550 nm to specifically track the 
elution times of “unbound” and ternary complex-bound Cy3-labeled Phe-tRNAPhe as indicated. This was 
repeated with GDPNP in the reaction and running buffer (blue triangles). 
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~20 s
-1
 (Figure 3.4), whereas in the presence of EF-Ts, the rate of ternary complex 
formation increased to ~85 s
-1
. These distinct asymptotic values suggest that EF-Ts 
accelerates the rate-determining step of ternary complex formation by directly 
facilitating the process of EF-Tu∙GTP loading onto Phe-tRNAPhe. Under these 
conditions, ternary complex dissociation was also observed to be accelerated by the 
presence of EF-Ts (Figure 3.3D). These findings suggest that our findings are relevant 
to ternary complex dynamics as they occur in the cell.  
 
 
3.4.4. Physical Isolation of the Dynamic Ternary Complex 
To directly test the hypothesis that ternary complex formation and decay are in 
dynamic equilibrium, we set out to examine its stability by gel filtration 
chromatography. Here, a strong prediction of the dynamic equilibrium model is that 
ternary complex will dissociate when efficiently separated from GTP. For these 
experiments, a single solution of ternary complex was prepared using saturating 
concentrations of GTP, EF-Tu (or EF-Tu/Ts), and Phe-tRNA
Phe
 (Cy3-acp
3
U47) (10, 
12, and 3 µM, respectively). Portions of this reaction were subjected to gel filtration 
experiments first in the absence and then in the presence of GTP in the running buffer 
while monitoring the elution time of Cy3-labeled Phe-tRNA
Phe
 by UV absorbance at 
550 nm (see “Chapter 2”).  
TABLE 3.2 Summary of kinetic parameters of ternary complex. Kinetic descriptors of ternary 
complex were determined from the apparent rates of ternary complex formation at 10 µM GTP. 
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Both in the absence and presence of EF-Ts, detection of the Cy3-labeled Phe-
tRNAPhe ternary complex, eluting at the predicted molecular mass of ~75,000 Da, 
was maximized when GTP was included in the running buffer (Figure 3.5). Consistent 
with the highly active nature of the components used in our investigations, ~90% of 
Cy3-labeled Phe-tRNA
Phe
 was found in a ternary complex under these conditions. 
When GTP was not included in the mobile phase, the amount of tRNA detected in 
ternary complex was significantly reduced in the absence of EF-Ts and completely 
FIGURE 3.6 EF-Ts directly facilitates ternary complex turnover.  Region I, the relative fluorescence 
intensities of Cy3 (green; right axis) and mant (black; left axis) obtained from a solution containing 
400 nM Phe-tRNA
Phe
 (unlabeled), 5 nM Phe-tRNA
Phe
 (Cy3-acp
3
U47), and 10 µM GTPmant in the absence 
of factor. Region II, the increase in mant fluorescence intensity (black; left axis) and Cy3 fluorescence 
intensity (green; right axis) resulting from addition of 400 nM EF-Tu/Ts to the mixture. Region III, 
addition of saturating amounts of unlabeled GTP (100 µM) resulted in a rapid decrease 
(kturnover = 0.6 ± 0.03 s
-1
) in the mant signal (black; left axis), whereas the Cy3 signal (green; right axis) 
exhibited a small increase in intensity. 
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abolished in the presence of EF-Ts. Analogous experiments conducted with 10 µM 
GDPNP in the mobile phase showed only ~5% of the total tRNA in ternary complex 
(Figure 3.5). These findings provide compelling evidence in support of the dynamic 
nature of ternary complex. They also support a model in which ternary complex 
dissociation proceeds through sequential conformational events in EF-Tu that first 
enable GTP dissociation and then aa-tRNA release. 
 
3.4.5. Direct Evidence That EF-Ts Facilitates Ternary Complex Dynamics 
Our previous data indicate that EF-Ts accelerates the disassembly of ternary 
complex upon GDP addition. To differentiate between a model where EF-Ts only 
breaks down ternary complex in response to GDP addition or where EF-Ts is 
continually facilitating ternary complex formation and decay, we set out to directly 
monitor the nucleotide exchange process on EF-Tu using the fluorescent GTP analog 
(10 µM) GTPmant under conditions where ternary complex appears to be stable for 
extended periods (as seen in Fig. 3A). To ensure that the majority of EF-Tu is bound to 
aa-tRNA at steady state, ternary complex was formed at component concentrations 
~10-fold the apparent KD (400 nM EF-Tu or EF-Tu/Ts, 400 nM Phe-tRNA
Phe
, 5 nM 
Phe-tRNA
Phe
 (Cy3-acp
3
U47) (Figure 3.2 and see “Chapter 2”). This experimental 
setup allowed us to monitor ternary complex formation by two distinct spectroscopic 
means in the same experiment: a change in Cy3 fluorescence intensity (Figure 3.1, 3.3, 
and 3.4) and FRET between tryptophan 184 in EF-Tu and the mant moiety of the 
GTPmant nucleotide
31
. As expected for a reaction in which the GTPmant nucleotide binds 
to EF-Tu, addition of the EF-Tu/Ts complex to Phe-tRNA
Phe
 and GTPmant resulted in a 
rapid increase in GTPmant fluorescence intensity (Figure 3.6, region II). Consistent 
with ternary complex formation, Cy3 fluorescence intensity also increased during this 
reaction.  
92 
 
To directly monitor the process of nucleotide exchange, a 10-fold molar excess of 
unlabeled GTP was added to the same reaction while monitoring GTPmant fluorescence 
(Figure 3.6, region III). Here, the GTPmant signal rapidly returned to base line (kturnover 
~0.6 ± 0.03 s
-1
; Tale 2), whereas examination of the Cy3 fluorescence intensity 
showed that ternary complex remained intact (Figure 3.6, region III). A slight increase 
in Cy3 fluorescence was also observed, likely reflecting a subtle change in ternary 
complex stability in the presence of unlabeled GTP. In similar experiments using only 
EF-Tu, the rate of the GTPmant exchange was greatly reduced 
(kturnover =  ~0.005 ± 4∙10
-5
 s
-1
). These experiments demonstrate that the EF-Ts 
activities observed are not in response to an insult (such as GDP) but are instead 
actively occurring in the presence of GTP where ternary complex appears stable. 
Inclusion of kirromycin in the experiment effectively blocked the GTPmant nucleotide 
exchange process. This finding suggests that rearrangements at the interface of 
domains 1 and 3 of EF-Tu are required for the exchange process.  
 
 
3.5 DISCUSSION 
In the present investigation, we developed a means to explore the kinetic and 
thermodynamic properties of the E. coli ternary complex EF-Tu∙GTP∙Phe-tRNAPhe 
using bulk fluorescence methods. Akin to earlier steady state measurements of ternary 
complex formation
78
, the fluorescence-based assays described here are based on 
changes in relative fluorescence intensity. However, unlike earlier work, the approach 
we describe is based on the environmentally sensitive Cy3 fluorophore
40,82
 at a distinct 
site of tRNA attachment, the naturally occurring modified nucleotide acp
3
U present at 
position 47 in E. coli tRNA
Phe
. Although this modification is not as ubiquitous as the 
s
4
U residue utilized previously, tRNA molecules modified at this site have been shown 
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to be fully functional in all aspects of the translation process, including 
aminoacylation, tRNA selection, and translocation
40,53,118
. The data presented show 
that the functionality of acp
3
U-labeled tRNA
Phe
 also extends to ternary complex 
formation. In agreement with prior fluorescence investigations of ternary complex 
formation obtained under steady state conditions
78
, we show that the formation of 
ternary complex strictly depends on the GTP nucleotide and the aminoacyl moiety of 
aa-tRNA. We also show that the EF-Tu∙GTP∙Phe-tRNAPhe complex forms a high 
affinity (nM KD) interaction (Figure 3.1C)
25,92,94,95,97,98
.  
Unexpectedly, however, we observed that the apparent affinity of ternary complex 
formation is significantly enhanced in the presence of EF-Ts, the GEF for EF-Tu 
(KD ~12 versus ~47 nM; Table 3.1). These findings could not be rationalized based on 
trivial differences in EF-Tu activities in the absence and presence of EF-Ts (e.g. that 
80% of the EF-Tu preparation was bound to GDP; Figure 3.2). Moreover, the 
propensity of EF-Ts to decrease the efficiency with which ternary complex was 
formed in the presence of non-hydrolyzable GTP analogs also suggested an 
unanticipated function of EF-Ts as a fidelity determinant of ternary complex formation 
and stability (Figure 3.1D). In striking contrast to contemporary models in which 
EF-Ts serves only as the GEF for EF-Tu
109,119
, these findings collectively led us to 
examine whether EF-Ts functions to regulate ternary complex stability in a direct 
manner through modulation of the nucleotide binding site.  
In line with previous investigations using yeast components
120
, pre-steady state 
measurements obtained under conditions designed to approximate the cellular 
concentrations of aa-tRNA, GTP, and EF-Tu suggested that the bacterial ternary 
complex forms via a rate-limiting conformational event in EF-Tu that occurs at a rate 
of ~20 s
-1
. However, in the presence of cellular concentrations of EF-Ts, ternary 
complex formation was observed to proceed at a rate 4 times faster (~85 s
-1
) (Figure 
94 
 
3.4). As the fluorescence signal detected here depends exquisitely on the presence of 
the aminoacyl moiety and the nature of the γ-phosphate of the GTP nucleotide, this 
conformational change likely reports on the ordering of S1, S2, and P loop elements in 
the G domain of EF-Tu, the structural scaffold of the nucleotide binding pocket 
(Figure 3.1, A and B).  
A trivial explanation for the observed disparity in rates would be that EF-Ts drives 
ternary complex formation by accelerating nucleotide loading (Reactions 1 and 2). 
However, in this case, the apparent rates of ternary complex formation would 
FIGURE 3.7 Ternary complex formation and disassembly can occur via two distinct pathways. In both 
pathways, the binary complex EF-Tu/Ts binds GTP, forming an EF-Tu∙GTP∙EF-Ts complex. In Path 1, 
this species directly binds aa-tRNA, forming a quaternary complex of EF-Tu∙GTP∙EF-Ts∙aa-tRNA, 
which decays to the EF-Tu∙GTP∙aa-tRNA ternary complex following EF-Ts dissociation. In Path 2, EF-
Ts dissociates from the EF-Tu∙GTP∙EF-Ts complex, allowing EF-Tu∙GTP to bind aa-tRNA directly to 
form ternary complex. 
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eventually plateau at the same maximum value (~85 s
-1
). Instead, two distinct 
maximum rates were observed. Moreover, these experiments were performed 
following preincubation of EF-Tu and the EF-Tu/Ts complex with saturating 
concentrations of GTP (1 mM). We conclude that EF-Ts directly facilitates ternary 
complex formation by accelerating EF-Tu∙GTP loading onto aa-tRNA. Indeed, direct 
interactions between EF-Ts and ternary complex have been suggested 
previously
93,121,122
. Such insights suggest that the established model of ternary 
complex formation (Reactions 1–3 above) needs revision. Thus, although the direct 
binding of EF-Tu∙GTP to aa-tRNA is feasible (Reaction 3)4,24,57,92,94,95,119, our findings 
suggest that the kinetically favored pathway for ternary complex formation proceeds 
via the direct binding of an EFTu∙GTP∙EF-Ts complex to aa-tRNA (Figure 3.7).  
Although previous investigations have shown that the EF-Tu∙GTP∙EF-Ts complex 
is labile, dissociating at a rate of 60 s
-1
 
31
, at cellular concentrations of EF-Ts 
(~10 µM)
37,58,100
, the rate of EF-Ts rebinding to EF-Tu∙GTP is estimated to be on the 
order of 300 s
-1
 
31
. These considerations predict that the EF-Tu∙GTP∙EF-Ts complex 
may be relatively abundant in the cell. Based on these insights, we conclude that EF-
Ts directly facilitates ternary complex formation and disassembly by lowering the 
effective activation barrier for a rate-determining conformational change in EF-Tu that 
is required for the protein to fully engage aa-tRNA and GTP ligands (Figure 3.7). Our 
nucleotide binding studies suggest that ordering of the switch-1 helix in EF-Tu plays a 
critical role in this process (Figure 3.1D). We speculate that EF-Ts influences the 
folding of the switch-1 helix in a manner that modulates this commitment step. Further 
experiments will be required to delineate precisely how EF-Ts impacts the reaction 
coordinate for ternary complex formation and disassembly.  
These previously unanticipated functions of EF-Ts may provide several 
advantages to the cell. First, the observed capacity to increase the rate of ternary 
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complex formation may increase the maximum rate of translation that can be achieved 
in the cell. Second, under steady state conditions, the capacity of EF-Ts to facilitate 
nucleotide turnover may allow a means of translational control under changing cellular 
conditions. For instance, under conditions of rapid growth where the concentration of 
FIGURE 3.8 Hypothetical EF-Tu∙GTP∙EF-Ts∙Phe-tRNAPhe quaternary complex. A, a top-down 
perspective of the EF-Tu∙GTP∙Phe-tRNAPhe ternary complex (Protein Data Bank code 1OB2) showing 
EF-Tu (blue) bound to Phe-tRNA
Phe
 (wheat) and GDPNP (green spheres). Here, the center panel shows 
an extended conformation (purple) of EF-Tu as it is observed in E. coli EF-Tu/Ts crystal structure 
(Protein Data Bank code 1EFU) where domains 2 and 3 of both EF-Tu structures are superimposed (N, 
Cα, CO, O root mean square deviation is 0.886Å). The right panel highlights the position of EF-Ts (red) 
in a quaternary complex if its interactions with EF-Tu are identical to those observed in E. coli EF-Tu/Ts 
crystal structure. This model reveals only minor steric clashes between EF-Ts and the D-stem of the 
aa-tRNA. The blue arrow indicates the hypothesized motions of the G domain of EF-Tu during ternary 
complex formation and decay. B, identical structures as in A from the perspective of looking down the 
axis of the tRNA acceptor stem. Structures were analyzed and rendered in PyMOL. 
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GTP (900 µM) is in great excess over GDP (100 µM), EF-Ts ensures that ternary 
complex is abundant. However, during stress where the GTP/GDP ratio drops, EF-Ts 
may enable an energy-neutral means of lowering the cellular concentrations of ternary 
complex and thus the rate of translation. The inferred capacity of EF-Ts to directly act 
on the EF-Tu∙GDP∙aa-tRNA complex also has potentially important implications for 
the mechanism of translation. Indeed, an EF-Tu∙GDP∙aa-tRNA complex is formed on 
the ribosome during every step of the elongation cycle of protein synthesis. Therefore, 
during active growth, the concentration of EF-Tu∙GDP∙aa-tRNA approaches the 
concentration of ribosomes in the cell (~10 µM). Notably, the concentrations of EF-Ts 
and ribosomes have been shown to exhibit a 1:1 stoichiometry over a range of cellular 
conditions
37,58,100
. To our knowledge, the kinetic impact of EF-Ts on the rates and 
fidelities of aa-tRNA selection have yet to be explored. However, experiments 
performed in the absence of EF-Ts suggest that the departure of EF-Tu∙GDP from the 
ribosome is rate-determining for the process (~2–4 s-1)4,24.  
The structure of the EF-Tu∙GTP∙EF-Ts complex is not presently known but has is 
speculated to adopt a conformation that is distinct from EF-Tu∙GTP, EF-Tu∙GDP, and 
the EF-Tu/Ts complex
31
. Structural modeling suggests that an EF-Tu∙GTP∙EF-Ts 
complex would be sterically permitted to bind the acceptor stem of aa-tRNA if it 
adopts a conformation that is globally similar to that of the EF-Tu∙EF-Ts complex 
(Figure 3.8). Functional investigations of the Qβ replicase, an RNA-dependent RNA 
polymerase that contains an EF-Tu/Ts complex, are consistent with this model as the 
template recognition in this system has been attributed to the direct binding of the 
EF-Tu/Ts component of Qβ replicase to a primer region that contains a single-stranded 
3′-CCA overhang123. We therefore speculate that initial interactions between the 
EF-Tu∙GTP∙EF-Ts and aa-tRNA may occur in a manner akin to what is observed for 
Qβ replicase and more recently for archaeal translation initiation factor-2124 wherein 
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domains 1 and 2 of EF-Tu bind the 3′-CCA end of aa-tRNA. Alternatively, initial 
interactions could occur via the direct binding of domains 2 and 3 of EF-Tu in 
complex with EF-Ts to the acceptor stem helix (Figure 3.8). Irrespective of these 
considerations, we propose that the rate-determining conformational change in EF-Tu 
that gives rise to the high affinity ternary complex interaction is initiated with the 
compaction of the G domain onto domains 2 and 3 and the aa-tRNA acceptor stem. 
This conformational change would terminate with the formation of the interaction 
network linking the amino acid to the switch domains of EF-Tu and the γ-phosphate of 
GTP followed by the release of EF-Ts (Figures 3.1 and 3.8).  
In direct support of a model in which EF-Ts can physically associate with EF-Tu 
while it is bound to aa-tRNA, we found that EF-Ts actively dissociates ternary 
complex in the presence of GDP (Figure 3.3, C and D). Ternary complex dissociation 
was inhibited by kirromycin (Figure 3.3F), suggesting that the dissociation pathway 
likely entails reorganization of the interface of domains 1, 2, and 3 in EF-Tu prior to 
EF-Tu release in a manner that mirrors the association pathway.  
Importantly, precedence for direct interactions between GEFs and activated G-
proteins exists in signal transduction cascades involving other small G-proteins that 
are regulatory in nature. In yeast, the GEF Scd1 chaperones its activated G-protein, 
Cdc42, to its effector Shk1 via interactions with Scd2
125
. GEFs for the monomeric G-
protein Ral, RalGDS and Rlf, interact with the GTP-bound state of upstream G-
proteins Ras and Rap through Ras association domains
13,126
. Effector-bound 
conformational changes of G-proteins have also been described previously. For 
instance, the monomeric G-protein Ras has been shown to bind to its effector protein 
Raf in a two-step process termed “dynamic triggering”127. NMR studies have revealed 
that switch-1 of Ras-GDPNP is dynamic, exhibiting at least two conformations in the 
Raf-bound state
127,128
. Thus, the findings presented here likely reflect a more general 
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capacity of GEFs to facilitate G-protein loading onto their effector substrates. In 
addition to accelerating signaling processes, such interactions may also serve to 
influence the choice of downstream effectors. Future experiments testing these 
hypotheses are warranted and will need to be explored using approaches that are 
amenable to probing the complexity and range of dynamics that are likely to be found.  
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CHAPTER 4 
4.1 OVERVIEW 
The data and figures presented in this chapter have been previously published in 
modified form: 
 
Burnett BJ
a
, Altman RB
b
, Ferguson A
b
, Wasserman MR
b
, Zhou Z
b
, Blanchard SC
c
. 
“Direct Evidence of Elongation Factor-Tu/Ts∙GTP∙Aminoacyl-tRNA Quaternary 
Complex” Journal of Biological Chemistry. 2014 289:23917-23927129. 
 
a
Burnett BJ designed and conducted all experiments solely, or in conjunction with 
other authors. 
b
Authors conducted experiments in conjunction with Burnett BJ. 
c
Corresponding author, designed experiments in conjunction with Burnett BJ. 
 
 
 
 
4.2 SUMMARY 
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During protein synthesis, elongation factor-Tu (EF-Tu) bound to GTP chaperones 
the entry of aminoacyl-tRNA (aa-tRNA) into actively translating ribosomes. In so 
doing, EF-Tu increases the rate and fidelity of the translation mechanism. Recent 
evidence suggests that EF-Ts, the guanosine nucleotide exchange factor for EF-Tu,  
directly accelerates both the formation and dissociation of the 
EF-Tu∙GTP∙Phe-tRNAPhe ternary complex83. A central feature of this model is the 
existence of a quaternary complex of EF-Tu/Ts∙GTP∙aa-tRNAaa. Here, through 
comparative investigations of phenylalanyl, methionyl, and arginyl ternary complexes, 
and the development of a strategy to monitor their formation and decay using 
fluorescence resonance energy transfer, we reveal the generality of this newly 
described EF-Ts function and the first direct evidence of the transient quaternary 
complex species. These findings suggest that EF-Ts may regulate ternary complex 
abundance in the cell through mechanisms that are distinct from its guanosine 
nucleotide exchange factor functions.   
 
 
4.3 INTRODUCTION 
Guanosine nucleotide-binding proteins (G-proteins) regulate a diverse range of 
essential cellular processes in all three kingdoms of life, including the universally 
conserved and energy- intensive process of protein synthesis. Elongation factor Tu 
(EF-Tu) in bacteria and elongation factor 1A (eEF1A) in eukaryotes are conserved 
members of the TRAFAC (translation factor) class of G-proteins comprising three 
globular domains (I–III). Both proteins play a critical role in translation by 
chaperoning messenger RNA (mRNA) codon-dependent incorporation of aminoacyl-
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tRNA (aa-tRNA) into the aminoacyl (A) site of the two-subunit ribosome during the 
substrate selection step of the elongation cycle
9,14,15,84,86
.  
EF-Tu, through its capacity to form a ternary complex with aa-tRNA in the 
presence of guanosine triphosphate (GTP) (EFTu∙GTP∙aa-tRNA), increases both the 
rate and fidelity of aa-tRNA selection on the ribosome
53,78,92,130
 (see Figure 4.1A). 
EF-Tu simultaneously promotes ribosome binding and couples the aa-tRNA selection 
mechanism to irreversible GTP hydrolysis
1
. Following the release of inorganic 
phosphate
3
, aa-tRNA dissociates from EF-Tu∙guanosine diphosphate (GDP) to enter 
the ribosome where it undergoes irreversible peptide bond formation
4,24
.  
The rates of protein synthesis and cellular growth critically depend on and are 
highly correlated with the availability of the complete complement of ternary complex 
species needed to translate the mRNA open reading frame
35,50,58,131,132
. In Escherichia 
coli, there are ~86 genes encoding for elongator tRNAs that exhibit a range of 
expression levels
132-134
. Depending on the species, organism, and cellular growth rate, 
the total tRNA concentration in the cell ranges from 100 µM to 1 mM
135
. Although a 
component of these fluctuations likely relates to the proximity of each gene to the 
origin of replication as postulated for ribosomal RNA
133,136
, changes in tRNA gene 
expression also reflect regulatory cues
134
.  
Ternary complex levels also depend on the extent to which tRNAs are 
aminoacylated, which is a prerequisite for EF-Tu∙GTP binding78,137. Direct 
measurements suggest that ~80% of expressed tRNAs are charged during logarithmic 
growth in nutrient-rich conditions
138,139
. Under nutrient poor conditions, however, 
where amino acid reserves become limiting, this level drops substantially
139,140
. Such 
103 
 
conditions may ultimately trigger the stringent response leading to the down-
regulation of the translational machinery
139
.  
The abundance of distinct ternary complex species is also dictated by the affinity 
of EF-Tu for each aa-tRNA. EF-Tu exhibits tRNA-specific dissociation constants 
ranging from a few nanomolar to a few hundred nanomolar
92,141,142
. A substantial 
proportion of the overall binding energy between EF-Tu∙GTP and aa-tRNA arises 
from contacts between the aminoacyl moiety of tRNA and the amino acid binding 
pocket formed at the interface of domains I and II of EF-Tu
57,88,95
 (see Figure 4.1B). In 
the case of the phenylalanyl-tRNA
Phe
 ternary complex (Phe-TC), the aromatic ring of 
the 2′-linked phenylalanyl moiety has been shown to directly interact with the 
conserved histidine 66 (His-66) residue of EF-Tu. The switch regions of EF-Tu (S1 
and S2), which are present in all G-proteins and facilitate nucleotide interactions, help 
position His-66, thereby enabling EF-Tu to read out the aminoacyl state of the tRNA 
molecule in a manner that depends on the phosphorylation state of the guanosine 
nucleotide
89,95
 (see Figure 4.1B).  
The distinct chemical and physical properties of each amino acid predict 
significant differences in EF-Tu binding affinity to distinct tRNA species
57,95
. These 
disparities are thought to be dampened by a thermodynamic compensation mechanism 
based on unique EF-Tu interactions with sequence determinants in the tRNA acceptor 
stem and T-loop (Figure 4.1C) that result in a relatively uniform EF-Tu∙GTP affinity 
for each aa-tRNA species
141,143,144
. In this model, the tRNA species bearing an 
aminoacyl moiety that contributes strongly to the free energy of ternary complex 
affinity have tRNA bodies that bind weakly to EF-Tu. Conversely, tRNAs bearing 
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aminoacyl moieties that contribute relatively little to the free energy of ternary 
complex formation bind strongly to EF-Tu
57,144
. Taken together with structural and 
kinetic evidence that EF-Tu undergoes large scale conformational changes during aa-
tRNA binding and release
89-91
, this model posits a degree of coupling between these 
two distinct determinants of EF-Tu affinity. Under steady-state, logarithmic growth 
conditions where aa-tRNA, EF-Tu, and GTP are at high concentrations, the vast 
majority of aa-tRNAs are bound to EF-Tu∙GTP in ternary complex96. At growth 
saturation or under nutrient-limited conditions, however, where the effective aa-tRNA 
concentrations are reduced, lower affinity species shift away from the 
EF-Tu∙GTP-bound state, reducing their cellular concentrations.  
Finally, the total ternary complex concentration in the cell is proportional to the 
concentration of GTP and the activated EF-Tu∙GTP pool. The concentration of this 
latter complex in turn depends on the function of elongation factor Ts (EF-Ts), the 
guanosine nucleotide exchange factor for EF-Tu. The guanosine nucleotide exchange 
factor functions of EF-Ts facilitate the conversion of EF-Tu∙GDP to EF-Tu∙GTP 
following each round of tRNA selection. Given that the amount of EF-Tu∙GDP is 
proportional to the concentration of ribosomes in the cell (10–100 µM) and the rate of 
protein synthesis (approximately 2–20 amino acids polymerized per second), high 
concentrations of EF-Ts promote a rapid rate of cell growth
36
. In E. coli, the 
concentration of EF-Ts is tightly coupled with ribosome biogenesis and thus the 
ribosome concentration
36,58,100,145-148
. Hence, a stoichiometry of EF-Tu/Ts∙GDP in the 
cell that approaches 1:1 with ribosomes would facilitate prompt nucleotide exchange 
on EF-Tu and the maintenance of the highest concentration of EF-Tu∙GTP possible.  
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Our recent efforts, which established a kinetic framework for examining ternary 
complex stability using fluorescence-based methods
83
, provided evidence that EF-Ts 
directly regulates conformational changes in EF-Tu that facilitate the formation and 
disassembly of the Phe-TC. These observations suggested that EF-Ts has a capacity to 
directly regulate ternary complex concentration via the formation of an 
EF-Tu/Ts∙GTP∙aa-tRNA quaternary complex83. Here, we directly examined whether 
such findings are general in nature by measuring the impact of EF-Ts on the kinetic 
properties of distinct ternary complex species that exhibit distinct apparent KD 
values
141
. These investigations, combined with fluorescence resonance energy transfer 
(FRET) methods that facilitated the direct monitoring of EF-Tu/Ts interactions, 
yielded a general kinetic framework that explains how EF-Ts may influence the 
thermodynamic compensation model underpinning ternary complex stability, why 
quaternary complex has escaped detection previously, and how cellular interactions 
between EF-Ts and ternary complex can influence the regulation of protein synthesis 
in the cell.  
 
 
4.4 RESULTS 
4.4.1 EF-Tu Binds Distinct aa-tRNAs with High Affinity 
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To monitor ternary complex formation, we used a steady-state, fluorescence- 
based approach that yields an increase in relative intensity of Cy3 fluorescence when 
EF-Tu binds to site-specifically labeled aa-tRNA
83
. We measured the apparent affinity 
of highly purified, nucleotide-free EF-Tu or an EF-Tu/Ts complex for three distinct 
elongator tRNA species, each containing the same acp3U post-transcriptional 
modification at position 47 used for Cy3 labeling: Phe-tRNA
Phe
, Met-tRNA
Met
, and 
Arg-tRNA
Arg
. For these experiments, EF-Tu and EF-Tu/Ts were preincubated with an 
excess of GTP (10 µM) to ensure complex formation (see Chapter 2). In each case, 
EF-Tu∙GTP or EF-Tu/Ts∙GTP was titrated into a 1.5-ml reaction containing 5 nM 
aa-tRNA (Cy3-acp
3
U) and 10 µM GTP (Chapter 2). As anticipated from previous 
studies on Phe-tRNA
Phe
 (Cy3-acp
3
U47) (1), each aa-tRNA species exhibited a marked 
FIGURE 4.1. EF-Tu binds ternary complex with nanomolar affinity. Titration of EF-Tu∙GTP (A) or EF-
Tu/Ts∙GTP (B) into a solution of Cy3-labeled Phe-tRNAPhe (solid triangles), Met-tRNAMet (solid squares), or 
Arg-tRNAArg (solid circles) in the presence of 10 µM GTP. The apparent dissociation constant (KD) for each 
tRNA species was estimated by fitting (see Methods). Identical experiments performed in the absence of GTP or 
the tRNA synthetase (open symbols). Error bars represent the S. D. of three separate experiments. 
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increase in Cy3 relative fluorescence as a function of increasing factor concentration 
(Figure 4.2). Under the current experimental conditions (Chapter 2), Cy3 fluorescence 
increased 32, 45, and 30% for Phe-tRNA
Phe
, Met-tRNA
Met
, and Arg-tRNA
Arg
, 
respectively. As expected, no change in fluorescence intensity was observed when 
identical experiments were performed either in the absence of GTP or when the tRNA 
was not aminoacylated. To provide an estimate of the affinity of each factor for aa-
tRNA from these experiments, each titration was fit to an equation for a bimolecular 
interaction
83
. As expected from prior investigations
78,141
, all three aa-tRNA species 
exhibited an apparent KD in the nanomolar range both in the presence and absence of 
EF-Ts (Figure 4.2 and Table 4.1). The lowest apparent KD was for Phe-tRNA
Phe
 
(6 nM), whereas Arg-tRNA
Arg
 was the highest (22 nM) (Table 4.1). Compared with 
FIGURE 4.2 EF-Ts directly facilitates ternary complex formation. The estimated rate of ternary complex 
formation (kapp,1) measured by a change in fluorescence intensity upon stopped-flow delivery of 5 µM 
EF-Tu∙GTP (open bars) or 5 µM EF-Tu/Ts (solid bars) to 100 nM Cy3-labeled Phe-tRNAPhe, Arg-tRNAArg, or 
Met-tRNAMet. Error bars represent the S.D. of three separate experiments. 
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the relatively large impact on Phe-TC affinity (a 3-fold increase) in the presence of 
EF-Ts
83
, the apparent KD values of Met-tRNA
Met
 and Arg-tRNA
Arg
 were only 
modestly affected (approximately ~20–30%; Table 4.1).  
 
4.4.2 EF-Ts Accelerates the Rate of Ternary Complex Formation 
To delineate the kinetic features governing ternary complex formation, pre-steady-
state, rapid mixing experiments were performed using the same Cy3-labeled 
Phe-tRNA
Phe
, Met-tRNA
Met
, and Arg-tRNA
Arg
 reagents under conditions estimating 
the physiological concentrations of each component (5 µM factor, 1 mM GTP, and 
100 nM aa-tRNA). Purified EF-Tu and EF-Tu/Ts complex were pre-incubated with 
saturating concentrations of GTP (1 mM) to ensure complete nucleotide binding. For 
all three aa-tRNAs, the apparent rate of ternary complex formation using EF-Tu was 
between ~8 and ~14 s
-1
 (Fig. 4.3, open bars). Identical experiments conducted using 
FIGURE 4.3 EF-Ts accelerates ternary complex decay in response to GDP. A, addition of a 10-fold molar excess 
of GDP to Arg-TC (blue) or Met-TC (black) preformed with EF-Tu (light colored curves) or EF-Tu/Ts (dark 
colored curves) in the presence of 10 µM GTP. B, the apparent rate of ternary complex dissociation (kapp,2) was 
estimated by fitting each decay process to a single exponential function. The relationship between kapp,2 and the 
concentration of EF-Tu (open symbols) or EF-Tu/Ts (solid symbols) is shown for both Met-TC (squares) and 
Arg-TC (circles). Error bars represent the S.D. of three separate experiments. For comparison, kapp,2 (acquired 
previously) is shown for Phe-TC (red triangles)). 
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the EF-Tu/Ts complex resulted in an increase in the apparent rate of ternary complex 
formation for each tRNA species to ~40 to ~70 s
-1
 (Figure 4.3, solid bars). As 
suggested for Phe-TC formation, these data argue that EF-Ts also facilitates rate-
determining conformational events in EF-Tu that are required for nucleotide-
dependent binding to both Met-tRNA
Met
 and Arg-tRNA
Arg
.  
 
4.4.3 EF-Ts Facilitates Ternary Complex Dissociation in the Presence of GDP 
To examine whether EF-Ts influences the dissociation pathways of these two 
distinct ternary complex species as has been demonstrated for the Phe-TC, we 
performed GDP chase experiments on Met-TC and Arg-TC preformed with either EF-
Tu or EF-Tu/Ts. As noted previously, a hallmark kinetic signature of the 
EF-Tu/Ts∙GTP∙aa-tRNA quaternary complex is the factor concentration dependence 
of the ternary complex dissociation rate in the presence of GDP. In such experiments, 
ternary complex is formed by adding 0.4 µM factor (preincubated with 10 µM GTP) 
to 5 nM Cy3-labeled Phe-tRNAPhe, Met-tRNAMet, or Arg-tRNA
Arg
. A 10-fold 
excess of GDP (100 µM) is then added, and the rate of fluorescence decay is then 
tracked over time.  
In the absence of EF-Ts, all three ternary complexes were observed to decay at a 
slow rate of ~0.01 s
-1
, consistent with ternary complex being a stable, high affinity 
species (Figure 4.4A). As shown previously for Phe-TC, the measured decay rate was 
independent of EF-Tu concentration as expected for a spontaneous dissociation 
process followed by GDP binding, an event that prevents ternary complex from re-
TABLE 4.1 Kinetic parameters measured in the presence and absence of EF-Ts. 
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forming (Figure 4.4B). When the same experiment was performed with EF-Tu/Ts, 
however, the rate of fluorescence intensity decay was ~25-, ~13-, and ~20-fold faster 
for Phe-TC, Met-TC, and Arg-TC, respectively (Figure 4.4A). The observed rate of 
decay was also linearly dependent on the concentration of EF-Tu/Ts (Figure 4.4B). 
This trend is inconsistent with a simple unimolecular dissociation pathway, suggesting 
that EF-Ts facilitates ternary complex dissociation through a bimolecular interaction 
that influences the nucleotide binding pocket of EF-Tu. Here, the apparent EF-Ts on-
rate estimated from the slope of the concentration dependent process ranged from ~0.3 
to 1.0 µM
-1
s
-1
 depending on the tRNA species and taking into account that the 
FIGURE 4.4 Measuring ternary complex formation and dissociation via FRET. A, schematic illustration of TC 
quenching assay showing Cy5Q-labeled EF-Tu (blue) bound to GTP (yellow) quenches the fluorescence of 
Cy3B-labeled aa-tRNA (white) upon ternary complex formation. B, addition of 0.4 µM EF-Tu∙GTP (Cy5Q) to 
5 nM Cy3B-labeled Phe-tRNAPhe (red), Met-tRNAMet (black), or Arg-tRNAArg (blue) in the presence of 10 µM 
GTP. Omission of the tRNA synthetase (-Amino acid) or GTP (-GTP) from the ternary complex formation assay 
resulted in no change in Cy3B fluorescence intensity. C, addition of excess unlabeled EF-Tu to the ternary 
complexes formed in B. Addition of excess GDP (bold colors) or unlabeled EF-Tu/Ts (light colors) to Phe-TC 
(D), Met-TC (E), and Arg-TC (F) preformed with EF-Tu/Ts (Cy5Q). Apparent rates of ternary complex decay 
were estimated by fitting to a single exponential function (see Chapter 2, Methods). 
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concentration of free EF-Ts is roughly 50% of the total factor concentration. As this 
rate is more than 2 orders of magnitude slower than a diffusion-limited process as well 
as the established rate of nucleotide binding to EF-Tu
31
, we conclude that one or more 
rate-determining events in EF-Tu, likely related to GTP release, precede the 
EF-Ts-facilitated ternary complex dissociation process leading to the loss of 
fluorescence.  
 
4.4.4 EF-Ts Increases the Rate of Ternary Complex Turnover under Steady State 
Conditions 
To probe whether EF-Ts influences rate-determining step that precede the 
dissociation process observed in the presence of GDP, we next sought to ascertain 
whether the rate of ternary complex turnover was influenced by EF-Ts under steady-
state conditions. To do so, we developed a FRET-based approach to directly examine 
the rate of ternary complex turnover by site-specifically labeling EF-Tu with a 
quencher fluorophore at its C terminus (see Chapter 2). The C terminus of EF-Tu and 
the acp
3
U47 residue in tRNA are in close proximity (approximately 30 Å) (Figure 
4.1). To dampen the environment-dependent increase in Cy3 fluorescence that 
accompanies ternary complex formation (Figure 4.2), Phe-tRNA
Phe
, Met-tRNA
Met
, and 
Arg-tRNA
Arg
 were labeled at their acp
3
U47 residues using Cy3B, a fluorophore less 
prone to cis-trans isomerization and environment-dependent changes in quantum 
yield
149-151
. Hence, the formation of ternary complex is anticipated to result in a 
substantial decrease in Cy3B fluorescence intensity as a result of energy transfer to the 
nearby quencher (Figure 4.5A). 
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Using this approach, ternary complex formation resulted in an ~65% decrease in 
Cy3B fluorescence intensity for all three aa-tRNAs examined (Figure 4.5B). As 
expected, this change in signal was strictly dependent on GTP and the aminoacyl 
moiety of aa-tRNA (Figure 4.5B). Consistent with the findings presented for unlabeled 
EF-Tu (Figure 4.4), this reduction in Cy3B fluorescence intensity could be fully 
recovered by the addition of a 10-fold molar excess of GDP. These data convincingly 
revealed that quencher-labeled EF-Tu is fully competent to form ternary complex.  
To directly examine ternary complex turnover under steady state conditions, a 
competition experiment was performed in which a 10-fold molar excess of unlabeled 
EF-Tu or EF-Tu/Ts was added to a preformed, quencher-labeled 
EF-Tu∙GTP∙PhetRNAPhe (Cy3B-acp3U47) ternary complex. As the vast majority of 
ternary complex re-formed after dissociation will not be quenched, the intrinsic rate of 
ternary complex turnover in this assay is revealed by the rate of increase in Cy3B 
fluorescence intensity.  
In both the absence and presence of EF-Ts, Cy3B fluorescence recovered at a rate 
that was tRNA-specific (Figure 4.5, C–F). For the unlabeled EF-Tu chase experiment, 
the rates of steady state ternary complex turnover approximated those observed upon 
quenching with GDP in the absence of EF-Ts (Figure 4.5C and compare Table 4.2 koff 
with Table 4.1 kapp,2). However, distinct responses were evidenced in each EF-Tu/Ts 
chase experiment (Figure 4.5, D–F). Here, the steady-state turnover rates were 
TABLE 4.2  Apparent rates of ternary complex dissociation. T BLE 4.3  Apparent rates of EF-Tu and EF-Ts interactions. 
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approximately an order of magnitude slower than those observed in the presence of 
GDP (compare Table 4.1 kapp,2 with Table 4.2 koff).  
These findings suggest that EF-Ts has the propensity to destabilize each ternary 
complex and to specifically promote ternary complex dissociation in the presence of 
GDP. Such trends are consistent with the notion that nucleotide exchange occurs at a 
slow rate within ternary complex and that EF-Ts increases the rate of such processes 
via direct interactions with EF-Tu while it remains bound to aa-tRNA. We speculate 
that, when only GTP is present in the reaction, nucleotide can reload onto EF-Tu prior 
to its dissociation from aa-tRNA. When GDP is present in excess of GTP, however, 
GDP binding to EF-Tu leads to ternary complex dissociation. We therefore infer that 
FIGURE 4.5 Significant amounts of EF-Tu/Ts remain bound to GTP under physiological nucleotide 
concentrations. A, schematic illustrating the EF-Tu/Ts FRET assay. 1, Cy3-labeled EF-Tu (blue) is added to 
Cy5-labeled EF-Ts (red). 2, EF-Tu(Cy3)/Ts(Cy5) mixed with unlabeled EF-Ts and GTP (yellow). 3, 
EF-Tu(Cy3)/Ts(Cy5) added to GTP. 4, EF-Tu(Cy3)/Ts(Cy5) mixed with unlabeled Phe-tRNAPhe (white) and GTP. 
B, 2 µM EF-Tu(Cy3) mixed with 2 µM EF-Ts(Cy5) while monitoring Cy5 fluorescence (curve 1), 2 µM 
EF-Tu(Cy3)/Ts(Cy5) added to 20 µM unlabeled EF-Ts and 1 mM GTP (curve 2), 2 µM  EF-Tu(Cy3)/Ts(Cy5) 
mixed with 1 mM GTP (curve 3), and 2 µM EF-Tu(Cy3)/Ts(Cy5) mixed with 0.5 µM Phe-tRNAPhe and 1 mM GTP 
(curve 4). A plot focusing on the early time points in the reactions is shown for clarity (inset). Apparent rates were 
estimated by fitting to either a single exponential function (curves 1, 2, and 4) or a double exponential function 
(curve 3). Error bars represent the S.D. of three separate experiments. 
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EF-Ts can act as a guanosine nucleotide exchange factor for EF-Tu while it is bound 
to aa-tRNA via a quaternary complex where the formation of an EF-Tu∙GDP∙aa-tRNA 
ternary complex stimulates EF-Tu release from aa-tRNA, which is accelerated by 
EF-Ts.  
4.4.5 EF-Tu/Ts∙GTP Is an Abundant Species under Cellular Conditions 
The notion that EF-Ts can interact with EF-Tu while it is bound to aa-tRNA 
provides a plausible model for the observation that EF-Ts accelerates the process of 
ternary complex formation (Figure 4.3). As speculated previously, EF-Ts may increase 
the rate of ternary complex formation via a transient EF-Tu/Ts∙GTP∙aa-tRNA 
quaternary complex. A key issue with this model is that the EF-Tu/Ts∙GTP species is 
expected to dissociate at a rate of ~60 s
-1
 at physiological GTP concentrations 
(approximately 1 mM)
31
. Meaningful concentrations of the EF-Tu/Ts∙GTP complex, 
however, are expected at EF-Ts concentrations above 1 µM as the bimolecular rate 
constant between EF-Ts and EF-Tu∙GTP is 3∙107 M-1s-1 31. Indeed, such considerations 
predict that ~50% of EF-Tu will be in an EF-Tu/Ts∙GTP complex under the conditions 
where EF-Ts is observed to accelerate ternary complex formation (Figure 4.3). At 
cellular EF-Ts concentrations, which under nutrient-rich conditions are estimated to be 
~10 µM 
36,145
, the proportion of EF-Tu/Ts∙GTP complex is expected to be even higher 
as the apparent rate of EF-Tu/Ts∙GTP reformation will be as much as ~5-fold faster 
than the rate of EF-Ts dissociation from EF-Tu∙GTP.  
To directly test these predictions, we set out to measure the interactions between 
EF-Tu and EF-Ts through a FRET-based approach (Figure 4.6A). To do so, we used 
enzymatic tagging procedures to site-specifically label EF-Tu with a Cy3 fluorophore 
TABLE 4.4  Apparent rates of quaternary complex formation and decay. 
115 
 
at its C terminus and EF-Ts with a Cy5 fluorophore through maleimide chemistry at a 
position engineered to yield high FRET (A160C)
91
 (Chapter 2). When 2 µM Cy3-
labeled EF-Tu was rapidly mixed with 2 µM Cy5-labeled EF-Ts under stopped flow 
(Chapter 2), a rapid increase in Cy5 emission was observed (kapp = 18.5 s
-1
), which as 
expected from the kinetics and high affinity nature of the EF-Tu/Ts interaction
31
 
remained stable over time (Figure 4.6, A and B, black curve, and Table 4.3).  
To determine the dissociation rate of the EF-Tu/Ts complex in the presence of 
saturating concentrations of GTP, a preformed EF-Tu(Cy3)/Ts(Cy5) complex was 
rapidly mixed with 1 mM GTP in the presence of a 10-fold molar excess of unlabeled 
EF-Ts to prevent the complex from re-forming (Figure 4.6, A and B, blue curve). As 
expected
31
, a rapid loss of fluorescence was observed (~148 s
-1
) (Table 4.3). This 
value is ~2-fold faster that the EF-Tu/Ts∙GTP dissociation rate estimated using native 
components
31
, suggesting that the modifications to EF-Tu and EF-Ts may modestly 
destabilize the EF-Tu/Ts complex.  
We next investigated the extent to which GTP disrupts the EF-Tu/Ts complex 
under steady state conditions in the absence of unlabeled EF-Ts where a dynamic 
equilibrium between dissociation and association is expected. In line with known 
kinetic parameters of this system
31
, mixing the preformed EF-Tu(Cy3)/Ts(Cy5) 
complex (2 µM) with GTP (1 mM) led to a rapid loss of FRET, which stabilized at 
approximately ~55% of the starting intensity (Figure 4.6, A and B, red curve, and 
Table 4.3). These data argue that the EF-Tu/Ts∙GTP complex is an abundant species 
both in our experiments and the cellular milieu. 
To test the hypothesis that EF-Ts accelerates the binding of aa-tRNA to 
EF-Tu∙GTP, a preformed EF-Tu(Cy3)/Ts(Cy5) complex was rapidly mixed with 
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1 mM GTP and 500 nM Phe-tRNA
Phe
 (Figure 4.6, A and B, cyan curve). Here, Cy5 
fluorescence was observed to decay at a rate of ~242 s
-1
 (Table 4.3), a rate 
significantly faster than when only GTP or unlabeled EF-Ts was added (Figure 4.6B, 
inset). This finding suggests that aa-tRNA contributes to the apparent rate of EF-
Tu(Cy3)/Ts(Cy5) dissociation as would be expected if ternary complex is formed 
rapidly (approximately ~140 s
-1
).  
4.4.6 Quaternary Complex Is Transient by Nature 
To directly observe the EF-Tu/Ts∙GTP∙aa-tRNA quaternary complex, we designed 
an experiment to detect FRET between EF-Ts and aa-tRNA during ternary complex 
formation where the hypothesized architecture of quaternary complex predicts a 
physical proximity between the Cy3B fluorophore at position U47 of aa-tRNA and 
Cy5 at position 160 of EF-Ts (Figure 4.7A). The conditions of this experiment were 
derived by simulating the expected rate of quaternary complex formation and decay 
that should accompany ternary complex formation based on a framework that included 
the known kinetic features of the interactions among EF-Tu, EF-Ts, guanosine 
nucleotide, and Phe-tRNA
Phe31,83
 (Figure 4.7B, red curve). Using this approach, the 
optimal conditions for detecting quaternary complex were determined to be a 
concentration of 2 µM EF-Tu/Ts, 250 nM Phe-tRNA
Phe
, and 1 mM GTP.  
As anticipated by these simulations, when 2 µM EF-Tu/Ts(Cy5) was rapidly 
mixed with 250 nM Phe-tRNA
Phe
 (Cy3B-acp
3
U47) and 1 mM GTP, FRET was 
observed between the excited Cy3B fluorophore and the Cy5-labeled EF-Ts (Figure 
4.7C, black). No evidence of FRET was observed when the exact same experiment 
was performed using deacylated tRNA
Phe
 (Figure 4.7C, gray). 
The biphasic nature of the transient FRET signal observed was fit to a double 
exponential process to estimate the apparent rates of quaternary complex formation 
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and decay, respectively. Here, the rise and decay portions were estimated to occur at 
rates of ~870 ± 23 and 143 ± 7 s
-1
, respectively (Table 4.4). These apparent rates 
suggest that the appearance of FRET is diffusion-limited and that the rate of 
quaternary complex decay and thus ternary complex formation may be as fast as 
140 s
-1
. Notably, this rate is strikingly consistent with our stopped-flow measurements 
based on changes in Cy3 relative fluorescence intensity where ternary complex 
formation occurs at a rate of ~70 s
-1
 (Figure 4.3) under conditions in which ~50% of 
FIGURE 4.6 Direct evidence of the transient intermediate, quaternary complex. A, schematic illustrating the 
FRET assay used to detect quaternary complex. Cy3B-labeled Phe-tRNAPhe (white) is mixed with EF-Tu/Ts∙GTP 
(blue/red) harboring a Cy5 fluorophore linked to EF-Ts. B, simulation of the time-dependent formation of 
quaternary complex (red curve, QC) and ternary complex (green curve, TC) based on the schematic presented in A. 
C, transient FRET observed upon mixing 2 µM EF-Tu/Ts(Cy5) and 250 nM Phe-tRNAPhe (Cy3B) in the presence of 
1 mM GTP (black). These data were fit to a double exponential function (red). This experiment was repeated with 
deacylated tRNAPhe (Cy3B) (grey). Error bars represent the S.D. of three separate experiments. 
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EF-Tu is expected to be in an EF-Tu/Ts∙GTP complex (Figure 4.6). Such findings 
provide compelling, direct evidence that ternary complex formation occurs via a 
highly transient quaternary complex species under cellular conditions.  
 
 
4.5 DISCUSSION 
Contemporary models posit that the EF-Tu life cycle parallels the quintessential 
model of G-protein function
7,109,119
. After aa-tRNA is delivered to the actively 
translating ribosome, EF-Tu∙GDP is released as an inactive species whereupon the 
guanosine nucleotide exchange factor, EF-Ts, operates on it to exchange GDP for 
GTP. Thereafter, EF-Tu∙GTP is released as an activated species that is again 
competent to bind free aa-tRNA with uniformly high affinity
4,17,24,31,109,119,144,152
.  
The data presented here and elsewhere
83,93
 argue that refinements to this model are 
needed. At cellular EF-Ts concentrations (approximately >1 µM), our findings suggest 
that ternary complex preferentially forms via a transient EF-Tu/Ts∙GTP∙aa-tRNA 
quaternary complex (Figure 4.8). This pathway is kinetically preferred because EF-Ts 
FIGURE 4.7 EF-Ts regulates ternary complex abundance. During growth-promoting conditions, 
EF-Ts (red) facilitates the formation of GTP (yellow)-bound EF-Tu (blue) to aa-tRNA (white) by 
accelerating rate-determining conformational processes in EF-Tu. The guanosine nucleotide exchange 
function of EF-Ts also serves to preferentially load GDP during conditions of cellular stress. 
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lowers the activation barrier for rate-determining conformational processes in EF-Tu 
that accompany the formation of a high affinity complex with aa-tRNA. Given what is 
presently known, the nature of these conformational processes likely surrounds the 
allosteric linkage between the aminoacyl moiety linked to the terminus of aa-tRNA 
and the switch regions surrounding the GTP nucleotide that coordinate magnesium 
and the γ-phosphate group (Figure 4.1).  
Our direct measurements suggest that the lifetime quaternary complex is on the 
order of ~10 ms (Figure 4.7). As the predominant means for investigating ternary 
complex formation have entailed size exclusion chromatography, filter binding, and 
gel mobility shift assays
25,92,153
 where rapid kinetic studies have been specifically 
lacking, its inherent instability is likely the key reason why quaternary complex has 
escaped detection previously. Although the existence of a quaternary encounter 
complex species is an expected result based on purely physical considerations, the 
capacity of EF-Ts to increase the rate of ternary complex formation substantially 
above that of protein synthesis (approximately 100 versus 10–20 s-1; Figure 4.3 and 
4.7) argues that it serves a critical biological role related to replenishing the supply of 
ternary complexes as they are consumed by the process of protein synthesis.  
The data presented also suggest that EF-Ts destabilizes ternary complex species to 
make their abundance sensitive to the nucleotide status of the cell (Figure 4.5). Such 
tendencies are consistent with EF-Ts remodeling the switch regions in EF-Tu while it 
is bound to aa-tRNA (as it does when EF-Tu is not bound to aa-tRNA)
60
 to influence 
the rate of nucleotide exchange. Two notable corollaries to this observation are that 1) 
the nucleotide exchange rate may not be the same for all tRNA species, and 2) the 
activated EF-Tu molecule in ternary complex may be deactivated by energy-neutral 
processes. Evidence supporting the first corollary is shown for the three tRNA species 
investigated in this study (Phe-tRNA
Phe
, Met-tRNA
Met
, and Arg-tRNA
Arg
) where the 
120 
 
effects of EF-Ts on ternary complex differ by as much as an order of magnitude 
(Figure 4.3, 4.4, and 4.5).  
As the effective concentration of quaternary complex will be strongly dependent 
on EF-Ts concentration, such effects are also expected to be highly responsive to the 
active EF-Ts pool. Although the second corollary is likely irrelevant under nutrient-
rich conditions where the intracellular concentration of GTP is much higher than GDP, 
it may play a significant role in regulating ternary complex abundance upon a change 
in the GTP/GDP ratio. EF-Ts rapidly dissociates ternary complex when GDP loads 
onto EF-Tu while it is bound to TC (Figure 4.4, 4.5, and 4.8). Correspondingly, 
changes in EF-Ts concentration as well as the GDP/GTP ratio are likely to contribute 
differentially to the relative stabilities and effective concentrations of specific ternary 
complex species in interdependent ways. Although it is not presently clear whether 
EF-Ts contributes evenly or differentially to the stabilities of distinct ternary complex 
species, the data obtained for the three ternary complex species assessed here suggest 
that ternary complex affinities become somewhat more dispersed in the presence of 
EF-Ts (Table 4.1). Such differences likely arise from a balance of the distinct 
contributions to ternary complex affinity, including contacts between aa-tRNA and 
EF-Tu as well as the nucleotide exchange rate. A key prediction of these 
considerations is that the abundance and lifetime of each ternary complex type will be 
sensitive to the metabolic state of the cell where EF-Ts can serve to rapidly dissipate 
the ternary complex pool through an energy-neutral mechanism in the event of cellular 
stress. Such a capacity would provide a means for the cell to immediately cease the 
energy-expensive process of translation without waiting for ternary complex to be 
consumed and allow for the repurposing of GTP.  
The demonstration that EF-Ts actively resolves quaternary complex species that 
contain GDP (Figure 4.5) also has potentially important implications for the 
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mechanism of tRNA selection as an EF-Tu∙GDP∙aa-tRNA ternary complex is formed 
each time an actively translating ribosome decodes mRNA
17
. A key open question that 
must be resolved through future investigations is whether EF-Ts is able to gain access 
to the EF-Tu∙GDP∙aa-tRNA ternary complex while engaged at the A site of the 
ribosome. If so, EF-Ts may accelerate the rate of EF-Tu∙GDP release from the 
ribosome following aa-tRNA entry into the peptidyl transferase center, a step reported 
to be rate-limiting to the process
4,24
. To our knowledge such questions have yet to be 
explored.  
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CHAPTER 5 
THE REACTION COORDINATE OF EF-Tu 
 
5. OVERVIEW 
Chapter 5 presents data aimed at measuring the lifetime of EF-Tu on the ribosome 
during tRNA selection. A summary is given in section 5.1, followed by an 
introduction in section 5.2 that contains relevant background and motivating themes 
for pursing the proposed hypothesis. Section 5.3 describes the results, the impact of 
which is then discussed in section 5.4. 
 
 
5.1 SUMMARY 
tRNA selection has been studied extensively from the perspective of the ribosome 
and the aa-tRNA. However, direct measurements of EF-Tu are conflicting with these 
studies in that its dissociation from the ribosome is predicted to be an order of 
magnitude slower than the rate of tRNA accommodation. Using both bulk and single 
molecule fluorescence assays, we are investigating the EF-Tu residence time on the 
ribosome during tRNA selection. We test the model that EF-Ts impacts this reaction 
coordinate by accelerating the removal of EF-Tu∙GDP from the ribosome, rendering 
this step compatible with the reported rate of protein synthesis in vivo. These data will 
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describe the role that EF-Ts plays in the context of EF-Tu’s inactivation and provide 
further understanding of how GEFs and GAPs regulate G-proteins. 
 
 
5.2 INTRODUCTION 
The final phase of gene expression involves the faithful translation of messenger 
RNA (mRNA) transcripts into amino acid polymers that ultimately gives rise to the 
cells diverse repertoire of proteins. Translation requires the orchestrated effort of a 
myriad of biomolecules, collectively referred to as the translational machinery. 
Among the most important member of this group is the ribosome, a 2.5 MDa complex 
consisting of 52 proteins and 4,660 nucleotides in E. coli. Once the translational 
machinery is assembled on an mRNA start site, the ribosome decodes the open 
reading frame by testing each triplet codon against the anticodon of adaptor transfer-
RNA (tRNA) molecules each carrying an amino acid. Successful matching of mRNA 
codons with tRNA anticodons leads to the subsequent addition of the newly 
incorporated amino acid to the nascent polypeptide chain.  
 
Crucial to the tRNA selection process, the three domain GTPase protein 
Elongation Factor Tu (EF-Tu) chaperones aminoacylated tRNA (aa-tRNA) to the 
ribosome as a ternary complex (TC) with GTP. EF-Tu is not only important for fast 
and efficient delivery of aa-tRNA to the ribosome, but it actively contributes to the 
decoding process via its catalytic GTPase functionality
154,155
. Drugs that serve to 
decouple GTP hydrolysis from EF-Tu function, such as kirromycin, are inhibitory to 
tRNA selection and are accordingly bactericidal in nature. Crystallographic data have 
revealed that EF-Tu simultaneously engages aa-tRNA and the leading edge of the 
large ribosomal subunit. Concurrently, the anticodon loop of aa-tRNA is also bound to  
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FIGURE 5.1 EF-Tu delivers aa-tRNA to the leading edge of the ribosome. Aa-tRNA (A/T, 
magenta, foreground) is delivered to the A-site of the small subunit of the ribosome by EF-Tu 
(green). In doing so, EF-Tu comes into close proximity to the small subunit protein S12 (purple) 
and the large subunit protein L11 (orange). Following initial selection, the CCA- end of the 
aa-tRNA samples the A-site of the large subunit during proofreading. tRNA selection culminates 
in the formation of a peptide bond resulting from the transfer of the nascent polypeptide from the 
P-site tRNA (P, magenta, background) to the accommodated A-site tRNA. 
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the A-site of the small ribosomal subunit in a bent-like conformation, referred to as the 
A/T-state (Figure 5.1). 
The precise order and timing of EF-Tu interactions in the translation of mRNA has 
been largely inferred from investigations of aa-tRNA and the ribosome
1,4,40,53,86,156-159
. 
Our kinetic understanding of EF-Tu’s role in tRNA selection has been predominantly 
constructed from GTP hydrolysis measurements resulting from interactions between 
EF-Tu and the GTPase Activating Center (GAC) of the large ribosomal subunit
3,14
. 
The only direct measurement of EF-Tu ever made during the decoding process
4,24
 has 
contrasted starkly with the rates of tRNA selection as measured from the tRNA 
reaction coordinate
1,42
, and as measured in vivo 
35
. This experiment argues that the 
rate-determining step in translation elongation is the release of EF-Tu∙GDP during the 
decoding process. Paradoxically, the predicted rate of EF-Tu∙GDP release is 5 to 10 
fold slower than the measured aa-tRNA accommodation rate. Moreover, it is an order 
of magnitude too slow to be compatible with protein synthesis rates measured in vivo, 
ca. 15-20 amino acids polymerized per ribosome per second
35,61,62
.  
Current models of protein synthesis (Figure 5.2) predict rapid testing of TCs with 
FIGURE 5.2 Kinetic model of tRNA selection. Reaction 1, ternary complex binds to the ribosome with 
a fast bimolecular rate leading to the codon recognition (CR) state. Reaction 2, reversible tRNA 
motions either lead to the rejection of ternary complex (not shown) or to the achievement of a second 
stable intermediate, termed the GTPase activated (GA) state. Reaction 3, GTP is irreversibly 
hydrolyzed. Reaction 4, Pi is released. Reaction 5, reversible tRNA motions ultimately lead to the fully 
accommodated (AC) state. Reaction 6, although EF-Tu has not been directly tracked during this 
process, it is inferred from off-rate studies that EF-Tu∙GDP releases slowly, and is therefore present 
throughout the decoding process. In contrast, some models posit that EF-Tu∙GDP dissociation is 
prerequisite for achieving the AC state. Rates presented in reactions 1, 2, 5, and 6 were determined from 
investigating the tRNA reaction coordinate
1
. Rates presented in reactions 3 and 5 were made using an 
orthogonal Pi sensor and global fitting
3
, while the * rate shown in reaction 6 is inferred from EF-Tumant 
dissociation studies
4
. 
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ribosomes at a bimolecular rate that is approaching a diffusion-limited process, ca. 
140 μM-1s-1. Upon successful interaction, the aa-tRNA anticodon is tested against the 
mRNA codon programmed in the A-site of the small subunit. Pre-steady state data 
tracking the tRNA throughout this process have revealed a stable intermediate at this 
first interaction step, termed codon recognition (CR). Here, the TC is either rejected, 
and thus dissociated from the ribosome, or the tRNA proceeds to a second stable 
intermediate, termed the GTPase activating (GA) state. All of the interactions that 
serve to bring the aa-tRNA to the GA state are collectively referred to as Initial 
Selection and together constitute a single testing of the codon-anticodon pair. As 
kirromycin inhibits progress beyond the GA state, it is largely thought that the 
kirromycin stalled crystal structure resembles the GA state (Figure 5.1). Initial 
Selection concludes with the hydrolysis of GTP, a process that is facilitated by 
ribosomal elements in the GTPase activating center (GAC) known as the sarcin-ricin 
loop.  
The second phase of tRNA selection involves another testing of the codon-
anticodon pair through a series of kinetic steps referred to as Proofreading. It is here 
that the canonical models of the decoding process begin to diverge substantially. Some 
models posit that EF-Tu∙GDP quickly dissociates from the aa-tRNA and the large 
ribosomal subunit and that this step is prerequisite for the continuation of the aa-tRNA 
accommodation process
17
. However, direct measurements of EF-Tu dissociation from 
ribosomes contradict this notion. Instead, an EF-Tu residence time greatly outlasting 
tRNA accommodation has been observed
4
. These data argue in favor of a model 
wherein EF-Tu∙GDP remains bound to the ribosome throughout the tRNA selection 
process and disembarks after a peptide bond has been formed. 
Although the order and timing of aa-tRNA accommodating into the ribosome has 
been described in detail, direct measurements of EF-Tu are lacking. To sufficiently 
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delineate between the different models of Proofreading, and to better reconcile 
biophysical measurements with in vivo observations, further understanding of the 
EF-Tu reaction coordinate during tRNA selection is needed. Here, we employ several 
new assays to directly monitor EF-Tu during the tRNA selection process and propose 
new refinements to the canonical model. 
 
 
5.3 RESULTS 
5.3.1 EF-Tu Hydrolyzes GTP In A Timeframe Consistent With aa-tRNA 
Accommodation 
During aa-tRNA selection, EF-Tu converts GTP to GDP after the codon-anticodon 
pair is successfully tested. Investigations of the tRNA reaction coordinate during 
tRNA selection have led to a model where the GTPase activated state is reached 
within an average of 30 ms after TC begins interacting with the ribosome. In order to 
investigate this more directly, we monitored tRNA selection using an orthogonal 
FIGURE 5.3 PBP binds Pi with a fast on-rate. A, Titration of Pi into a reaction containing 
MDCC-PBP reveal a large increase in relative fluorescence and a dissociation constant of ~1 µM. B, 
the rate of Pi binding is fast relative to the published rates of GTP hydrolysis during tRNA selection (ca. 
30 s
-1
). Instruments used to acquire data for A, and B were a QM4 PTI fluorometer and a SX20 
stopped-flow spectrometer, respectively. 
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inorganic phosphate (Pi) biosensor
76
. E. coli Phosphate Binding Protein (PBP) labeled 
with the environmentally sensitive MDCC fluorophore was used to detect free Pi as it 
is produced from the hydrolysis of GTP (see Chapter 2)
3
. Upon PBP binding to Pi, the 
relative fluorescence of MDCC increases irreversibly at timescales of less than one 
second (Figure 5.3). 
The rate of GTP hydrolysis during tRNA selection was measured by rapidly 
mixing 800 nM of cognate Phe-TC and 400 nM ribosomal initiation complexes (IC) in 
the presence of 2 μM MDCC-PBP. This resulted in a fast increase in MDCC 
fluorescence that was dependent on the complete repertoire of translational machinery 
(Figure 5.4). The rate of GTP hydrolysis, kGTP, was estimated to be 38 s
-1
 by fitting the 
process to a single exponential. Our measurements indicate that EF-Tu hydrolyzes 
GTP on times scales that are consistent with the rate of the decoding process as 
measured from the perspective of the tRNA reaction coordinate
1
. 
 
FIGURE 5.4 GTP Hydrolysis during tRNA selection. GTP hydrolysis resulting from mixing Phe-TC 
and IC in the presence of MDCC-PBP reveals a relative fluorescence increase (black). An apparent rate 
of 38 s
-1
 was estimated by fitting to a single exponential function. An identical experiment lacking Phe-
tRNA
Phe
 results in no fluorescence change (grey).  
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5.3.2 EF-Tu∙GDPmant release is slow in the absence of EF-Ts 
To directly monitor the rate of aa-tRNA selection along the EF-Tu reaction 
coordinate, the GTP fluorescent analog GTPmant was used. Here, the fluorescent mant 
moiety is conjugated to either the 2′ or 3′ of the ribose of GTP. EF-Tu binds to both 
GTPmant and to GDPmant with high affinity and, importantly, the mant moiety does not 
significantly perturb the interaction between EF-Tu and EF-Ts (Figures 5.5, 5.6). 
Phe-TCmant was formed with 2.5 μM EF-Tu, 0.1 µM EF-Ts, 0.3 µM GTPmant, and 
0.3 μM Phe-tRNAPhe and rapidly mixed with ICs using an SX20 stopped-flow 
spectrometer. Consistent with previous studies
4,24
, ternary complex binding to 
ribosomes resulted in an increase in the mant relative fluorescence (Figure 5.7, dark 
blue curve). This is likely due to alterations in the environment (water exposure) and 
diffusional freedom (steric hindrance) that occur upon EF-Tu∙GTPmant binding to the 
ribosome. This process is quickly followed by a return to baseline fluorescence, 
consistent with EF-Tu∙GDPmant releasing from the ribosome. Each component of the 
biphasic process was fit to a single exponential to estimate the rate of ternary complex 
association and the rate of EF-Tu∙GDPmant release.  
The rate of association, kon, was estimated to be ~55 s
-1
. This is consistent with 
previous measurements of tRNA selection using EF-Tu∙GTPmant 
4,24
, as well as initial 
binding measurements tracking the accommodating aa-tRNA into the ribosome
1
. The 
observed fluorescence decay process, koff, is observed to be ~7 s
-1
, in line with what 
has been previously reported with this assay
4,24
.  
Although this signal does not distinguish between productive and non-productive 
interactions, the lifetime of non-productive interactions as measured from the aa-tRNA 
reaction coordinate are much shorter than the off rate measured here, ca. 30 s
-1
 versus 
7 s
-1
 
1
.    It    therefore    seems    plausible    that    this    signal    is    dominated   by  
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FIGURE 5.5 EF-Tu binds mant nucleotides with high affinity.  1 µM EF-Tu, A, or 1 µM EF-Tu/Ts, B, 
is rapidly mixed with 10 µM GTPmant using an SX20. The relative fluorescence of mant was monitored by 
illuminating at 280 nm with a monochromator and measuring emission intensity using a 440 nm long 
pass filter. These experiments were repeated with GDPmant without, C, and with, D, EF-Ts. Apparent rates 
are estimated by fitting to a single exponential function. 
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FIGURE 5.6 EF-Ts accelerates nucleotide release from EF-Tu. 1 µM EF-Tu∙GTPmant was rapidly 
mixed with nucleotide free buffer, A, or 1 µM EF-Ts, B, using a SX20. The relative fluorescence of 
mant was monitored by illuminating at 280 nm with a monochromator and measuring emission 
intensity using a 440 nm long pass filter. These experiments were repeated with EF-Tu∙GDPmant 
without, C, and with, D, EF-Ts. Apparent rates are estimated by fitting to a single exponential function. 
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productive EF-Tu interactions and that the fluorescence decay is product of 
EF-Tu∙GDPmant dissociation. As this rate is vastly slower than the anticipated rate of 
tRNA accommodation
1
, we further investigated this process using cellular 
concentrations of EF-Ts (1 μM and 2.5 μM). However, the Phe-tRNAPhe concentration 
is unchanged and therefore it is assumed that the concentration of Phe-TC also 
remains the same. Increasing EF-Ts to 1 µM had little impact on the observed rates of 
fluorescence increase and decay (Figure 5.7, medium blue curve). However, the effect 
of increasing EF-Ts to 2.5 µM, now equimolar with EF-Tu, resulted in a drastically 
faster process. Here, the increase of fluorescence was not quantifiable, and the 
decrease is estimated to be approximately two orders of magnitude faster than what 
was observed at the lower EF-Ts concentrations (Figure 5.7, light blue curve). 
The release of EF-Tu∙GDP from the ribosome is prerequisite for EF-G binding and 
thus translocation
32
. Therefore, the slow release of EF-Tu∙GDPmant measured here at 
sub-micromolar amounts of EF-Ts argues in favor of a model where this is the rate-
FIGURE 5.7 tRNA selection monitored using mant labeled EF-Tu. EF-Tumant∙GTP∙Phe-tRNA
Phe
 
ternary complex is rapidly mixed with initiation complexes at increasing concentrations of protein 
factor. The fluorescence process is fit to a double exponential model for 100 nM and 1 µM data point. 
The 2.5 µM protein factor data was fit to a single exponential model.  
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limiting step for not only the decoding process, but also for the broader elongation 
cycle. Based on current models of tRNA selection
1,17,24,53
, it is unclear how increasing 
the concentration of a GEF, and not ternary complex, could account for the faster 
process observed.  
In a previous study, EF-Tu dissociation from aa-tRNA was observed to be 
accelerated in the presence of GDP and EF-Ts (Figures 3.3C,D, Figures 4.5D,E,F). 
Furthermore, the rate-determining step of ternary complex formation was previously 
identified to be catalyzed by EF-Ts through a direct EF-Tu/Ts∙GTP∙aa-tRNA 
quaternary complex interaction (Figure 4.7). Importantly, this interaction is postulated 
to occur at high concentrations of protein factor, with an estimated KD of ~2 μM 
between EF-Ts and Phe-TC. Based on these previous observations, and the faster mant 
fluorescence decay observed here (Figure 5.6, light blue curve), we hypothesize that 
EF-Ts accelerates the dissociation of EF-Tu∙GDP during tRNA accommodation. 
Specifically, we speculate that, at near cellular concentrations of EF-Ts, EF-Tu∙GDP 
dissociation is accelerated by directly binding to EF-Ts while it is still bound to the 
ribosome.  
 
5.3.3 EF-Tu Releases aa-tRNA In A Timeframe Consistent With aa-tRNA 
Accommodation 
To test the impact that EF-Ts has on the EF-Tu reaction coordinate, we performed 
tRNA selection experiments using a quenched ternary complex. This reagent enables 
us to track the proximity of EF-Tu to the accommodating aa-tRNA during the 
decoding process. Quenched TC is formed with a quencher labeled EF-Tu (Cy5Q) 
bound to a fluorescently  labeled  aa-tRNA  (Cy3B-acp
3
U47)  (Figure  5.8A).  Upon 
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FIGURE 5.8 Schematic of quenched TC formation and tRNA selection. A, Quenched Phe-TC is 
formed by the addition of EF-Tu (C-Term Cy5Q) and Phe-tRNA
Phe
 (Cy3B-acp
3
U47) in the presence of 
GTP. Excitation of Cy3B fluorescence reveals a diminished value upon formation of ternary complex as 
a result of the proximal Cy5Q. B, Quenched Phe-TC is mixed with ribosomes formed with an initiator 
tRNA in the P-site and an empty A-site cognate for tRNA
Phe
 (referred to as an initiation complex (IC) in 
the text). Upon successful delivery of Cy3B Phe-tRNA
Phe
, the quencher labeled EF-Tu dissociates thus 
removing the quenching effect of Cy5Q. This results in a measureable  increase in Cy3B fluorescence.  
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successful delivery of the fluorescently labeled aa-tRNA, the EF-Tu separates from 
the aa-tRNA, thus eliminating the quenching effect (Figure 5.8B). 
The activity of quenched Phe-TC is demonstrated using ICs programmed with an 
initiator tRNA in the P-site and an empty A-site cognate for tRNA
Phe
. Varying 
concentrations of ICs are mixed with 20 nM quenched Phe-TC in the presence of 
1 mM GTP and incubated at room temperature for 10 minutes. Measurement of Cy3B 
fluorescence reveals that quenched Phe-TC is fully active in translation (Figure 5.9, 
black squares). This experiment was repeated with 1 mM GDPNP in replace of GTP 
(Figure 5.9, open squares) and with ICs lacking an mRNA (Figure 5.9, open triangles) 
demonstrating that the dequenched effect requires productive interactions between 
Phe-TC and ICs. 
To track the interaction between EF-Tu and aa-tRNA in real time, pre-steady state 
experiments were conducted with quenched Phe-TC and ICs using a SX20 stopped-
flow spectrometer. Quenched Phe-TC, previously formed with 1 μM Cy5Q labeled 
FIGURE 5.9 Initiation complexes are active in translation. Quenched Phe-TC (20 nM) is mixed with 
increasing amounts of ICs in the presence of 1 mM GTP and incubated for 10 minutes (black squares). 
Upon Phe-tRNA
Phe
 accommodation, Cy3B fluorescence increases. Experiments are repeated with either 
GDPNP (open squares) or using ICs lacking mRNA (open triangles). Inset, fitting the linear portions of 
the data reveal an intersection at the earliest maximum value of 10 nM IC. 
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EF-Tu, 120 nM Cy3B labeled Phe-tRNA
Phe
, and 1 mM GTP, is rapidly mixed with 
varying concentrations of IC (0 to 2 μM) while monitoring Cy3B fluorescence. Rapid 
mixing of quenched Phe-TC with IC resulted in a two-step process. First, an initial 
delay of 17 ms is observed to precede the predicted increase in Cy3B fluorescence 
(Figure 5.10A, inset). This initial delay was also observed to be invariable to IC 
concentration, consistent with the notion that at least one rate-determining 
intermediate step precedes the separation of EF-Tu from the aa-tRNA during the 
decoding process. Significantly, the delay in Cy3B fluorescence is also consistent with 
the previously reported rate of aa-tRNA achieving the GTPase activating (GA) state, 
ca. 67 s
-1
, an on-path intermediate described for the tRNA reaction coordinate
1
.  
After the initial delay, Cy3B fluorescence was observed to increase at a rate that is 
dependent on the concentration of IC (Figure 5.10B). Expectantly, the dequencing 
process is dependent on a cognate interaction (Figure 5.10A, light grey curve) and on 
GTP (Figure 5.10A, dark grey curve). The rate at which dequencing occurs, after the 
delay period, approaches an asymptotic value of 30 s
-1
, at which the rate no longer 
bears any concentration dependence. This rate is consistent with the rate previously 
FIGURE 5.10 tRNA selection occurs in multiple steps. A, quenched Phe-TC (60 nM) is rapidly mixed 
with 400 nM ICs in the presence of 1 mM GTP (black curve). A delay of ~17 ms is observed (inset) 
before dequencing. The apparent rate of the fluorescence increase was estimated to be 15 s
-1
 by fitting 
to a single exponential function. B, concentration dependence of Cy3B dequenching. An asymptotic 
rate of ~32 s
-1
 is observed to occur at micromolar IC concentrations. 
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described for aa-tRNA traversing from the GA state into the fully accommodated 
(AC) state
1
. Both the intermediate delay period, and the maximal rate of dequenching 
agree with current models of the decoding process and indicate that the slow mant 
fluorescent decay signal is capturing a component of the reaction coordinate that 
follows after the separation of EF-Tu from the aa-tRNA. 
After evaluating the concentration dependence of our signal, we set out to test the 
impact that EF-Ts has on the dequencing signal. Specifically, we predicted that this 
would manifest by accelerating the rate of Cy3B dequenching, but have no bearing on 
the initial delay process. This experiment was performed by rapidly mixing 2 μM IC 
along with 60 nM quenched Phe-TC in the presence of 10 μM EF-Tu(Cy5Q)/Ts. As 
expected, the initial delay phase was identical to experiments conducted in the absence 
of EF-Ts (Figure 5.11). However, under these conditions, no change was observed in 
the maximum rate of dequencing. Here, at micromolar concentrations of EF-Ts, we 
still observed EF-Tu separating from aa-tRNA at a rate of ca. 30 s
-1
. 
FIGURE 5.11 EF-Ts does not accelerate EF-Tu dissociation for Phe-tRNA
Phe
. Quenched Phe-TC, 
formed in the presence of 10 μM EF-Tu(Cy5Q)/Ts and 1 mM GTP, is rapidly mixed with 2 μM IC. A 
delay period of ~15 ms is observed (inset) followed by an increase in Cy3B fluorescence at an 
apparent rate of 33 s-1. 
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5.3.4 Direct Measurements of EF-Tu Reveal A Short Residence Time With The 
Small Subunit 
Although we observed no direct impact on EF-Tu release from the aa-tRNA, we 
were not able to directly ascertain when EF-Tu·GDP is released from the ribosome. In 
order to do so, we developed a single molecule FRET (smFRET) assay to measure the 
residence time of EF-Tu on the ribosome (Figure 5.12). This was done by labeling the 
C-terminus of the small subunit protein S12 with Cy3B∙3S and labeling a non-natural 
amino acid incorporated into position 305 of EF-Tu with Cy5∙4S∙COT (see Chapter 2). 
By utilizing FRET between the donor fluorophore on the ribosome and the acceptor 
fluorophore on EF-Tu, the residence time of EF-Tu can be directly measured.  
To determine the FRET efficiency between the donor and acceptor fluorophore 
upon EF-Tu binding, Phe-TC (EF-Tu-Cy5) was incubated with surface immobilized 
ICs  (S12-Cy3B) in a TIRF-based microscope (see Chapter 2) in the presence of 2 μM 
kirromycin. This revealed a high FRET signal, indicating that EF-Tu and S12 are in 
close proximity in the kirromycin stabilized state (Figure 5.13). This is consistent with 
FIGURE 5.12 Schematic for smFRET tRNA selection assay. A, Phe-TC, formed with Cy5 labeled 
EF-Tu, GTP, and Phe-tRNA
Phe
 is rapidly mixed with ICs containing a Cy3B fluorophore on the 
C-terminus of S12 which is positioned near the A-site of the small subunit. B, using a TIRF based 
microscope, Cy3B will be directly excited while monitoring the fluorescence intensity of both Cy3B 
(donor) and Cy5 (acceptor).  Based on the canonical model of tRNA selection, we predict that the 
residence time of EF-Tu will manifest as a transient, high FRET signal A, B. 
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crystallographic data of the kirromycin-stalled A/T-state which predicts that the 
fluorophore labeling sites used here are within 20 Å of one another. 
Having established the EF-Tu bound FRET value, this experiment was repeated 
without kirromycin and the tRNA selection process was tracked in real time (Figure 
5.14). Ternary complex was formed by incubating 100 nM Phe-tRNA
Phe
 and 20 nM 
EF-Tu(Cy5) in the presence of 1 mM GTP. This was delivered to surface immobilized 
ICs (S12-Cy3B), while illuminating Cy3B fluorescence. At a population level, we  
 
FIGURE 5.13 EF-Tu engages the ribosome in close proximity to protein S12.  Phe-TC, formed with 
Cy5 labeled EF-Tu in the presence of 2 μM kirromycin, is incubated with ICs (S12-Cy3B) for 
2 minutes forming a stabilized EF-Tu bound intermediate, A. At a population level, the resulting 
interaction results in high FRET, B. Individual molecules reveal long lived, stable interactions , C, D.  
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FIGURE 5.14 EF-Tu interacts transiently with the ribosome. A, Rapid mixing of Phe-TC (EF-Tu-
Cy5) with IC (S12-Cy3B) resulted in a transient interaction with a FRET value that is consistent with 
the kirromycin stabilized intermediate. B, fitting the high FRET interaction lifetimes with a single 
exponential model revealed an EF-Tu off rate, koff, of 32 s
-1
. C, D, individual molecules show fast, high 
FRET interactions.  
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observed a transient interaction at a FRET value consistent with the kirromycin stalled 
intermediate state. Individual molecules reveal EF-Tu∙Ribosome interactions that are 
transient in nature. The residence time of EF-Tu, estimated by fitting the distribution 
of high FRET lifetimes to a single exponential, is measured to be 33 s
-1
 under the 
conditions used here. 
 
5.3.5 EF-Tu, aa-tRNA, and the ribosome are tracked simultaneously 
The smFRET assay used to track EF-Tu binding to the ribosome reports on all 
interactions, both productive and non-productive. Based on prior investigations of 
tRNA selection
1
, we anticipate that roughly 30-50% of cognate TC interactions result 
in the successful delivery of aa-tRNA. To delineate between productive and non-
productive interactions, a three-color smFRET experiment was implemented. Here, 
the donor fluorophore Cy3B is conjugated to protein S12 as before, but now the 
acceptors Cy5∙4S∙COT and Cy7∙4S∙COT are conjugated to Phe-tRNAPhe and to EF-Tu 
respectively (Figure 5.15A). This enables the simultaneous measurements of 
Phe-tRNA
Phe
 and EF-Tu with respect to each other, and with respect to the ribosome. 
To establish the FRET efficiency to each of the acceptors when TC is bound in the 
A/T-state, tRNA selection experiments were conducted using 2 μM kirromycin 
(Figure 5.15). Consistent with Phe-tRNA
Phe
, EF-Tu and the C-terminus of S12 being 
in close proximity to one another, high FRET efficiencies were observed for both 
acceptor fluorophores. Individual molecules reveal long-lived, stable interactions. 
However, poor labeling efficiencies, and possibly diminished functionality greatly 
diminished the number of molecules observed (compare Figures 5.14 and 5.15). As a 
result, pre-steady state measurements in the absence of kirromycin is not possible with 
these reagents.  
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FIGURE 5.15 EF-Tu and Phe-tRNAPhe can be tracked simultaneously. A, schematic of three-color 
FRET assay.  Phe-TC is formed with Phe-tRNA
Phe
 (Cy5-acp
3
U47) and EF-Tu(Cy7) in the presence 
of  1mM GTP and 2 μM kirromycin is mixed with surface immobilized ICs (S12-Cy3B). A 2 minute 
incubation reveals stable FRET to both Cy5, B, and Cy7, C, at a population level. D, E, individual 
molecules show long-lived, stable interactions between the ribosome, the tRNA, and the protein factor 
EF-Tu.  
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5.4 DISCUSSION 
Measurements tracking the accommodating aa-tRNA into the ribosome have 
revealed that decoding occurs in multiple steps with long-lived intermediates that 
correlate with Initial Selection and Proofreading (Figure 5.2). EF-Tu has long been 
recognized as playing a critical role in the fidelity of tRNA selection
130,160,161
. 
However, the knowledge of the precise order and timing of EF-Tu function during 
decoding has lagged far behind investigations of other coordinates of this process. As 
such, a complete framework for tRNA selection has not been realized. In this study, 
we present direct measurements of EF-Tu with respect to both the accommodating 
aa-tRNA and the ribosome.  
Our measurements of EF-Tu fit within the known paradigm of tRNA selection 
and serve to augment current models with the EF-Tu reaction coordinate (Figure 
5.16). EF-Tu delivers aa-tRNA to the ribosome where, at least one rate-determining 
step lasting ~17 ms delays EF-Tu’s release of the aa-tRNA (Figure 5.10, inset). This 
delay period coincides with the time it takes for aa-tRNAs to successfully traverse 
through the CR state and to begin sampling the GA state
1
. Bulk measurements of GTP 
hydrolysis indicate that EF-Tu hydrolyzes GTP at a rate that coincides with the time it 
takes for aa-tRNAs to traverse through the GA state and begin sampling the AC state, 
31 ms. The rapid mixing experiments tracking the dequenching of TC reveal that EF-
Tu separates from aa-tRNA at a rate of 30 s
-1
. This corroborates smFRET experiments 
tracking EF-Tu’s proximity to the small subunit protein S12, which also reveal a rate 
of separation of 30 s
-1
. It should be noted, however, that these experiments do not 
distinguish between productive and non-productive interactions. Finally, experiments 
using GTPmant betray a dissociation rate, τoff that coincides with published rates of 
peptide bond formation, ~145 ms (7 s
-1
)
2
.  
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The prediction of our model is that inclusion of EF-Ts in the reaction will 
specifically manifest in the τoff value. Direct experiments tracking EF-Tu’s residence 
time with respect to the accommodating aa-tRNA and to the ribosome are needed. 
Based on the τoff measured using mant nucleotides (Figure 5.7), we predict that EF-Ts 
will have a significant impact at concentrations > 2 μM. 
  
 
 
 
 
FIGURE 5.16 Measurements of tRNA selection. 1, TC samples the CR state at fast timescales. 
Experiments of near cognate tRNA selection reveal that τ1 is on the order of ~10 ms. 2, EF-Tu remains 
bound to the aa-tRNA in a TC-like conformation for ~17 ms (Figure 5.10, inset). 3, the aa-tRNA begins 
sampling the second intermediate sate, GA, with a τ3 of ~15-20 ms
1
. 4, GTP is hydrolyzed with a τ4 of 
26 ms (Figure 5.4). 5, the aa-tRNA begins sampling the AC state with a τ5 of ~30 ms during 
Proofreading
1
. 6, EF-Tu separates from aa-tRNA with a τ6 of 31 ms (Figures 5.9, 5.10). 7, EF-Tu 
separates from the 30S subunit with a τ7 of 31 ms (Figure 5.14). 8, aa-tRNAs fully accommodate into 
the AC state and stop sampling the GA state
1
, 9, a peptide bond is formed with the A-site tRNA with a 
τ9 of ~145 ms
2
. Finally, EF-Tu∙GDP putatively dissociates from the large subunit with a τoff of ~145 ms. 
This will be verified with pre-steady state experiments designed to directly resolve this step (see Figure 
5.15). 
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CHAPTER 6 
IMPACT AND FUTURE IMPLICATIONS 
 
6. IMPACT AND FUTURE IMPLICATIONS 
This chapter focuses on broad implications of the themes discussed in earlier 
chapters, as summarized in section 6.1. Section 6.2 outlines important concepts from 
Chapters 3, 4, and 5. The general implications of our discovery of quaternary complex 
are discussed in Section 6.3 followed by the impact of measuring the deactivation of 
EF-Tu in Section 6.4. Future directions and conclusions are discussed in sections 6.5 
and 6.6 respectively. 
 
6.1 SUMMARY 
The data presented in prior chapters argue for an update to the canonical G-protein 
model. EF-Ts was shown to catalyze the formation of TC through the production of a 
previously unidentified intermediate, QC. In doing so, the rate of TC formation is 
accelerated above the rate of protein synthesis. Thus, TC formation is not rate-limiting 
in the presence of EF-Ts. Beyond protein synthesis, the observation that GEFs may 
catalyze the formation of the G-protein∙effector complex has implications for other 
systems. Small G-proteins have been observed to participate in multiple signal 
transduction cascades through the interaction of distinct effectors. We propose a 
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model wherein GEFs chaperone activated small G-proteins to specific effectors 
thereby imparting specificity to the signal being transduced. Additionally, we have 
also predicted EF-Ts to impact the disassembly of EF-Tu∙GDP from the ribosome. 
These studies are ongoing but will reveal a more complete framework for G-protein 
activation and deactivation.   
 
6.2 INTRODUCTION 
Our general understanding of G-protein activation and inactivation is largely a 
product of investigations of select model systems. These include studies of Ras, a 
member of the small GTPase family
10,162,163
, Gα, a member of the heterotrimeric 
class
164-166
, and EF-Tu
167,168
. Together, these investigations led to a model wherein G-
proteins are able to sample between two distinct functional conformations, and that 
nucleotide binding stabilizes these states. In all observed cases, GDP binding stabilizes 
the G-protein in an inert state while GTP binding favors a conformation that induces 
active participation with downstream effector molecules (Figure 1.2). Further 
investigations uncovered a direct relationship between the γ-phosphate of GTP and 
structural elements within the active conformation, namely switch 1 and switch 2 
(Figure 1.1, 1.7, 3.1)
7,88
.  
Biochemical data has revealed that a significant number of G-proteins have higher 
affinities for GDP than for GTP. Even when considering the excess of GTP over GDP 
in the cell, Guanosine Nucleotide Exchange Factors (GEFs) are often required to 
catalyze the removal of GDP and the subsequent binding of GTP. The resulting 
GEF•G-protein interaction leads to a lower the nucleotide binding transition state on, 
thus accelerating the rates of nucleotide exchange. Much of what is known about the 
kinetics underpinning GEFs and G-proteins have been determined from steady state 
experiments, or from isolated G-protein-GEF systems that did not include target 
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effectors
31,169-172
. Furthermore, many of these studies were designed to measure high 
affinity, long-lived interactions. Given this, it is perhaps not surprising that the 
transient observations made here between EF-Ts and ternary complex (Chapter 3, 
Chapter 4) have not been described elsewhere. As such, the prevailing model of G-
protein activation and inactivation predicts that GEFs serve only to activate G-
proteins. The data presented here (Chapters 3, 4) argue for a more active role for 
GEFs. Considering that EF-Tu and EF-Ts have been studied as a basis for the 
canonical model (Figure 1.2), we speculate that the expanded role of EF-Ts may 
represent GEFs more generally.  
 
 
6.3 QUATERNARY COMPLEX 
6.3.1 EF-Ts catalyzed Ternary complex formation is not rate-limiting 
At cellular concentrations, EF-Ts was shown to catalyze the formation of ternary 
complex by chaperoning EF-Tu to the aa-tRNA. Given that the in vivo elongation rate 
is ~20 amino acids per second per ribosome in log-phase growth
35
, the rate of TC 
formation, kon(TC) would be rate limiting to protein synthesis in the absence of EF-Ts 
for all tRNA species tested. A major impact of the EF-Ts catalyzed reaction 
coordinate is that the rate determining step of TC formation was accelerated 7.5-, 3.5-, 
and 4.8-fold in the case of Phe-, Met-, and Arg-TC (Figure 4.4, Table 4.1). Thus, the 
involvement of EF-Ts pushes the rate of TC formation to well above the rate of 
protein synthesis.  
The rate of TC formation appears to be finely tuned with the amount of EF-Ts in 
the reaction (Figure 3.4B,D). The expression of EF-Ts is believed to occur in tandem 
with the critical ribosomal protein S2
70
 as they are on the same operon. In cells, 
ribosome concentrations have been measured to be in the range of 20μM – 100 μM 
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depending on growth conditions
36
. Since S2 is critical for ribosome maturation, the 
concentration of EF-Ts likely corresponds to the concentration of ribosomes (ca. 
>10 μM). At low concentrations of EF-Ts, TC presumably forms without the 
involvement of quaternary complex (Figure 3.7, Path 2). If the concentration of EF-Ts 
increases above 2 μM, the predicted on rate of EF-Ts binding to EF-Tu∙GTP of 
30 μM-1s-1 begins to outweigh the fast off rate of 60 s-1. Thus, although this is a 
transient, low-affinity interaction (KD = 2 μM)
31
, the fraction of EF-Tu∙GTP bound to 
EF-Ts increases to >80% at cellular concentrations of EF-Ts as predicted by: 
 
𝑇𝑢/𝑇𝑠𝐺𝑇𝑃% =
1
2 ∙ 𝑇𝑢𝐺𝑇𝑃
(𝑇𝑢𝐺𝑇𝑃 + 𝑇𝑠 +  𝐾𝐷 − √(𝑇𝑢𝐺𝑇𝑃 + 𝑇𝑠 +  𝐾𝐷)2 − 4 ∙ 𝑇𝑢𝐺𝑇𝑃 ∙ 𝑇𝑠) 
EQUATION 6.1 
 
Here, Tu/TsGTP% denotes the fraction of EF-Tu∙GTP bound to EF-Ts, and TuGTP 
and Ts represent the total amount of EF-Tu∙GTP and EF-Ts in the reaction (bound + 
unbound). At high concentrations of EF-Ts, the species EF-Tu/Ts∙GTP exists at high 
enough proportions for TC to form via the quaternary complex intermediate (Figure 
3.7, Path 1). By simply altering the concentration of EF-Ts in the cell, the rate of TC 
formation can be modulated. This opens up the possibility that, by adjusting the 
expression of EF-Ts, the cell may be able to tune the steady state concentration of TC, 
and thus globally affect the rate of protein synthesis. 
   
6.3.2 EF-Ts may couple global protein synthesis rates to GTP abundance 
In the presence of GTP, EF-Ts has no impact on the steady state concentrations of 
TC (Figure 3.5, Figure 4.2A, B). Intriguingly, when either GTP was removed from the 
reaction (Figure 3.5) or when saturating amounts of GDP was added (Figures 3.3C, 
149 
 
4.4), EF-Ts was shown to have a major impact on the stability of TC. Further 
investigation revealed that EF-Ts constantly exchanges nucleotide with EF-Tu, even 
when it is bound to aa-tRNA (Figure 3.6). These observations led to a model wherein 
EF-Ts continually interacts with TC and facilitates guanine nucleotide exchange with 
EF-Tu bound to aa-tRNA much the same way as it does with unbound EF-Tu. When 
EF-Ts engages EF-Tu∙GTP bound to aa-tRNA in the presence of saturating GTP, the 
bound GTP molecule is exchanged for another GTP molecule in the milieu, having no 
net effect (Figure 6.1, path 1). However, when GTP is removed from the system 
(Figure 3.5), EF-Ts removes the bound GTP and remains bound to EF-Tu, which 
subsequently dissociates from the aa-tRNA (Figure 6.1, path 2). Similarly, when GDP 
FIGURE 6.1 EF-Ts couples TC stability with local nucleotide abundance. The formation of TC 
occurs via the intermediate QC. Likewise, EF-Ts can bind to TC in the reverse pathway to form QC. 
Under conditions of saturating GTP, the equilibrium of TC and QC is unperturbed (Path 1). However, if 
GTP is removed from the local environment (Path 2), or if GDP is present at high concentrations 
relative to GTP (Path 3), the formation of QC will lead to the disassembly of TC. 
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is abruptly added in excess (Figures 3.3C, 4.4), EF-Ts exchanges the bound GTP with 
GDP, causing EF-Tu to adopt an inactive conformation and rapidly dissociate from the 
aa-tRNA (Figure 6.1, path 3). 
The model that EF-Ts can perform its GEF function on EF-Tu while it is bound to 
its effector may have important implications for coupling protein production to 
cellular GTP concentrations. Should the cellular environment change rapidly from a 
nutrient rich condition to a nutrient poor condition, it may be important for the cell to 
quickly down regulate the energy intensive process of protein synthesis. Furthermore, 
it may also be important to quickly repurpose the >100 μM GTP that is bound in TC 
under fast growing conditions. The observation that EF-Ts can rapidly dissociate TC 
leads to a model wherein EF-Ts serves to couple the steady state concentration of TC 
with the abundance of free GTP (Figure 4.8). 
 
6.3.3. Quaternary complex may represent a general mechanism of G-protein 
activation 
The observation that, at cellular concentrations, EF-Ts physically chaperones the 
activated G-protein EF-Tu∙GTP to its effector aa-tRNA has stark implications for 
other G-protein systems. As a class, small G-proteins function in a variety of signaling 
pathways. Paradoxically, some small G-proteins function in multiple signaling 
pathways involving multiple effectors expressed in the same cell simultaneously
173
. 
For example, activated Rho has been shown to stimulate a number of different targets 
such as: the kinases PIP5 kinase, PKN, PRK2, and ROK; the proteins REM-1 and 
REM-2; as well as MBS to name a few. Precisely how binding specificity is achieved 
for each of the effectors is not entirely understood
174
. In addition to having multiple 
effectors as potential targets, Rho also has multiple GEFs that can facilitate GTP 
binding
173
.  
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Based on the observations of EF-Ts presented here, one model that would explain 
how target specificity is achieved would be that the GEFs physically catalyze the 
binding of activated Rho to its effector (Figure 6.2). Furthermore, the larger repertoire 
of GEFs may provide specificity to the equally large repertoire of effectors such that 
signaling pathways are determined by the particular GEF∙G-protein complex formed. 
Investigations focused on measuring GEF∙G-protein∙effector interactions are needed to 
evaluate this validity of this model. 
 
 
6.4 DEACTIVATION OF G-PROTEINS 
6.4.1 Do GEFs facilitate the removal of inactive G-proteins from their effectors? 
The data presented in Chapters 3 and 4 have led to the corollary that, in addition to 
interacting with an effector-bound G-protein, GEFs may also play a role in their 
deactivation. This model is intriguing in the context of protein synthesis because it 
would resolve a long-standing dilemma with the kinetic framework of tRNA selection. 
FIGURE 6.2 General mechanism for GEF mediated signal transduction. The observation of a GEF  
impacting G-protein∙effector binding may have broad implications for other G-protein systems. Some 
small GTPases, such as Rho, have a large number of effector targets giving rise to the predicament of 
signal specificity. Furthermore, GEFs that activate small GTPases outnumber them by roughly 3 to 1. 
We propose a general mechanism whereby GEFs shunt activated G-proteins towards one effector or 
another thereby maintaining signal specificity and minimizing cross talk. 
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This model would also be appealing to the broader G-protein field because it would 
assert GEFs as important for both activation and deactivation. Such a finding would 
require a complete redrafting of the generally accepted model of G-proteins (Figure 
1.2). 
 
 
6.5 FUTURE DIRECTIONS 
6.5.1 Measuring the residence time of EF-Tu 
The GTPmant assay used to estimate koff has two significant drawbacks. The first is 
that the mant fluorophore group could alter the binding interface between EF-Tu and 
the GAC of the large subunit. Without controlling for this, the possibility that the 
measured off rate is an artifact of the nucleotide analog cannot be sufficiently ruled 
out. Secondly, the biphasic signal that is observed is the result of a multistep process. 
Global fitting can be used to estimate the rates of each of these steps, though koff 
cannot be directly isolated. It is for these reasons that new methods are needed. 
Here, we are developing a smFRET assay to resolve the residence time of EF-Tu 
with respect to the accommodating aa-tRNA and the ribosome (Figure 5.15). This will 
allow us to distinguish between productive and nonproductive interactions, a 
necessary procedure to properly identify the characteristic koff for each.  It may also be 
crucial to distinguish the residence time of EF-Tu with respect to the individual 
subunits of the ribosome. Our efforts to measure this with respect to the small subunit 
have thus far revealed a fast interaction. Furthermore, a histogram of dwell times 
appear to be modeled well by a single exponential process, suggesting that one rate is 
dominating. This was interpreted as a failure to distinguish between productive and 
non-productive events, though an alternative hypothesis would be that the dwell time 
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with respect to the small subunit is short for all interactions. Therefore, it may be 
necessary to track EF-Tu with respect to a large subunit protein, such as L11. 
 
6.6 CONCLUSION 
The endeavor to develop a comprehensive framework of tRNA selection is 
important and should continue to be pursued with conviction. As an exercise, the 
construction of a model that explains all the data provides some consolation that our 
understanding of the underlying mechanism is complete – or as complete as the data 
will allow. More practically, a kinetic framework aids in our ability to predict 
perturbations. In the case of tRNA selection, a complete model will guide our 
understanding of antibiotics and small molecules that target the protein synthesis 
machinery. Perhaps more importantly, it will also be critical to future in silico models 
of cellular processes. Although beyond our capabilities today, in silico modeling of 
molecular networks, and even larger scale cell, and tissue modeling will rely on a 
complete understanding of fundamental processes. As our understanding and our 
capabilities advance, detailed kinetic frameworks will only become more important. 
These models will be the foundation for modern medicine and will ultimately enable 
the next generation of biotechnology. 
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APPENDIX: BUFFERS AND SOLUTIONS 
 
EF-Tu Lysis Buffer 
20 mM Tris-HCl, pH 7.5 
200 mM KCl 
1 mM BME 
 
EF-Tu Lysis Buffer With Imidazole 
20 mM Tris-HCl, pH 7.5 
200 mM KCl 
10 mM Imidazole, pH 8 
1 mM BME 
 
EF-Tu Wash Buffer 
20 mM Tris-HCl, pH 7.5 
500 mM KCl 
10 mM Imidazole, pH 8 
1 mM BME 
 
EF-Tu Elution Buffer 
20 mM Tris-HCl, pH 7.5 
200 mM KCl 
250 mM Imidazole, pH 8 
1 mM BME 
 
EF-Tu Dialysis Buffer (Cleavage    
Buffer)  
20 mM Tris-HCl, pH 7.5 
200 mM KCl 
1 mM BME 
0.05% Triton X-100 Surfactant 
 
2xFactor Buffer 
20 mM Tris Acetate, pH 7 
100 mM KCl 
 
Factor Storage Buffer 
10 mM Tris Acetate, pH 7 
50 mM KCl 
1 mM DTT 
50%V Glycerol 
PheRS Lysis Buffer 
50 mM NaH2PO4 
1 mM BME 
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PheRS Lysis Buffer With Imidazole 
50 mM NaH2PO4 
10 mM Imidazole, pH 8 
1 mM BME 
 
 
PheRS Wash Buffer 
50 mM NaH2PO4 
200 mM NaCl 
10 mM Imidazole, pH 8 
1 mM BME 
 
PheRS Elution Buffer 
50 mM NaH2PO4 
100 mM NaCl 
250 mM Imidazole, pH 8 
1 mM BME 
 
PheRS Dialysis Buffer 
10 mM Tris Acetate, pH 7.5 
100 mM KCl 
1 mM BME 
 
TEV Lysis Buffer 
20 mM Tris-HCl, pH 7.5 
200 mM NaCl 
1 mM BME 
Protease inhibitor (1:10,000). 
 
TEV Lysis Buffer With Imidazole 
20 mM Tris-HCl, pH 7.5 
200 mM NaCl 
1 mM BME 
10 mM Imidazole, pH 8 
Protease inhibitor (1:10,000). 
 
TEV Wash Buffer 
20 mM Tris-HCl, pH 7.5 
500 mM NaCl 
10 mM Imidazole, pH 8 
1 mM BME 
TEV Elution Buffer 
20 mM Tris-HCl, pH 7.5 
200 mM NaCl 
250 mM Imidazole, pH 8 
1 mM BME 
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Polymix 
50 mM Tris Acetate, pH 7.5 
100 mM KCl 
5 mM NH4AOc 
0.5 mM CaCl2 
 
 
 
0.1 mM EDTA 
5 mM Putrecine 
1 mM Spermidine 
5 mM MgCl2 
5 mM BME 
 
TC70S Buffer A 
20 mM Tris HCl, pH 7.5 
100 mM NH4Cl 
10 mM MgCl2 
0.5 mM EDTA 
6 mM BME 
 
TC70S Buffer B 
20 mM Tris HCl, pH 7.5 
500 mM NH4Cl 
10 mM MgCl2 
0.5 mM EDTA 
6 mM BME 
 
PBP Lysis Buffer 
20 mM Tris-HCl, pH 8 
1 mM EDTA 
5 mM BME 
 
tRNA
Phe
 Lysis Buffer 
20 mM Tris HCl, pH 7.5 
50 mM MgCl2 
20 mM BME 
 
tRNA
Phe
 Buffer A 
10 mM NH4OAc, pH 5.85 
1.7 M (NH4)2SO4 
 
tRNA
Phe
 Buffer B 
10 mM NH4OAc, pH 5.85 
10%V Methanol 
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tRNA
Phe
 Deacyl Buffer 
0.5 M Tris HCl, pH 8.8 
1 mM EDTA 
 
tRNA
Phe
 Storage Buffer 
50 mM K4OAc, pH 6 
1 mM MgCl2 
 
GTP Buffer A 
20 mM KOAc, pH 6 
 
GTP Buffer B 
20 mM KOAc, pH 6 
2 M KCl 
 
TC Buffer (Chapter 3) 
50 mM HEPES, pH 7 
20 mM KCl 
100 mM NH4Cl 
1 mM DTT 
0.5 mM EDTA 
2.5 mM MgCl2 
 
TC Buffer (Chapter 4) 
100 mM HEPES, pH 7 
20 mM KCl 
100 mM NH4Cl 
1 mM DTT 
0.5 mM EDTA 
2.5 mM MgCl2 
 
tRNA Charge Buffer 
50 mM Tris HCl, pH 8 
20 mM KCl 
100 mM NH4Cl 
1 mM DTT 
0.5 mM EDTA 
2.5 mM ATP 
10 mM MgCl2 
 
SOB Media 
2% Bactotryptone 
0.5% Bactoyeast extract 
10 mM NaCl 
10 mM KCl 
1 mL of 2M (1M MgCl2, 1M MgSO4) 
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RF 1 
100 mM RbCl2 
50 mM MnCl2∙4H2O 
30 mM KOAc 
10 mM CaCl2∙2H2O 
15%(w/v) glycerol 
 
RF 2 
10 MOPS, 6.8 
10 mM RbCl2 
75 mM CaCl2∙2H2O 
15%(w/v) glycerol 
 
EF-Tu/Ts Buffer 
50 mM Tris HCl, pH 7.5 
100 mM NH4Cl 
10 mM MgCl2 
50 mM KCl 
0.5 mM EDTA 
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